Section 9 SE Tables - Results from the 2024 National Survey on Drug Use and Health: Detailed Tables, SAMHSA, CBHSQ

250616

Table 9.1C – Types of Illicit Drug, Tobacco Product, and Alcohol Use in Lifetime: Among People Aged 12 or Older; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
ILLICIT DRUGS^1,2	1,261	1,187	1,128	1,156
Marijuana	1,268	1,192	1,113	1,157
Cocaine	904	873	838	865
Crack	493	425	403	460
Heroin	395	309	329	324
Hallucinogens	955	867	861	900
LSD	780	720	707	732
PCP	439	364	343	331
Ecstasy	625	562	579	558
Inhalants³	--	--	--	650
Methamphetamine	698	538	547	525
Misuse of Prescription Psychotherapeutics	nr	nr	nr	nr
Pain Relievers	nr	nr	nr	nr
Prescription Opioids	--	--	--	--
Stimulants	nr	nr	nr	nr
Tranquilizers or Sedatives	nr	nr	nr	nr
Tranquilizers	nr	nr	nr	nr
Sedatives	nr	nr	nr	nr
Benzodiazepines	--	--	--	--
Opioids²	--	--	--	--
Central Nervous System Stimulants	nr	nr	nr	nr
Illicit Drugs Other than Marijuana^2,4	nr	nr	nr	nr
TOBACCO PRODUCTS	1,258	1,088	1,062	1,133
Cigarettes	1,260	1,117	1,087	1,111
Daily Cigarettes	1,209	1,091	1,038	1,046
Smokeless Tobacco	831	760	757	799
Cigars	1,079	1,019	1,006	1,058
Pipe Tobacco	779	679	668	640
ALCOHOL	1,002	935	881	929
Binge Alcohol Use	--	--	--	--
Heavy Alcohol Use	--	--	--	--
SUBSTANCE USE
Illicit Drugs, Tobacco Products, or Alcohol^1,2	906	839	799	839
Illicit Drugs or Alcohol^1,2	961	895	852	892
Tobacco Products or Alcohol	939	876	820	862
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Does not include illegally made fentanyl (IMF). ³ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.1D – Types of Illicit Drug, Tobacco Product, and Alcohol Use in Lifetime: Among People Aged 12 or Older; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
ILLICIT DRUGS^1,2	0.45	0.42	0.40	0.40
Marijuana	0.45	0.42	0.39	0.40
Cocaine	0.32	0.31	0.30	0.30
Crack	0.18	0.15	0.14	0.16
Heroin	0.14	0.11	0.12	0.11
Hallucinogens	0.34	0.31	0.30	0.31
LSD	0.28	0.26	0.25	0.25
PCP	0.16	0.13	0.12	0.11
Ecstasy	0.22	0.20	0.20	0.19
Inhalants³	--	--	--	0.23
Methamphetamine	0.25	0.19	0.19	0.18
Misuse of Prescription Psychotherapeutics	nr	nr	nr	nr
Pain Relievers	nr	nr	nr	nr
Prescription Opioids	--	--	--	--
Stimulants	nr	nr	nr	nr
Tranquilizers or Sedatives	nr	nr	nr	nr
Tranquilizers	nr	nr	nr	nr
Sedatives	nr	nr	nr	nr
Benzodiazepines	--	--	--	--
Opioids²	--	--	--	--
Central Nervous System Stimulants	nr	nr	nr	nr
Illicit Drugs Other than Marijuana^2,4	nr	nr	nr	nr
TOBACCO PRODUCTS	0.45	0.39	0.37	0.39
Cigarettes	0.45	0.40	0.38	0.39
Daily Cigarettes	0.43	0.39	0.37	0.36
Smokeless Tobacco	0.30	0.27	0.27	0.28
Cigars	0.39	0.36	0.35	0.37
Pipe Tobacco	0.28	0.24	0.24	0.22
ALCOHOL	0.36	0.33	0.31	0.32
Binge Alcohol Use	--	--	--	--
Heavy Alcohol Use	--	--	--	--
SUBSTANCE USE
Illicit Drugs, Tobacco Products, or Alcohol^1,2	0.32	0.30	0.28	0.29
Illicit Drugs or Alcohol^1,2	0.34	0.32	0.30	0.31
Tobacco Products or Alcohol	0.34	0.31	0.29	0.30
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Does not include illegally made fentanyl (IMF). ³ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.1P – Types of Illicit Drug, Tobacco Product, and Alcohol Use in Lifetime: Among People Aged 12 or Older; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
ILLICIT DRUGS^1,2	0.0006	0.0268	0.1254
Marijuana	0.0175	0.2797	0.4193
Cocaine	0.8758	0.5450	0.6216
Crack	0.6442	0.7041	0.3257
Heroin	0.4735	0.6752	0.6597
Hallucinogens	0.0065	0.1987	0.0625
LSD	0.9404	0.4215	0.8627
PCP	0.0955	0.1645	0.7454
Ecstasy	0.9819	0.5179	0.4420
Inhalants³	--	--	--
Methamphetamine	0.0027	0.0289	0.1360
Misuse of Prescription Psychotherapeutics	nr	nr	nr
Pain Relievers	nr	nr	nr
Prescription Opioids	--	--	--
Stimulants	nr	nr	nr
Tranquilizers or Sedatives	nr	nr	nr
Tranquilizers	nr	nr	nr
Sedatives	nr	nr	nr
Benzodiazepines	--	--	--
Opioids²	--	--	--
Central Nervous System Stimulants	nr	nr	nr
Illicit Drugs Other than Marijuana^2,4	nr	nr	nr
TOBACCO PRODUCTS	0.4247	0.6241	0.1926
Cigarettes	0.3386	0.2601	0.1591
Daily Cigarettes	0.0090	0.0895	0.1659
Smokeless Tobacco	0.0102	0.0842	0.4783
Cigars	0.1198	0.1622	0.0366
Pipe Tobacco	0.0000	0.0239	0.0194
ALCOHOL	0.2126	0.0927	0.7969
Binge Alcohol Use	--	--	--
Heavy Alcohol Use	--	--	--
SUBSTANCE USE
Illicit Drugs, Tobacco Products, or Alcohol^1,2	0.0977	0.1007	0.4403
Illicit Drugs or Alcohol^1,2	0.0279	0.0077	0.3054
Tobacco Products or Alcohol	0.5274	0.5442	0.7966
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Does not include illegally made fentanyl (IMF). ³ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.2C – Types of Illicit Drug, Tobacco Product, and Alcohol Use in Lifetime: Among People Aged 12 to 17; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
ILLICIT DRUGS^1,2	161	139	138	161
Marijuana	145	119	115	116
Cocaine	23	16	18	21
Crack	12	2	5	13
Heroin	3	4	10	10
Hallucinogens	62	47	47	51
LSD	57	31	33	33
PCP	11	10	14	12
Ecstasy	27	24	22	24
Inhalants³	--	--	--	115
Methamphetamine	15	8	23	27
Misuse of Prescription Psychotherapeutics	nr	nr	nr	nr
Pain Relievers	nr	nr	nr	nr
Prescription Opioids	--	--	--	--
Stimulants	nr	nr	nr	nr
Tranquilizers or Sedatives	nr	nr	nr	nr
Tranquilizers	nr	nr	nr	nr
Sedatives	nr	nr	nr	nr
Benzodiazepines	--	--	--	--
Opioids²	--	--	--	--
Central Nervous System Stimulants	nr	nr	nr	nr
Illicit Drugs Other than Marijuana^2,4	nr	nr	nr	nr
TOBACCO PRODUCTS	131	96	94	87
Cigarettes	114	86	86	73
Daily Cigarettes	40	26	24	30
Smokeless Tobacco	65	40	37	38
Cigars	73	55	54	50
Pipe Tobacco	35	30	26	30
ALCOHOL	174	148	154	149
Binge Alcohol Use	--	--	--	--
Heavy Alcohol Use	--	--	--	--
SUBSTANCE USE
Illicit Drugs, Tobacco Products, or Alcohol^1,2	185	163	165	174
Illicit Drugs or Alcohol^1,2	182	160	164	175
Tobacco Products or Alcohol	184	153	160	154
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Does not include illegally made fentanyl (IMF). ³ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.2D – Types of Illicit Drug, Tobacco Product, and Alcohol Use in Lifetime: Among People Aged 12 to 17; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
ILLICIT DRUGS^1,2	0.62	0.54	0.53	0.62
Marijuana	0.56	0.46	0.44	0.45
Cocaine	0.09	0.06	0.07	0.08
Crack	0.04	0.01	0.02	0.05
Heroin	0.01	0.02	0.04	0.04
Hallucinogens	0.24	0.18	0.18	0.20
LSD	0.22	0.12	0.13	0.13
PCP	0.04	0.04	0.05	0.05
Ecstasy	0.10	0.09	0.08	0.09
Inhalants³	--	--	--	0.44
Methamphetamine	0.06	0.03	0.09	0.11
Misuse of Prescription Psychotherapeutics	nr	nr	nr	nr
Pain Relievers	nr	nr	nr	nr
Prescription Opioids	--	--	--	--
Stimulants	nr	nr	nr	nr
Tranquilizers or Sedatives	nr	nr	nr	nr
Tranquilizers	nr	nr	nr	nr
Sedatives	nr	nr	nr	nr
Benzodiazepines	--	--	--	--
Opioids²	--	--	--	--
Central Nervous System Stimulants	nr	nr	nr	nr
Illicit Drugs Other than Marijuana^2,4	nr	nr	nr	nr
TOBACCO PRODUCTS	0.50	0.37	0.36	0.33
Cigarettes	0.44	0.33	0.33	0.28
Daily Cigarettes	0.15	0.10	0.09	0.12
Smokeless Tobacco	0.25	0.16	0.14	0.15
Cigars	0.28	0.21	0.21	0.19
Pipe Tobacco	0.14	0.11	0.10	0.11
ALCOHOL	0.67	0.57	0.60	0.57
Binge Alcohol Use	--	--	--	--
Heavy Alcohol Use	--	--	--	--
SUBSTANCE USE
Illicit Drugs, Tobacco Products, or Alcohol^1,2	0.71	0.63	0.64	0.67
Illicit Drugs or Alcohol^1,2	0.70	0.62	0.63	0.67
Tobacco Products or Alcohol	0.71	0.59	0.62	0.59
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Does not include illegally made fentanyl (IMF). ³ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.2P – Types of Illicit Drug, Tobacco Product, and Alcohol Use in Lifetime: Among People Aged 12 to 17; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
ILLICIT DRUGS^1,2	0.0147	0.0000	0.0000
Marijuana	0.3185	0.4062	0.5252
Cocaine	0.8472	0.1082	0.3670
Crack	0.6940	0.1191	0.2664
Heroin	0.1484	0.2604	0.7876
Hallucinogens	0.6884	0.4442	0.3054
LSD	0.0005	0.1452	0.5384
PCP	0.8381	0.9828	0.7776
Ecstasy	0.4493	0.9534	0.9091
Inhalants³	--	--	--
Methamphetamine	0.2541	0.0822	0.9213
Misuse of Prescription Psychotherapeutics	nr	nr	nr
Pain Relievers	nr	nr	nr
Prescription Opioids	--	--	--
Stimulants	nr	nr	nr
Tranquilizers or Sedatives	nr	nr	nr
Tranquilizers	nr	nr	nr
Sedatives	nr	nr	nr
Benzodiazepines	--	--	--
Opioids²	--	--	--
Central Nervous System Stimulants	nr	nr	nr
Illicit Drugs Other than Marijuana^2,4	nr	nr	nr
TOBACCO PRODUCTS	0.0008	0.2037	0.5932
Cigarettes	0.0218	0.3254	0.2638
Daily Cigarettes	0.6412	0.2079	0.1344
Smokeless Tobacco	0.0026	0.7062	0.3166
Cigars	0.0005	0.2312	0.8861
Pipe Tobacco	0.4159	0.9482	0.3195
ALCOHOL	0.0065	0.2038	0.7447
Binge Alcohol Use	--	--	--
Heavy Alcohol Use	--	--	--
SUBSTANCE USE
Illicit Drugs, Tobacco Products, or Alcohol^1,2	0.6194	0.0599	0.0053
Illicit Drugs or Alcohol^1,2	0.4132	0.0176	0.0042
Tobacco Products or Alcohol	0.0008	0.0780	0.4515
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Does not include illegally made fentanyl (IMF). ³ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.3C – Types of Illicit Drug, Tobacco Product, and Alcohol Use in Lifetime: Among People Aged 18 or Older; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
ILLICIT DRUGS^1,2	1,231	1,154	1,110	1,108
Marijuana	1,226	1,154	1,093	1,112
Cocaine	895	862	828	857
Crack	492	424	403	459
Heroin	394	307	328	324
Hallucinogens	947	853	849	890
LSD	776	714	700	725
PCP	439	364	343	330
Ecstasy	624	558	576	556
Inhalants³	--	--	--	633
Methamphetamine	697	536	546	525
Misuse of Prescription Psychotherapeutics	nr	nr	nr	nr
Pain Relievers	nr	nr	nr	nr
Prescription Opioids	--	--	--	--
Stimulants	nr	nr	nr	nr
Tranquilizers or Sedatives	nr	nr	nr	nr
Tranquilizers	nr	nr	nr	nr
Sedatives	nr	nr	nr	nr
Benzodiazepines	--	--	--	--
Opioids²	--	--	--	--
Central Nervous System Stimulants	nr	nr	nr	nr
Illicit Drugs Other than Marijuana^2,4	nr	nr	nr	nr
TOBACCO PRODUCTS	1,196	1,021	1,018	1,081
Cigarettes	1,203	1,060	1,054	1,073
Daily Cigarettes	1,185	1,069	1,026	1,033
Smokeless Tobacco	817	756	752	788
Cigars	1,064	996	990	1,039
Pipe Tobacco	769	678	665	634
ALCOHOL	905	851	806	828
Binge Alcohol Use	--	--	--	--
Heavy Alcohol Use	--	--	--	--
SUBSTANCE USE
Illicit Drugs, Tobacco Products, or Alcohol^1,2	808	750	718	739
Illicit Drugs or Alcohol^1,2	873	824	780	793
Tobacco Products or Alcohol	827	775	733	761
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Does not include illegally made fentanyl (IMF). ³ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.3D – Types of Illicit Drug, Tobacco Product, and Alcohol Use in Lifetime: Among People Aged 18 or Older; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
ILLICIT DRUGS^1,2	0.49	0.45	0.43	0.42
Marijuana	0.48	0.45	0.42	0.42
Cocaine	0.35	0.34	0.32	0.33
Crack	0.19	0.17	0.16	0.17
Heroin	0.16	0.12	0.13	0.12
Hallucinogens	0.37	0.33	0.33	0.34
LSD	0.31	0.28	0.27	0.28
PCP	0.17	0.14	0.13	0.13
Ecstasy	0.25	0.22	0.22	0.21
Inhalants³	--	--	--	0.24
Methamphetamine	0.27	0.21	0.21	0.20
Misuse of Prescription Psychotherapeutics	nr	nr	nr	nr
Pain Relievers	nr	nr	nr	nr
Prescription Opioids	--	--	--	--
Stimulants	nr	nr	nr	nr
Tranquilizers or Sedatives	nr	nr	nr	nr
Tranquilizers	nr	nr	nr	nr
Sedatives	nr	nr	nr	nr
Benzodiazepines	--	--	--	--
Opioids²	--	--	--	--
Central Nervous System Stimulants	nr	nr	nr	nr
Illicit Drugs Other than Marijuana^2,4	nr	nr	nr	nr
TOBACCO PRODUCTS	0.47	0.40	0.40	0.41
Cigarettes	0.47	0.41	0.41	0.41
Daily Cigarettes	0.47	0.42	0.40	0.39
Smokeless Tobacco	0.32	0.29	0.29	0.30
Cigars	0.42	0.39	0.38	0.40
Pipe Tobacco	0.30	0.26	0.26	0.24
ALCOHOL	0.36	0.33	0.31	0.32
Binge Alcohol Use	--	--	--	--
Heavy Alcohol Use	--	--	--	--
SUBSTANCE USE
Illicit Drugs, Tobacco Products, or Alcohol^1,2	0.32	0.29	0.28	0.28
Illicit Drugs or Alcohol^1,2	0.34	0.32	0.30	0.30
Tobacco Products or Alcohol	0.33	0.30	0.28	0.29
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Does not include illegally made fentanyl (IMF). ³ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.3P – Types of Illicit Drug, Tobacco Product, and Alcohol Use in Lifetime: Among People Aged 18 or Older; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
ILLICIT DRUGS^1,2	0.0023	0.0913	0.3839
Marijuana	0.0168	0.2585	0.4225
Cocaine	0.7901	0.4890	0.5651
Crack	0.6002	0.7446	0.3508
Heroin	0.4301	0.6413	0.6808
Hallucinogens	0.0075	0.2256	0.0756
LSD	0.9565	0.4340	0.8717
PCP	0.0897	0.1589	0.7395
Ecstasy	0.9460	0.4913	0.4181
Inhalants³	--	--	--
Methamphetamine	0.0019	0.0233	0.1274
Misuse of Prescription Psychotherapeutics	nr	nr	nr
Pain Relievers	nr	nr	nr
Prescription Opioids	--	--	--
Stimulants	nr	nr	nr
Tranquilizers or Sedatives	nr	nr	nr
Tranquilizers	nr	nr	nr
Sedatives	nr	nr	nr
Benzodiazepines	--	--	--
Opioids²	--	--	--
Central Nervous System Stimulants	nr	nr	nr
Illicit Drugs Other than Marijuana^2,4	nr	nr	nr
TOBACCO PRODUCTS	0.4295	0.6009	0.1466
Cigarettes	0.2921	0.2270	0.1346
Daily Cigarettes	0.0047	0.0681	0.1254
Smokeless Tobacco	0.0121	0.0724	0.4147
Cigars	0.1030	0.1518	0.0278
Pipe Tobacco	0.0000	0.0213	0.0151
ALCOHOL	0.1344	0.0620	0.9051
Binge Alcohol Use	--	--	--
Heavy Alcohol Use	--	--	--
SUBSTANCE USE
Illicit Drugs, Tobacco Products, or Alcohol^1,2	0.1790	0.2264	0.9729
Illicit Drugs or Alcohol^1,2	0.0577	0.0249	0.7764
Tobacco Products or Alcohol	0.3210	0.4127	0.7079
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Does not include illegally made fentanyl (IMF). ³ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.4C – Types of Illicit Drug, Tobacco Product, and Alcohol Use in Lifetime: Among People Aged 18 to 25; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
ILLICIT DRUGS^1,2	254	244	239	234
Marijuana	253	249	241	238
Cocaine	149	144	127	110
Crack	50	28	30	25
Heroin	53	26	31	27
Hallucinogens	181	181	163	178
LSD	147	139	127	135
PCP	42	31	22	28
Ecstasy	131	119	106	106
Inhalants³	--	--	--	129
Methamphetamine	62	61	47	51
Misuse of Prescription Psychotherapeutics	nr	nr	nr	nr
Pain Relievers	nr	nr	nr	nr
Prescription Opioids	--	--	--	--
Stimulants	nr	nr	nr	nr
Tranquilizers or Sedatives	nr	nr	nr	nr
Tranquilizers	nr	nr	nr	nr
Sedatives	nr	nr	nr	nr
Benzodiazepines	--	--	--	--
Opioids²	--	--	--	--
Central Nervous System Stimulants	nr	nr	nr	nr
Illicit Drugs Other than Marijuana^2,4	nr	nr	nr	nr
TOBACCO PRODUCTS	258	237	235	240
Cigarettes	251	225	212	226
Daily Cigarettes	150	139	125	130
Smokeless Tobacco	171	132	132	139
Cigars	222	199	194	188
Pipe Tobacco	118	104	100	85
ALCOHOL	228	220	220	214
Binge Alcohol Use	--	--	--	--
Heavy Alcohol Use	--	--	--	--
SUBSTANCE USE
Illicit Drugs, Tobacco Products, or Alcohol^1,2	215	196	196	200
Illicit Drugs or Alcohol^1,2	222	199	208	204
Tobacco Products or Alcohol	223	215	206	216
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Does not include illegally made fentanyl (IMF). ³ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.4D – Types of Illicit Drug, Tobacco Product, and Alcohol Use in Lifetime: Among People Aged 18 to 25; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
ILLICIT DRUGS^1,2	0.76	0.70	0.70	0.67
Marijuana	0.75	0.72	0.71	0.68
Cocaine	0.45	0.41	0.37	0.31
Crack	0.15	0.08	0.09	0.07
Heroin	0.16	0.08	0.09	0.08
Hallucinogens	0.54	0.52	0.48	0.51
LSD	0.44	0.40	0.37	0.39
PCP	0.13	0.09	0.06	0.08
Ecstasy	0.39	0.34	0.31	0.30
Inhalants³	--	--	--	0.37
Methamphetamine	0.18	0.17	0.14	0.15
Misuse of Prescription Psychotherapeutics	nr	nr	nr	nr
Pain Relievers	nr	nr	nr	nr
Prescription Opioids	--	--	--	--
Stimulants	nr	nr	nr	nr
Tranquilizers or Sedatives	nr	nr	nr	nr
Tranquilizers	nr	nr	nr	nr
Sedatives	nr	nr	nr	nr
Benzodiazepines	--	--	--	--
Opioids²	--	--	--	--
Central Nervous System Stimulants	nr	nr	nr	nr
Illicit Drugs Other than Marijuana^2,4	nr	nr	nr	nr
TOBACCO PRODUCTS	0.77	0.68	0.69	0.69
Cigarettes	0.75	0.65	0.62	0.65
Daily Cigarettes	0.45	0.40	0.37	0.37
Smokeless Tobacco	0.51	0.38	0.39	0.40
Cigars	0.66	0.57	0.57	0.54
Pipe Tobacco	0.35	0.30	0.29	0.24
ALCOHOL	0.68	0.63	0.65	0.61
Binge Alcohol Use	--	--	--	--
Heavy Alcohol Use	--	--	--	--
SUBSTANCE USE
Illicit Drugs, Tobacco Products, or Alcohol^1,2	0.64	0.56	0.58	0.57
Illicit Drugs or Alcohol^1,2	0.66	0.57	0.61	0.58
Tobacco Products or Alcohol	0.67	0.62	0.61	0.62
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Does not include illegally made fentanyl (IMF). ³ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.4P – Types of Illicit Drug, Tobacco Product, and Alcohol Use in Lifetime: Among People Aged 18 to 25; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
ILLICIT DRUGS^1,2	0.2680	0.1244	0.8213
Marijuana	0.0413	0.0020	0.2251
Cocaine	0.0000	0.0000	0.0013
Crack	0.0021	0.0999	0.0125
Heroin	0.0028	0.3037	0.2222
Hallucinogens	0.7831	0.3232	0.3072
LSD	0.0016	0.0001	0.1530
PCP	0.1084	0.5023	0.6843
Ecstasy	0.0000	0.0000	0.0615
Inhalants³	--	--	--
Methamphetamine	0.0409	0.0066	0.0989
Misuse of Prescription Psychotherapeutics	nr	nr	nr
Pain Relievers	nr	nr	nr
Prescription Opioids	--	--	--
Stimulants	nr	nr	nr
Tranquilizers or Sedatives	nr	nr	nr
Tranquilizers	nr	nr	nr
Sedatives	nr	nr	nr
Benzodiazepines	--	--	--
Opioids²	--	--	--
Central Nervous System Stimulants	nr	nr	nr
Illicit Drugs Other than Marijuana^2,4	nr	nr	nr
TOBACCO PRODUCTS	0.0000	0.0353	0.0230
Cigarettes	0.0049	0.1346	0.2961
Daily Cigarettes	0.0000	0.0002	0.0293
Smokeless Tobacco	0.0002	0.9631	0.7387
Cigars	0.0001	0.0077	0.0041
Pipe Tobacco	0.0001	0.0001	0.0594
ALCOHOL	0.2572	0.8430	0.3145
Binge Alcohol Use	--	--	--
Heavy Alcohol Use	--	--	--
SUBSTANCE USE
Illicit Drugs, Tobacco Products, or Alcohol^1,2	0.4991	0.7735	0.5103
Illicit Drugs or Alcohol^1,2	0.7041	0.8361	0.6586
Tobacco Products or Alcohol	0.0929	0.5834	0.1232
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Does not include illegally made fentanyl (IMF). ³ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.5C – Types of Illicit Drug, Tobacco Product, and Alcohol Use in Lifetime: Among People Aged 26 or Older; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
ILLICIT DRUGS^1,2	1,187	1,115	1,065	1,060
Marijuana	1,185	1,110	1,050	1,057
Cocaine	865	846	802	831
Crack	485	423	400	456
Heroin	388	306	327	320
Hallucinogens	919	818	829	851
LSD	755	686	681	692
PCP	436	361	343	329
Ecstasy	598	546	567	537
Inhalants³	--	--	--	624
Methamphetamine	686	529	544	517
Misuse of Prescription Psychotherapeutics	nr	nr	nr	nr
Pain Relievers	nr	nr	nr	nr
Prescription Opioids	--	--	--	--
Stimulants	nr	nr	nr	nr
Tranquilizers or Sedatives	nr	nr	nr	nr
Tranquilizers	nr	nr	nr	nr
Sedatives	nr	nr	nr	nr
Benzodiazepines	--	--	--	--
Opioids²	--	--	--	--
Central Nervous System Stimulants	nr	nr	nr	nr
Illicit Drugs Other than Marijuana^2,4	nr	nr	nr	nr
TOBACCO PRODUCTS	1,123	959	962	1,023
Cigarettes	1,132	1,001	1,003	1,025
Daily Cigarettes	1,120	1,033	996	1,004
Smokeless Tobacco	786	739	732	763
Cigars	1,023	960	959	1,001
Pipe Tobacco	747	664	653	624
ALCOHOL	851	808	749	775
Binge Alcohol Use	--	--	--	--
Heavy Alcohol Use	--	--	--	--
SUBSTANCE USE
Illicit Drugs, Tobacco Products, or Alcohol^1,2	745	716	667	692
Illicit Drugs or Alcohol^1,2	817	792	729	749
Tobacco Products or Alcohol	764	733	674	707
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Does not include illegally made fentanyl (IMF). ³ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.5D – Types of Illicit Drug, Tobacco Product, and Alcohol Use in Lifetime: Among People Aged 26 or Older; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
ILLICIT DRUGS^1,2	0.54	0.50	0.48	0.47
Marijuana	0.54	0.50	0.47	0.46
Cocaine	0.39	0.38	0.36	0.37
Crack	0.22	0.19	0.18	0.20
Heroin	0.18	0.14	0.15	0.14
Hallucinogens	0.42	0.37	0.37	0.37
LSD	0.34	0.31	0.30	0.30
PCP	0.20	0.16	0.15	0.14
Ecstasy	0.27	0.25	0.25	0.24
Inhalants³	--	--	--	0.27
Methamphetamine	0.31	0.24	0.24	0.23
Misuse of Prescription Psychotherapeutics	nr	nr	nr	nr
Pain Relievers	nr	nr	nr	nr
Prescription Opioids	--	--	--	--
Stimulants	nr	nr	nr	nr
Tranquilizers or Sedatives	nr	nr	nr	nr
Tranquilizers	nr	nr	nr	nr
Sedatives	nr	nr	nr	nr
Benzodiazepines	--	--	--	--
Opioids²	--	--	--	--
Central Nervous System Stimulants	nr	nr	nr	nr
Illicit Drugs Other than Marijuana^2,4	nr	nr	nr	nr
TOBACCO PRODUCTS	0.51	0.43	0.43	0.45
Cigarettes	0.51	0.45	0.45	0.45
Daily Cigarettes	0.51	0.47	0.45	0.44
Smokeless Tobacco	0.36	0.33	0.33	0.34
Cigars	0.46	0.43	0.43	0.44
Pipe Tobacco	0.34	0.30	0.29	0.27
ALCOHOL	0.39	0.36	0.33	0.34
Binge Alcohol Use	--	--	--	--
Heavy Alcohol Use	--	--	--	--
SUBSTANCE USE
Illicit Drugs, Tobacco Products, or Alcohol^1,2	0.34	0.32	0.30	0.30
Illicit Drugs or Alcohol^1,2	0.37	0.36	0.33	0.33
Tobacco Products or Alcohol	0.35	0.33	0.30	0.31
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Does not include illegally made fentanyl (IMF). ³ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.5P – Types of Illicit Drug, Tobacco Product, and Alcohol Use in Lifetime: Among People Aged 26 or Older; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
ILLICIT DRUGS^1,2	0.0007	0.0375	0.3323
Marijuana	0.0033	0.0635	0.2583
Cocaine	0.6793	0.9971	0.9281
Crack	0.8070	0.7007	0.2605
Heroin	0.6734	0.6792	0.5890
Hallucinogens	0.0059	0.1420	0.1045
LSD	0.5015	0.9758	0.6566
PCP	0.1217	0.1635	0.7255
Ecstasy	0.2650	0.8480	0.6648
Inhalants³	--	--	--
Methamphetamine	0.0034	0.0401	0.1751
Misuse of Prescription Psychotherapeutics	nr	nr	nr
Pain Relievers	nr	nr	nr
Prescription Opioids	--	--	--
Stimulants	nr	nr	nr
Tranquilizers or Sedatives	nr	nr	nr
Tranquilizers	nr	nr	nr
Sedatives	nr	nr	nr
Benzodiazepines	--	--	--
Opioids²	--	--	--
Central Nervous System Stimulants	nr	nr	nr
Illicit Drugs Other than Marijuana^2,4	nr	nr	nr
TOBACCO PRODUCTS	0.7103	0.8522	0.3501
Cigarettes	0.6628	0.2853	0.2001
Daily Cigarettes	0.0219	0.1310	0.2224
Smokeless Tobacco	0.0635	0.0614	0.3742
Cigars	0.0096	0.3142	0.0901
Pipe Tobacco	0.0002	0.0687	0.0286
ALCOHOL	0.0520	0.0524	0.6501
Binge Alcohol Use	--	--	--
Heavy Alcohol Use	--	--	--
SUBSTANCE USE
Illicit Drugs, Tobacco Products, or Alcohol^1,2	0.0916	0.2643	0.8426
Illicit Drugs or Alcohol^1,2	0.0309	0.0264	0.6457
Tobacco Products or Alcohol	0.1035	0.3472	0.9036
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Does not include illegally made fentanyl (IMF). ³ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.6C – Types of Illicit Drug, Tobacco Product, and Alcohol Use in Past Year: Among People Aged 12 or Older; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
ILLICIT DRUGS¹	1,005	983	918	1,015
Marijuana	997	940	876	974
Cocaine	259	274	264	221
Crack	133	119	139	117
Heroin	143	121	84	86
Hallucinogens	330	327	294	388
LSD	170	158	126	138
PCP	77	72	45	27
Ecstasy	175	151	170	136
Inhalants²	--	--	--	163
Methamphetamine	242	219	212	184
Misuse of Prescription Psychotherapeutics	492	414	422	416
Pain Relievers	404	325	334	326
Prescription Opioids	393	315	324	312
Stimulants	217	211	193	209
Tranquilizers or Sedatives	261	247	259	248
Tranquilizers	250	225	225	221
Sedatives	95	111	148	127
Benzodiazepines	234	213	230	207
Opioids^1,3	406	327	329	318
Central Nervous System Stimulants	381	378	355	327
Illicit Drugs Other than Marijuana^1,2,4	--	--	--	573
TOBACCO PRODUCTS⁵	1,131	1,058	889	916
Cigarettes	1,049	948	836	810
Daily Cigarettes	--	--	--	--
Smokeless Tobacco	452	350	381	353
Cigars	603	506	494	502
Pipe Tobacco⁵	--	--	--	--
ALCOHOL	1,243	1,143	1,167	1,143
Binge Alcohol Use	--	--	--	--
Heavy Alcohol Use	--	--	--	--
SUBSTANCE USE
Illicit Drugs, Tobacco Products, or Alcohol¹	1,174	1,071	1,070	1,101
Illicit Drugs or Alcohol¹	1,222	1,116	1,135	1,135
Tobacco Products or Alcohol	1,195	1,097	1,077	1,109
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Information about past year use of pipe tobacco was not collected. Tobacco product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.6D – Types of Illicit Drug, Tobacco Product, and Alcohol Use in Past Year: Among People Aged 12 or Older; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
ILLICIT DRUGS¹	0.36	0.35	0.32	0.35
Marijuana	0.36	0.33	0.31	0.34
Cocaine	0.09	0.10	0.09	0.08
Crack	0.05	0.04	0.05	0.04
Heroin	0.05	0.04	0.03	0.03
Hallucinogens	0.12	0.12	0.10	0.13
LSD	0.06	0.06	0.04	0.05
PCP	0.03	0.03	0.02	0.01
Ecstasy	0.06	0.05	0.06	0.05
Inhalants²	--	--	--	0.06
Methamphetamine	0.09	0.08	0.07	0.06
Misuse of Prescription Psychotherapeutics	0.18	0.15	0.15	0.14
Pain Relievers	0.14	0.12	0.12	0.11
Prescription Opioids	0.14	0.11	0.11	0.11
Stimulants	0.08	0.07	0.07	0.07
Tranquilizers or Sedatives	0.09	0.09	0.09	0.09
Tranquilizers	0.09	0.08	0.08	0.08
Sedatives	0.03	0.04	0.05	0.04
Benzodiazepines	0.08	0.08	0.08	0.07
Opioids^1,3	0.15	0.12	0.12	0.11
Central Nervous System Stimulants	0.14	0.13	0.13	0.11
Illicit Drugs Other than Marijuana^1,2,4	--	--	--	0.20
TOBACCO PRODUCTS⁵	0.40	0.38	0.31	0.32
Cigarettes	0.37	0.34	0.29	0.28
Daily Cigarettes	--	--	--	--
Smokeless Tobacco	0.16	0.12	0.13	0.12
Cigars	0.22	0.18	0.17	0.17
Pipe Tobacco⁵	--	--	--	--
ALCOHOL	0.44	0.41	0.41	0.40
Binge Alcohol Use	--	--	--	--
Heavy Alcohol Use	--	--	--	--
SUBSTANCE USE
Illicit Drugs, Tobacco Products, or Alcohol¹	0.42	0.38	0.38	0.38
Illicit Drugs or Alcohol¹	0.44	0.40	0.40	0.39
Tobacco Products or Alcohol	0.43	0.39	0.38	0.38
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Information about past year use of pipe tobacco was not collected. Tobacco product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.6P – Types of Illicit Drug, Tobacco Product, and Alcohol Use in Past Year: Among People Aged 12 or Older; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
ILLICIT DRUGS¹	0.0000	0.2097	0.1562
Marijuana	0.0000	0.4901	0.3021
Cocaine	0.0622	0.0015	0.0126
Crack	0.1206	0.2427	0.1502
Heroin	0.0013	0.0006	0.3138
Hallucinogens	0.0000	0.0012	0.0020
LSD	0.0000	0.0004	0.5376
PCP	0.2328	0.1770	0.4922
Ecstasy	0.2038	0.5103	0.4286
Inhalants²	--	--	--
Methamphetamine	0.2661	0.1851	0.3028
Misuse of Prescription Psychotherapeutics	0.0805	0.2257	0.1285
Pain Relievers	0.0342	0.1613	0.1107
Prescription Opioids	0.0201	0.2105	0.0779
Stimulants	0.6748	0.0990	0.7588
Tranquilizers or Sedatives	0.2957	0.3034	0.5200
Tranquilizers	0.0878	0.2104	0.4557
Sedatives	0.9175	0.7340	0.3990
Benzodiazepines	0.0323	0.1966	0.1913
Opioids^1,3	0.0044	0.0807	0.0490
Central Nervous System Stimulants	0.2252	0.0062	0.0928
Illicit Drugs Other than Marijuana^1,2,4	--	--	--
TOBACCO PRODUCTS⁵	0.0000	0.0062	0.0045
Cigarettes	0.0000	0.0011	0.0454
Daily Cigarettes	--	--	--
Smokeless Tobacco	0.0332	0.1201	0.4875
Cigars	0.1285	0.0859	0.0061
Pipe Tobacco⁵	--	--	--
ALCOHOL	0.6512	0.1719	0.3020
Binge Alcohol Use	--	--	--
Heavy Alcohol Use	--	--	--
SUBSTANCE USE
Illicit Drugs, Tobacco Products, or Alcohol¹	0.6029	0.3392	0.6003
Illicit Drugs or Alcohol¹	0.2646	0.6233	0.8713
Tobacco Products or Alcohol	0.1296	0.0952	0.3644
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates that are used in these comparisons may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Information about past year use of pipe tobacco was not collected. Tobacco product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.7C – Types of Illicit Drug, Tobacco Product, and Alcohol Use in Past Year: Among People Aged 12 to 17; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
ILLICIT DRUGS¹	150	116	119	131
Marijuana	133	109	107	107
Cocaine	11	14	17	18
Crack	2	1	4	4
Heroin	1	2	4	6
Hallucinogens	48	37	41	43
LSD	43	24	26	24
PCP	10	7	12	1
Ecstasy	22	18	17	16
Inhalants²	--	--	--	67
Methamphetamine	13	6	17	24
Misuse of Prescription Psychotherapeutics	83	48	58	53
Pain Relievers	62	37	53	44
Prescription Opioids	61	36	50	39
Stimulants	42	31	32	31
Tranquilizers or Sedatives	52	21	25	26
Tranquilizers	52	19	18	23
Sedatives	13	10	18	17
Benzodiazepines	50	19	18	20
Opioids^1,3	61	36	50	39
Central Nervous System Stimulants	43	34	36	41
Illicit Drugs Other than Marijuana^1,2,4	--	--	--	101
TOBACCO PRODUCTS⁵	102	75	77	66
Cigarettes	86	66	62	55
Daily Cigarettes	--	--	--	--
Smokeless Tobacco	48	27	28	35
Cigars	64	40	44	44
Pipe Tobacco⁵	--	--	--	--
ALCOHOL	153	130	142	139
Binge Alcohol Use	--	--	--	--
Heavy Alcohol Use	--	--	--	--
SUBSTANCE USE
Illicit Drugs, Tobacco Products, or Alcohol¹	174	145	151	153
Illicit Drugs or Alcohol¹	172	142	148	152
Tobacco Products or Alcohol	162	133	146	140
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Information about past year use of pipe tobacco was not collected. Tobacco product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.7D – Types of Illicit Drug, Tobacco Product, and Alcohol Use in Past Year: Among People Aged 12 to 17; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
ILLICIT DRUGS¹	0.58	0.45	0.46	0.51
Marijuana	0.51	0.42	0.41	0.41
Cocaine	0.04	0.05	0.06	0.07
Crack	0.01	<0.01	0.02	0.02
Heroin	<0.01	0.01	0.02	0.02
Hallucinogens	0.18	0.14	0.16	0.16
LSD	0.16	0.09	0.10	0.09
PCP	0.04	0.03	0.05	<0.01
Ecstasy	0.08	0.07	0.06	0.06
Inhalants²	--	--	--	0.26
Methamphetamine	0.05	0.02	0.07	0.09
Misuse of Prescription Psychotherapeutics	0.32	0.19	0.23	0.20
Pain Relievers	0.24	0.14	0.21	0.17
Prescription Opioids	0.23	0.14	0.19	0.15
Stimulants	0.16	0.12	0.12	0.12
Tranquilizers or Sedatives	0.20	0.08	0.10	0.10
Tranquilizers	0.20	0.07	0.07	0.09
Sedatives	0.05	0.04	0.07	0.07
Benzodiazepines	0.19	0.07	0.07	0.08
Opioids^1,3	0.23	0.14	0.19	0.15
Central Nervous System Stimulants	0.16	0.13	0.14	0.16
Illicit Drugs Other than Marijuana^1,2,4	--	--	--	0.39
TOBACCO PRODUCTS⁵	0.39	0.29	0.30	0.26
Cigarettes	0.33	0.25	0.24	0.21
Daily Cigarettes	--	--	--	--
Smokeless Tobacco	0.18	0.10	0.11	0.13
Cigars	0.25	0.16	0.17	0.17
Pipe Tobacco⁵	--	--	--	--
ALCOHOL	0.59	0.50	0.55	0.53
Binge Alcohol Use	--	--	--	--
Heavy Alcohol Use	--	--	--	--
SUBSTANCE USE
Illicit Drugs, Tobacco Products, or Alcohol¹	0.67	0.56	0.58	0.59
Illicit Drugs or Alcohol¹	0.66	0.55	0.57	0.59
Tobacco Products or Alcohol	0.62	0.52	0.56	0.54
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Information about past year use of pipe tobacco was not collected. Tobacco product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.7P – Types of Illicit Drug, Tobacco Product, and Alcohol Use in Past Year: Among People Aged 12 to 17; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
ILLICIT DRUGS¹	0.5330	0.2540	0.5930
Marijuana	0.3969	0.0622	0.1858
Cocaine	0.0737	0.1701	0.7084
Crack	0.3015	0.0991	0.5212
Heroin	0.1051	0.2262	0.3907
Hallucinogens	0.6473	0.4350	0.7584
LSD	0.0012	0.0931	0.3770
PCP	0.0272	0.0558	0.0752
Ecstasy	0.1530	0.7929	0.4279
Inhalants²	--	--	--
Methamphetamine	0.4404	0.1233	0.5656
Misuse of Prescription Psychotherapeutics	0.0099	0.9841	0.0773
Pain Relievers	0.1084	0.7860	0.0328
Prescription Opioids	0.0810	0.7977	0.0659
Stimulants	0.0625	0.5729	0.5309
Tranquilizers or Sedatives	0.1893	0.3304	0.9519
Tranquilizers	0.0974	0.7510	0.8285
Sedatives	0.3058	0.0733	0.8652
Benzodiazepines	0.0776	0.8058	0.8607
Opioids^1,3	0.0944	0.7221	0.0697
Central Nervous System Stimulants	0.4652	0.7254	0.8924
Illicit Drugs Other than Marijuana^1,2,4	--	--	--
TOBACCO PRODUCTS⁵	0.0200	0.9934	0.9434
Cigarettes	0.0385	0.2682	0.2619
Daily Cigarettes	--	--	--
Smokeless Tobacco	0.1648	0.0358	0.0972
Cigars	0.0798	0.4018	0.3244
Pipe Tobacco⁵	--	--	--
ALCOHOL	0.0135	0.6180	0.4406
Binge Alcohol Use	--	--	--
Heavy Alcohol Use	--	--	--
SUBSTANCE USE
Illicit Drugs, Tobacco Products, or Alcohol¹	0.3231	0.7693	0.9363
Illicit Drugs or Alcohol¹	0.3619	0.5530	0.9293
Tobacco Products or Alcohol	0.0033	0.3303	0.2149
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates that are used in these comparisons may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Information about past year use of pipe tobacco was not collected. Tobacco product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.8C – Types of Illicit Drug, Tobacco Product, and Alcohol Use in Past Year: Among People Aged 18 or Older; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
ILLICIT DRUGS¹	988	968	908	1,003
Marijuana	972	925	866	957
Cocaine	259	272	264	220
Crack	133	119	139	117
Heroin	143	120	84	86
Hallucinogens	329	326	289	385
LSD	162	157	124	139
PCP	77	71	44	27
Ecstasy	174	150	169	134
Inhalants²	--	--	--	147
Methamphetamine	241	219	212	181
Misuse of Prescription Psychotherapeutics	486	409	421	411
Pain Relievers	403	323	333	322
Prescription Opioids	392	314	324	309
Stimulants	216	205	190	206
Tranquilizers or Sedatives	253	245	258	245
Tranquilizers	243	224	225	219
Sedatives	94	110	147	125
Benzodiazepines	228	212	230	205
Opioids^1,3	405	325	328	315
Central Nervous System Stimulants	377	375	351	325
Illicit Drugs Other than Marijuana^1,2,4	--	--	--	568
TOBACCO PRODUCTS⁵	1,109	1,039	886	905
Cigarettes	1,030	934	838	806
Daily Cigarettes	--	--	--	--
Smokeless Tobacco	451	348	381	349
Cigars	598	501	493	499
Pipe Tobacco⁵	--	--	--	--
ALCOHOL	1,207	1,105	1,117	1,094
Binge Alcohol Use	--	--	--	--
Heavy Alcohol Use	--	--	--	--
SUBSTANCE USE
Illicit Drugs, Tobacco Products, or Alcohol¹	1,115	1,022	1,023	1,046
Illicit Drugs or Alcohol¹	1,179	1,078	1,088	1,079
Tobacco Products or Alcohol	1,138	1,047	1,033	1,060
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Information about past year use of pipe tobacco was not collected. Tobacco product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.8D – Types of Illicit Drug, Tobacco Product, and Alcohol Use in Past Year: Among People Aged 18 or Older; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
ILLICIT DRUGS¹	0.39	0.38	0.35	0.38
Marijuana	0.38	0.36	0.34	0.36
Cocaine	0.10	0.11	0.10	0.08
Crack	0.05	0.05	0.05	0.04
Heroin	0.06	0.05	0.03	0.03
Hallucinogens	0.13	0.13	0.11	0.15
LSD	0.06	0.06	0.05	0.05
PCP	0.03	0.03	0.02	0.01
Ecstasy	0.07	0.06	0.07	0.05
Inhalants²	--	--	--	0.06
Methamphetamine	0.09	0.09	0.08	0.07
Misuse of Prescription Psychotherapeutics	0.19	0.16	0.16	0.16
Pain Relievers	0.16	0.13	0.13	0.12
Prescription Opioids	0.15	0.12	0.13	0.12
Stimulants	0.09	0.08	0.07	0.08
Tranquilizers or Sedatives	0.10	0.10	0.10	0.09
Tranquilizers	0.10	0.09	0.09	0.08
Sedatives	0.04	0.04	0.06	0.05
Benzodiazepines	0.09	0.08	0.09	0.08
Opioids^1,3	0.16	0.13	0.13	0.12
Central Nervous System Stimulants	0.15	0.15	0.14	0.12
Illicit Drugs Other than Marijuana^1,2,4	--	--	--	0.22
TOBACCO PRODUCTS⁵	0.44	0.41	0.34	0.34
Cigarettes	0.41	0.36	0.33	0.31
Daily Cigarettes	--	--	--	--
Smokeless Tobacco	0.18	0.14	0.15	0.13
Cigars	0.24	0.20	0.19	0.19
Pipe Tobacco⁵	--	--	--	--
ALCOHOL	0.48	0.43	0.43	0.42
Binge Alcohol Use	--	--	--	--
Heavy Alcohol Use	--	--	--	--
SUBSTANCE USE
Illicit Drugs, Tobacco Products, or Alcohol¹	0.44	0.40	0.40	0.40
Illicit Drugs or Alcohol¹	0.46	0.42	0.42	0.41
Tobacco Products or Alcohol	0.45	0.41	0.40	0.40
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Information about past year use of pipe tobacco was not collected. Tobacco product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.8P – Types of Illicit Drug, Tobacco Product, and Alcohol Use in Past Year: Among People Aged 18 or Older; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
ILLICIT DRUGS¹	0.0000	0.2739	0.1820
Marijuana	0.0000	0.3768	0.2393
Cocaine	0.0439	0.0009	0.0110
Crack	0.1114	0.2243	0.1428
Heroin	0.0010	0.0004	0.2844
Hallucinogens	0.0000	0.0015	0.0021
LSD	0.0000	0.0012	0.6573
PCP	0.3468	0.2406	0.7899
Ecstasy	0.2622	0.5182	0.4653
Inhalants²	--	--	--
Methamphetamine	0.2234	0.1390	0.2684
Misuse of Prescription Psychotherapeutics	0.1625	0.2137	0.1908
Pain Relievers	0.0553	0.1443	0.1976
Prescription Opioids	0.0352	0.1931	0.1320
Stimulants	0.9161	0.1100	0.8241
Tranquilizers or Sedatives	0.3840	0.2531	0.5145
Tranquilizers	0.1391	0.1929	0.4346
Sedatives	0.9726	0.5774	0.4114
Benzodiazepines	0.0595	0.1985	0.1927
Opioids^1,3	0.0079	0.0698	0.0844
Central Nervous System Stimulants	0.2393	0.0050	0.0842
Illicit Drugs Other than Marijuana^1,2,4	--	--	--
TOBACCO PRODUCTS⁵	0.0000	0.0048	0.0036
Cigarettes	0.0000	0.0011	0.0494
Daily Cigarettes	--	--	--
Smokeless Tobacco	0.0411	0.1723	0.3830
Cigars	0.1561	0.0677	0.0040
Pipe Tobacco⁵	--	--	--
ALCOHOL	0.6869	0.1427	0.2673
Binge Alcohol Use	--	--	--
Heavy Alcohol Use	--	--	--
SUBSTANCE USE
Illicit Drugs, Tobacco Products, or Alcohol¹	0.5030	0.2474	0.4946
Illicit Drugs or Alcohol¹	0.2916	0.4851	0.7722
Tobacco Products or Alcohol	0.1431	0.0822	0.3574
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates that are used in these comparisons may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Information about past year use of pipe tobacco was not collected. Tobacco product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.9C – Types of Illicit Drug, Tobacco Product, and Alcohol Use in Past Year: Among People Aged 18 to 25; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
ILLICIT DRUGS¹	257	246	235	227
Marijuana	254	247	238	224
Cocaine	111	91	84	63
Crack	28	13	21	15
Heroin	18	14	8	14
Hallucinogens	133	125	111	117
LSD	90	71	47	46
PCP	22	4	1	10
Ecstasy	69	63	60	49
Inhalants²	--	--	--	60
Methamphetamine	39	31	19	29
Misuse of Prescription Psychotherapeutics	134	121	103	107
Pain Relievers	86	78	63	84
Prescription Opioids	83	74	59	82
Stimulants	103	89	79	73
Tranquilizers or Sedatives	80	66	48	55
Tranquilizers	77	64	45	53
Sedatives	27	19	19	19
Benzodiazepines	77	63	43	51
Opioids^1,3	83	75	59	82
Central Nervous System Stimulants	135	121	113	89
Illicit Drugs Other than Marijuana^1,2,4	--	--	--	155
TOBACCO PRODUCTS⁵	220	205	212	206
Cigarettes	191	176	185	185
Daily Cigarettes	--	--	--	--
Smokeless Tobacco	101	87	95	107
Cigars	167	151	139	140
Pipe Tobacco⁵	--	--	--	--
ALCOHOL	243	235	237	230
Binge Alcohol Use	--	--	--	--
Heavy Alcohol Use	--	--	--	--
SUBSTANCE USE
Illicit Drugs, Tobacco Products, or Alcohol¹	227	214	217	218
Illicit Drugs or Alcohol¹	232	219	226	221
Tobacco Products or Alcohol	229	226	225	229
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Information about past year use of pipe tobacco was not collected. Tobacco product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.9D – Types of Illicit Drug, Tobacco Product, and Alcohol Use in Past Year: Among People Aged 18 to 25; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
ILLICIT DRUGS¹	0.77	0.71	0.69	0.65
Marijuana	0.76	0.71	0.70	0.64
Cocaine	0.33	0.26	0.25	0.18
Crack	0.09	0.04	0.06	0.04
Heroin	0.05	0.04	0.02	0.04
Hallucinogens	0.40	0.36	0.33	0.33
LSD	0.27	0.20	0.14	0.13
PCP	0.07	0.01	<0.01	0.03
Ecstasy	0.21	0.18	0.18	0.14
Inhalants²	--	--	--	0.17
Methamphetamine	0.12	0.09	0.06	0.08
Misuse of Prescription Psychotherapeutics	0.40	0.35	0.30	0.31
Pain Relievers	0.26	0.22	0.19	0.24
Prescription Opioids	0.25	0.21	0.17	0.23
Stimulants	0.31	0.26	0.23	0.21
Tranquilizers or Sedatives	0.24	0.19	0.14	0.16
Tranquilizers	0.23	0.18	0.13	0.15
Sedatives	0.08	0.06	0.06	0.05
Benzodiazepines	0.23	0.18	0.13	0.14
Opioids^1,3	0.25	0.21	0.17	0.23
Central Nervous System Stimulants	0.40	0.35	0.33	0.26
Illicit Drugs Other than Marijuana^1,2,4	--	--	--	0.44
TOBACCO PRODUCTS⁵	0.66	0.59	0.62	0.59
Cigarettes	0.57	0.51	0.54	0.53
Daily Cigarettes	--	--	--	--
Smokeless Tobacco	0.30	0.25	0.28	0.31
Cigars	0.50	0.43	0.41	0.40
Pipe Tobacco⁵	--	--	--	--
ALCOHOL	0.73	0.67	0.70	0.66
Binge Alcohol Use	--	--	--	--
Heavy Alcohol Use	--	--	--	--
SUBSTANCE USE
Illicit Drugs, Tobacco Products, or Alcohol¹	0.68	0.62	0.64	0.63
Illicit Drugs or Alcohol¹	0.69	0.63	0.66	0.63
Tobacco Products or Alcohol	0.69	0.65	0.66	0.66
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Information about past year use of pipe tobacco was not collected. Tobacco product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.9P – Types of Illicit Drug, Tobacco Product, and Alcohol Use in Past Year: Among People Aged 18 to 25; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
ILLICIT DRUGS¹	0.3696	0.0033	0.3422
Marijuana	0.1947	0.0008	0.0961
Cocaine	0.0005	0.0000	0.0138
Crack	0.3380	0.7365	0.3880
Heroin	0.3353	0.8384	0.1509
Hallucinogens	0.2424	0.0590	0.8694
LSD	0.0000	0.0000	0.0235
PCP	0.2389	0.2195	0.0105
Ecstasy	0.0001	0.0029	0.0946
Inhalants²	--	--	--
Methamphetamine	0.5563	0.9890	0.1454
Misuse of Prescription Psychotherapeutics	0.0000	0.0009	0.6904
Pain Relievers	0.2424	0.2014	0.3842
Prescription Opioids	0.2425	0.2042	0.4572
Stimulants	0.0005	0.0068	0.2681
Tranquilizers or Sedatives	0.0001	0.0011	0.7767
Tranquilizers	0.0001	0.0013	0.8296
Sedatives	0.0286	0.5292	0.5379
Benzodiazepines	0.0001	0.0009	0.9374
Opioids^1,3	0.2733	0.2256	0.3265
Central Nervous System Stimulants	0.0000	0.0000	0.0476
Illicit Drugs Other than Marijuana^1,2,4	--	--	--
TOBACCO PRODUCTS⁵	0.0010	0.3373	0.0265
Cigarettes	0.0689	0.5213	0.2600
Daily Cigarettes	--	--	--
Smokeless Tobacco	0.1096	0.0008	0.0182
Cigars	0.0992	0.4512	0.1636
Pipe Tobacco⁵	--	--	--
ALCOHOL	0.1965	0.2651	0.1819
Binge Alcohol Use	--	--	--
Heavy Alcohol Use	--	--	--
SUBSTANCE USE
Illicit Drugs, Tobacco Products, or Alcohol¹	0.0519	0.1995	0.0756
Illicit Drugs or Alcohol¹	0.1134	0.1901	0.1847
Tobacco Products or Alcohol	0.0478	0.1284	0.0437
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates that are used in these comparisons may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Information about past year use of pipe tobacco was not collected. Tobacco product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.10C – Types of Illicit Drug, Tobacco Product, and Alcohol Use in Past Year: Among People Aged 26 or Older; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
ILLICIT DRUGS¹	920	904	834	954
Marijuana	892	858	792	909
Cocaine	227	251	245	208
Crack	131	117	137	116
Heroin	141	119	84	85
Hallucinogens	284	291	263	370
LSD	126	136	110	129
PCP	73	71	44	25
Ecstasy	157	132	152	124
Inhalants²	--	--	--	133
Methamphetamine	235	216	211	178
Misuse of Prescription Psychotherapeutics	467	380	398	395
Pain Relievers	391	312	322	309
Prescription Opioids	381	303	314	295
Stimulants	187	178	170	193
Tranquilizers or Sedatives	242	236	252	238
Tranquilizers	231	215	217	210
Sedatives	91	108	146	124
Benzodiazepines	217	201	223	197
Opioids^1,3	394	315	318	300
Central Nervous System Stimulants	342	350	329	314
Illicit Drugs Other than Marijuana^1,2,4	--	--	--	545
TOBACCO PRODUCTS⁵	1,063	1,009	850	877
Cigarettes	998	909	816	789
Daily Cigarettes	--	--	--	--
Smokeless Tobacco	435	336	369	325
Cigars	552	472	473	459
Pipe Tobacco⁵	--	--	--	--
ALCOHOL	1,158	1,063	1,064	1,053
Binge Alcohol Use	--	--	--	--
Heavy Alcohol Use	--	--	--	--
SUBSTANCE USE
Illicit Drugs, Tobacco Products, or Alcohol¹	1,069	996	972	1,003
Illicit Drugs or Alcohol¹	1,128	1,048	1,035	1,041
Tobacco Products or Alcohol	1,100	1,017	982	1,016
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Information about past year use of pipe tobacco was not collected. Tobacco product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.10D – Types of Illicit Drug, Tobacco Product, and Alcohol Use in Past Year: Among People Aged 26 or Older; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
ILLICIT DRUGS¹	0.42	0.41	0.37	0.42
Marijuana	0.40	0.39	0.35	0.40
Cocaine	0.10	0.11	0.11	0.09
Crack	0.06	0.05	0.06	0.05
Heroin	0.06	0.05	0.04	0.04
Hallucinogens	0.13	0.13	0.12	0.16
LSD	0.06	0.06	0.05	0.06
PCP	0.03	0.03	0.02	0.01
Ecstasy	0.07	0.06	0.07	0.05
Inhalants²	--	--	--	0.06
Methamphetamine	0.11	0.10	0.09	0.08
Misuse of Prescription Psychotherapeutics	0.21	0.17	0.18	0.17
Pain Relievers	0.18	0.14	0.14	0.14
Prescription Opioids	0.17	0.14	0.14	0.13
Stimulants	0.08	0.08	0.08	0.08
Tranquilizers or Sedatives	0.11	0.11	0.11	0.10
Tranquilizers	0.10	0.10	0.10	0.09
Sedatives	0.04	0.05	0.07	0.05
Benzodiazepines	0.10	0.09	0.10	0.09
Opioids^1,3	0.18	0.14	0.14	0.13
Central Nervous System Stimulants	0.15	0.16	0.15	0.14
Illicit Drugs Other than Marijuana^1,2,4	--	--	--	0.24
TOBACCO PRODUCTS⁵	0.48	0.46	0.38	0.39
Cigarettes	0.45	0.41	0.37	0.35
Daily Cigarettes	--	--	--	--
Smokeless Tobacco	0.20	0.15	0.17	0.14
Cigars	0.25	0.21	0.21	0.20
Pipe Tobacco⁵	--	--	--	--
ALCOHOL	0.53	0.48	0.48	0.46
Binge Alcohol Use	--	--	--	--
Heavy Alcohol Use	--	--	--	--
SUBSTANCE USE
Illicit Drugs, Tobacco Products, or Alcohol¹	0.49	0.45	0.44	0.44
Illicit Drugs or Alcohol¹	0.51	0.47	0.46	0.46
Tobacco Products or Alcohol	0.50	0.46	0.44	0.45
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Information about past year use of pipe tobacco was not collected. Tobacco product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.10P – Types of Illicit Drug, Tobacco Product, and Alcohol Use in Past Year: Among People Aged 26 or Older; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
ILLICIT DRUGS¹	0.0000	0.0462	0.0999
Marijuana	0.0000	0.0521	0.0927
Cocaine	0.4524	0.0420	0.0509
Crack	0.1489	0.1983	0.1753
Heroin	0.0014	0.0004	0.1994
Hallucinogens	0.0000	0.0000	0.0015
LSD	0.4700	0.4117	0.6643
PCP	0.5367	0.1738	0.4507
Ecstasy	0.6817	0.5821	0.8732
Inhalants²	--	--	--
Methamphetamine	0.2560	0.1283	0.1930
Misuse of Prescription Psychotherapeutics	0.7514	0.7470	0.2101
Pain Relievers	0.0846	0.2381	0.1273
Prescription Opioids	0.0554	0.3084	0.0867
Stimulants	0.1419	0.5908	0.8425
Tranquilizers or Sedatives	0.8453	0.6970	0.5454
Tranquilizers	0.6840	0.6076	0.4481
Sedatives	0.6535	0.6395	0.4661
Benzodiazepines	0.4413	0.6632	0.1861
Opioids^1,3	0.0121	0.1150	0.0471
Central Nervous System Stimulants	0.8940	0.1146	0.2441
Illicit Drugs Other than Marijuana^1,2,4	--	--	--
TOBACCO PRODUCTS⁵	0.0000	0.0072	0.0149
Cigarettes	0.0000	0.0012	0.0822
Daily Cigarettes	--	--	--
Smokeless Tobacco	0.0109	0.6267	0.1084
Cigars	0.2944	0.0962	0.0076
Pipe Tobacco⁵	--	--	--
ALCOHOL	0.8755	0.2030	0.3959
Binge Alcohol Use	--	--	--
Heavy Alcohol Use	--	--	--
SUBSTANCE USE
Illicit Drugs, Tobacco Products, or Alcohol¹	0.7762	0.3537	0.7667
Illicit Drugs or Alcohol¹	0.1538	0.6588	1.0000
Tobacco Products or Alcohol	0.2694	0.1414	0.6318
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates that are used in these comparisons may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Information about past year use of pipe tobacco was not collected. Tobacco product use in the past year excludes past year pipe tobacco use, but includes past month pipe tobacco use. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.11C – Types of Illicit Drug, Tobacco Product, and Alcohol Use in Past Month: Among People Aged 12 or Older; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
ILLICIT DRUGS¹	857	854	829	845
Marijuana	830	790	787	795
Cocaine	168	182	170	152
Crack	99	99	104	93
Heroin	103	104	65	68
Hallucinogens	198	171	152	179
LSD	93	62	45	59
PCP	72	50	10	22
Ecstasy	96	59	65	69
Inhalants²	--	--	--	96
Methamphetamine	200	177	168	150
Misuse of Prescription Psychotherapeutics	247	256	239	254
Pain Relievers	207	185	174	185
Prescription Opioids	202	176	169	181
Stimulants	111	122	111	118
Tranquilizers or Sedatives	149	137	124	146
Tranquilizers	138	126	112	132
Sedatives	55	57	72	61
Benzodiazepines	--	--	--	--
Opioids^1,3	214	200	177	190
Central Nervous System Stimulants	267	266	255	220
Illicit Drugs Other than Marijuana^1,2,4	--	--	--	368
TOBACCO PRODUCTS	1,066	986	843	847
Cigarettes	1,006	897	783	774
Daily Cigarettes	792	714	634	643
Smokeless Tobacco	387	305	330	309
Cigars	447	382	390	370
Pipe Tobacco	175	178	179	171
ALCOHOL	1,237	1,195	1,203	1,144
Binge Alcohol Use	951	868	855	826
Heavy Alcohol Use⁵	565	454	456	458
SUBSTANCE USE
Illicit Drugs, Tobacco Products, or Alcohol¹	1,278	1,155	1,156	1,147
Illicit Drugs or Alcohol¹	1,277	1,183	1,205	1,173
Tobacco Products or Alcohol	1,240	1,160	1,145	1,145
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.11D – Types of Illicit Drug, Tobacco Product, and Alcohol Use in Past Month: Among People Aged 12 or Older; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
ILLICIT DRUGS¹	0.31	0.30	0.29	0.29
Marijuana	0.30	0.28	0.28	0.28
Cocaine	0.06	0.06	0.06	0.05
Crack	0.04	0.03	0.04	0.03
Heroin	0.04	0.04	0.02	0.02
Hallucinogens	0.07	0.06	0.05	0.06
LSD	0.03	0.02	0.02	0.02
PCP	0.03	0.02	<0.01	0.01
Ecstasy	0.03	0.02	0.02	0.02
Inhalants²	--	--	--	0.03
Methamphetamine	0.07	0.06	0.06	0.05
Misuse of Prescription Psychotherapeutics	0.09	0.09	0.08	0.09
Pain Relievers	0.07	0.07	0.06	0.06
Prescription Opioids	0.07	0.06	0.06	0.06
Stimulants	0.04	0.04	0.04	0.04
Tranquilizers or Sedatives	0.05	0.05	0.04	0.05
Tranquilizers	0.05	0.04	0.04	0.05
Sedatives	0.02	0.02	0.03	0.02
Benzodiazepines	--	--	--	--
Opioids^1,3	0.08	0.07	0.06	0.07
Central Nervous System Stimulants	0.10	0.09	0.09	0.08
Illicit Drugs Other than Marijuana^1,2,4	--	--	--	0.13
TOBACCO PRODUCTS	0.38	0.35	0.30	0.29
Cigarettes	0.36	0.32	0.28	0.27
Daily Cigarettes	0.28	0.25	0.22	0.22
Smokeless Tobacco	0.14	0.11	0.12	0.11
Cigars	0.16	0.14	0.14	0.13
Pipe Tobacco	0.06	0.06	0.06	0.06
ALCOHOL	0.44	0.42	0.42	0.40
Binge Alcohol Use	0.34	0.31	0.30	0.29
Heavy Alcohol Use⁵	0.20	0.16	0.16	0.16
SUBSTANCE USE
Illicit Drugs, Tobacco Products, or Alcohol¹	0.46	0.41	0.41	0.40
Illicit Drugs or Alcohol¹	0.46	0.42	0.43	0.41
Tobacco Products or Alcohol	0.44	0.41	0.40	0.40
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.11P – Types of Illicit Drug, Tobacco Product, and Alcohol Use in Past Month: Among People Aged 12 or Older; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
ILLICIT DRUGS¹	0.0000	0.6237	0.8364
Marijuana	0.0000	0.3657	0.9146
Cocaine	0.3154	0.1061	0.4306
Crack	0.3064	0.1352	0.3761
Heroin	0.0067	0.0002	0.1952
Hallucinogens	0.1317	0.0892	0.6739
LSD	0.0040	0.0473	0.4133
PCP	0.4112	0.4154	0.3208
Ecstasy	0.4460	0.1487	0.5897
Inhalants²	--	--	--
Methamphetamine	0.2971	0.1891	0.3680
Misuse of Prescription Psychotherapeutics	0.6992	0.2422	0.7296
Pain Relievers	0.1667	0.1409	0.7084
Prescription Opioids	0.0999	0.1547	0.6524
Stimulants	0.6173	0.4164	0.7269
Tranquilizers or Sedatives	0.6387	0.6960	0.2527
Tranquilizers	0.6797	0.7024	0.2823
Sedatives	0.7942	0.7208	0.7101
Benzodiazepines	--	--	--
Opioids^1,3	0.0186	0.0096	0.4007
Central Nervous System Stimulants	0.3072	0.0704	0.3449
Illicit Drugs Other than Marijuana^1,2,4	--	--	--
TOBACCO PRODUCTS	0.0000	0.0021	0.0206
Cigarettes	0.0000	0.0005	0.1442
Daily Cigarettes	0.0000	0.0143	0.3201
Smokeless Tobacco	0.0203	0.3056	0.2996
Cigars	0.0222	0.0306	0.0067
Pipe Tobacco	0.5729	0.8900	0.3614
ALCOHOL	0.2175	0.0002	0.0892
Binge Alcohol Use	0.0004	0.0001	0.0001
Heavy Alcohol Use⁵	0.0069	0.0034	0.0007
SUBSTANCE USE
Illicit Drugs, Tobacco Products, or Alcohol¹	0.0854	0.0006	0.0948
Illicit Drugs or Alcohol¹	0.6161	0.0036	0.2308
Tobacco Products or Alcohol	0.0015	0.0000	0.0808
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates that are used in these comparisons may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.12C – Types of Illicit Drug, Tobacco Product, and Alcohol Use in Past Month: Among People Aged 12 to 17; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
ILLICIT DRUGS¹	114	90	91	95
Marijuana	103	83	83	83
Cocaine	3	2	12	5
Crack	1	<1	4	<1
Heroin	<1	<1	4	1
Hallucinogens	26	19	21	27
LSD	24	14	11	7
PCP	3	1	4	<1
Ecstasy	7	5	8	5
Inhalants²	--	--	--	35
Methamphetamine	9	1	16	22
Misuse of Prescription Psychotherapeutics	35	21	34	26
Pain Relievers	28	19	30	20
Prescription Opioids	28	18	29	19
Stimulants	21	9	10	11
Tranquilizers or Sedatives	17	10	14	13
Tranquilizers	15	10	13	11
Sedatives	9	4	6	6
Benzodiazepines	--	--	--	--
Opioids^1,3	28	18	29	19
Central Nervous System Stimulants	23	9	20	26
Illicit Drugs Other than Marijuana^1,2,4	--	--	--	56
TOBACCO PRODUCTS	74	47	44	43
Cigarettes	57	39	38	36
Daily Cigarettes	35	4	10	4
Smokeless Tobacco	31	13	16	20
Cigars	42	25	19	24
Pipe Tobacco	21	18	14	9
ALCOHOL	115	81	96	92
Binge Alcohol Use	86	57	75	58
Heavy Alcohol Use⁵	29	13	27	17
SUBSTANCE USE
Illicit Drugs, Tobacco Products, or Alcohol¹	143	110	116	117
Illicit Drugs or Alcohol¹	140	105	114	114
Tobacco Products or Alcohol	123	88	102	99
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.12D – Types of Illicit Drug, Tobacco Product, and Alcohol Use in Past Month: Among People Aged 12 to 17; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
ILLICIT DRUGS¹	0.44	0.35	0.35	0.37
Marijuana	0.39	0.32	0.32	0.32
Cocaine	0.01	0.01	0.04	0.02
Crack	<0.01	<0.01	0.02	<0.01
Heroin	<0.01	<0.01	0.02	<0.01
Hallucinogens	0.10	0.07	0.08	0.11
LSD	0.09	0.05	0.04	0.03
PCP	0.01	0.01	0.02	<0.01
Ecstasy	0.03	0.02	0.03	0.02
Inhalants²	--	--	--	0.14
Methamphetamine	0.03	0.01	0.06	0.09
Misuse of Prescription Psychotherapeutics	0.13	0.08	0.13	0.10
Pain Relievers	0.11	0.08	0.12	0.08
Prescription Opioids	0.11	0.07	0.11	0.07
Stimulants	0.08	0.03	0.04	0.04
Tranquilizers or Sedatives	0.07	0.04	0.05	0.05
Tranquilizers	0.06	0.04	0.05	0.04
Sedatives	0.03	0.02	0.02	0.02
Benzodiazepines	--	--	--	--
Opioids^1,3	0.11	0.07	0.11	0.07
Central Nervous System Stimulants	0.09	0.04	0.08	0.10
Illicit Drugs Other than Marijuana^1,2,4	--	--	--	0.22
TOBACCO PRODUCTS	0.29	0.18	0.17	0.17
Cigarettes	0.22	0.15	0.15	0.14
Daily Cigarettes	0.13	0.02	0.04	0.02
Smokeless Tobacco	0.12	0.05	0.06	0.08
Cigars	0.16	0.10	0.07	0.09
Pipe Tobacco	0.08	0.07	0.05	0.03
ALCOHOL	0.44	0.32	0.37	0.36
Binge Alcohol Use	0.33	0.22	0.29	0.22
Heavy Alcohol Use⁵	0.11	0.05	0.10	0.06
SUBSTANCE USE
Illicit Drugs, Tobacco Products, or Alcohol¹	0.55	0.43	0.45	0.45
Illicit Drugs or Alcohol¹	0.54	0.41	0.44	0.44
Tobacco Products or Alcohol	0.47	0.34	0.39	0.38
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.12P – Types of Illicit Drug, Tobacco Product, and Alcohol Use in Past Month: Among People Aged 12 to 17; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
ILLICIT DRUGS¹	0.9534	0.7045	0.5241
Marijuana	0.8355	0.3713	0.9247
Cocaine	0.1746	0.1282	0.4242
Crack	0.5054	0.5960	0.3432
Heroin	0.0819	0.3814	0.4872
Hallucinogens	0.3901	0.5211	0.7198
LSD	0.1233	0.1287	0.1868
PCP	0.2407	0.0986	0.3056
Ecstasy	0.8694	0.7901	0.2587
Inhalants²	--	--	--
Methamphetamine	0.4216	0.1469	0.8273
Misuse of Prescription Psychotherapeutics	0.2648	0.6133	0.4904
Pain Relievers	0.5707	0.8701	0.4143
Prescription Opioids	0.4775	0.9018	0.5385
Stimulants	0.0429	0.9965	0.9028
Tranquilizers or Sedatives	0.4994	0.9690	0.7264
Tranquilizers	0.6833	0.6583	0.5782
Sedatives	0.3736	0.6255	0.7117
Benzodiazepines	--	--	--
Opioids^1,3	0.4921	0.8916	0.4847
Central Nervous System Stimulants	0.5594	0.1466	0.8006
Illicit Drugs Other than Marijuana^1,2,4	--	--	--
TOBACCO PRODUCTS	0.0030	0.7195	0.9319
Cigarettes	0.1025	0.9764	0.6417
Daily Cigarettes	0.0983	0.7242	0.4838
Smokeless Tobacco	0.2966	0.0140	0.0901
Cigars	0.2068	0.3172	0.4478
Pipe Tobacco	0.0667	0.1768	0.4009
ALCOHOL	0.2881	0.7290	0.5664
Binge Alcohol Use	0.1869	0.4835	0.2223
Heavy Alcohol Use⁵	0.8703	0.1037	0.1739
SUBSTANCE USE
Illicit Drugs, Tobacco Products, or Alcohol¹	0.4442	0.7890	0.9678
Illicit Drugs or Alcohol¹	0.5454	0.7820	0.8485
Tobacco Products or Alcohol	0.0612	0.6609	0.3741
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates that are used in these comparisons may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.13C – Types of Illicit Drug, Tobacco Product, and Alcohol Use in Past Month: Among People Aged 18 or Older; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
ILLICIT DRUGS¹	840	851	813	832
Marijuana	813	786	774	781
Cocaine	168	182	170	152
Crack	99	99	104	93
Heroin	103	104	65	67
Hallucinogens	197	171	152	177
LSD	90	61	43	58
PCP	72	50	9	22
Ecstasy	95	58	64	69
Inhalants²	--	--	--	88
Methamphetamine	199	177	168	149
Misuse of Prescription Psychotherapeutics	248	254	237	253
Pain Relievers	205	184	173	186
Prescription Opioids	200	176	168	181
Stimulants	109	122	111	117
Tranquilizers or Sedatives	147	137	123	145
Tranquilizers	138	126	110	131
Sedatives	55	57	72	61
Benzodiazepines	--	--	--	--
Opioids^1,3	213	199	176	190
Central Nervous System Stimulants	267	266	254	222
Illicit Drugs Other than Marijuana^1,2,4	--	--	--	368
TOBACCO PRODUCTS	1,053	972	843	842
Cigarettes	994	888	784	772
Daily Cigarettes	787	711	634	639
Smokeless Tobacco	385	304	330	307
Cigars	443	379	391	368
Pipe Tobacco	175	178	178	170
ALCOHOL	1,229	1,171	1,175	1,131
Binge Alcohol Use	945	854	839	817
Heavy Alcohol Use⁵	561	452	455	456
SUBSTANCE USE
Illicit Drugs, Tobacco Products, or Alcohol¹	1,242	1,112	1,122	1,121
Illicit Drugs or Alcohol¹	1,254	1,156	1,172	1,148
Tobacco Products or Alcohol	1,219	1,122	1,117	1,128
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.13D – Types of Illicit Drug, Tobacco Product, and Alcohol Use in Past Month: Among People Aged 18 or Older; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
ILLICIT DRUGS¹	0.33	0.33	0.32	0.32
Marijuana	0.32	0.31	0.30	0.30
Cocaine	0.07	0.07	0.07	0.06
Crack	0.04	0.04	0.04	0.04
Heroin	0.04	0.04	0.03	0.03
Hallucinogens	0.08	0.07	0.06	0.07
LSD	0.04	0.02	0.02	0.02
PCP	0.03	0.02	<0.01	0.01
Ecstasy	0.04	0.02	0.02	0.03
Inhalants²	--	--	--	0.03
Methamphetamine	0.08	0.07	0.07	0.06
Misuse of Prescription Psychotherapeutics	0.10	0.10	0.09	0.10
Pain Relievers	0.08	0.07	0.07	0.07
Prescription Opioids	0.08	0.07	0.07	0.07
Stimulants	0.04	0.05	0.04	0.04
Tranquilizers or Sedatives	0.06	0.05	0.05	0.06
Tranquilizers	0.05	0.05	0.04	0.05
Sedatives	0.02	0.02	0.03	0.02
Benzodiazepines	--	--	--	--
Opioids^1,3	0.08	0.08	0.07	0.07
Central Nervous System Stimulants	0.11	0.10	0.10	0.08
Illicit Drugs Other than Marijuana^1,2,4	--	--	--	0.14
TOBACCO PRODUCTS	0.41	0.38	0.33	0.32
Cigarettes	0.39	0.35	0.30	0.29
Daily Cigarettes	0.31	0.28	0.25	0.24
Smokeless Tobacco	0.15	0.12	0.13	0.12
Cigars	0.17	0.15	0.15	0.14
Pipe Tobacco	0.07	0.07	0.07	0.06
ALCOHOL	0.48	0.46	0.46	0.43
Binge Alcohol Use	0.37	0.33	0.33	0.31
Heavy Alcohol Use⁵	0.22	0.18	0.18	0.17
SUBSTANCE USE
Illicit Drugs, Tobacco Products, or Alcohol¹	0.49	0.43	0.44	0.43
Illicit Drugs or Alcohol¹	0.49	0.45	0.45	0.44
Tobacco Products or Alcohol	0.48	0.44	0.43	0.43
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.13P – Types of Illicit Drug, Tobacco Product, and Alcohol Use in Past Month: Among People Aged 18 or Older; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
ILLICIT DRUGS¹	0.0000	0.6710	0.7476
Marijuana	0.0000	0.3255	0.8908
Cocaine	0.2879	0.0973	0.4499
Crack	0.3032	0.1344	0.3883
Heroin	0.0063	0.0002	0.2035
Hallucinogens	0.1656	0.1055	0.7158
LSD	0.0089	0.0816	0.5518
PCP	0.4393	0.4383	0.2368
Ecstasy	0.4445	0.1422	0.5170
Inhalants²	--	--	--
Methamphetamine	0.2529	0.1419	0.3486
Misuse of Prescription Psychotherapeutics	0.7915	0.2157	0.6711
Pain Relievers	0.1830	0.1427	0.7956
Prescription Opioids	0.1150	0.1484	0.7149
Stimulants	0.4281	0.4103	0.7411
Tranquilizers or Sedatives	0.5972	0.6864	0.2409
Tranquilizers	0.6598	0.7229	0.2601
Sedatives	0.7059	0.6847	0.7323
Benzodiazepines	--	--	--
Opioids^1,3	0.0217	0.0088	0.4545
Central Nervous System Stimulants	0.3206	0.0533	0.3273
Illicit Drugs Other than Marijuana^1,2,4	--	--	--
TOBACCO PRODUCTS	0.0000	0.0017	0.0172
Cigarettes	0.0000	0.0004	0.1362
Daily Cigarettes	0.0000	0.0127	0.3042
Smokeless Tobacco	0.0220	0.3782	0.2455
Cigars	0.0250	0.0329	0.0054
Pipe Tobacco	0.6824	0.9703	0.3843
ALCOHOL	0.1703	0.0001	0.0732
Binge Alcohol Use	0.0003	0.0001	0.0001
Heavy Alcohol Use⁵	0.0057	0.0025	0.0007
SUBSTANCE USE
Illicit Drugs, Tobacco Products, or Alcohol¹	0.0534	0.0003	0.0655
Illicit Drugs or Alcohol¹	0.7191	0.0020	0.1710
Tobacco Products or Alcohol	0.0009	0.0000	0.0679
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates that are used in these comparisons may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.14C – Types of Illicit Drug, Tobacco Product, and Alcohol Use in Past Month: Among People Aged 18 to 25; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
ILLICIT DRUGS¹	240	223	200	198
Marijuana	236	223	198	196
Cocaine	54	52	30	33
Crack	17	5	3	6
Heroin	14	5	6	5
Hallucinogens	59	52	55	50
LSD	36	24	16	15
PCP	15	2	<1	6
Ecstasy	37	21	22	23
Inhalants²	--	--	--	33
Methamphetamine	33	13	14	19
Misuse of Prescription Psychotherapeutics	59	62	59	56
Pain Relievers	37	29	28	40
Prescription Opioids	36	29	28	38
Stimulants	43	49	48	31
Tranquilizers or Sedatives	25	31	24	32
Tranquilizers	23	29	23	30
Sedatives	13	13	8	12
Benzodiazepines	--	--	--	--
Opioids^1,3	36	29	28	38
Central Nervous System Stimulants	71	72	60	46
Illicit Drugs Other than Marijuana^1,2,4	--	--	--	76
TOBACCO PRODUCTS	186	167	162	155
Cigarettes	158	145	133	131
Daily Cigarettes	82	76	70	57
Smokeless Tobacco	75	66	71	70
Cigars	112	108	97	93
Pipe Tobacco	50	46	49	42
ALCOHOL	270	264	262	251
Binge Alcohol Use	253	219	218	219
Heavy Alcohol Use⁵	130	130	118	98
SUBSTANCE USE
Illicit Drugs, Tobacco Products, or Alcohol¹	267	249	248	242
Illicit Drugs or Alcohol¹	270	249	254	240
Tobacco Products or Alcohol	264	261	255	250
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.14D – Types of Illicit Drug, Tobacco Product, and Alcohol Use in Past Month: Among People Aged 18 to 25; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
ILLICIT DRUGS¹	0.72	0.64	0.59	0.57
Marijuana	0.71	0.64	0.58	0.56
Cocaine	0.16	0.15	0.09	0.09
Crack	0.05	0.02	0.01	0.02
Heroin	0.04	0.02	0.02	0.01
Hallucinogens	0.17	0.15	0.16	0.14
LSD	0.11	0.07	0.05	0.04
PCP	0.04	<0.01	<0.01	0.02
Ecstasy	0.11	0.06	0.06	0.07
Inhalants²	--	--	--	0.10
Methamphetamine	0.10	0.04	0.04	0.06
Misuse of Prescription Psychotherapeutics	0.18	0.18	0.17	0.16
Pain Relievers	0.11	0.08	0.08	0.12
Prescription Opioids	0.11	0.08	0.08	0.11
Stimulants	0.13	0.14	0.14	0.09
Tranquilizers or Sedatives	0.07	0.09	0.07	0.09
Tranquilizers	0.07	0.08	0.07	0.09
Sedatives	0.04	0.04	0.02	0.03
Benzodiazepines	--	--	--	--
Opioids^1,3	0.11	0.08	0.08	0.11
Central Nervous System Stimulants	0.21	0.21	0.18	0.13
Illicit Drugs Other than Marijuana^1,2,4	--	--	--	0.22
TOBACCO PRODUCTS	0.56	0.48	0.47	0.44
Cigarettes	0.47	0.42	0.39	0.37
Daily Cigarettes	0.24	0.22	0.21	0.16
Smokeless Tobacco	0.22	0.19	0.21	0.20
Cigars	0.34	0.31	0.28	0.27
Pipe Tobacco	0.15	0.13	0.14	0.12
ALCOHOL	0.81	0.76	0.77	0.72
Binge Alcohol Use	0.76	0.63	0.64	0.63
Heavy Alcohol Use⁵	0.39	0.37	0.35	0.28
SUBSTANCE USE
Illicit Drugs, Tobacco Products, or Alcohol¹	0.80	0.71	0.73	0.69
Illicit Drugs or Alcohol¹	0.81	0.72	0.75	0.69
Tobacco Products or Alcohol	0.79	0.75	0.75	0.72
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.14P – Types of Illicit Drug, Tobacco Product, and Alcohol Use in Past Month: Among People Aged 18 to 25; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
ILLICIT DRUGS¹	0.6274	0.0347	0.3685
Marijuana	0.5858	0.0385	0.2109
Cocaine	0.0134	0.0027	0.9302
Crack	0.2987	0.9951	0.1967
Heroin	0.3700	0.7185	0.8773
Hallucinogens	0.2801	0.3421	0.0970
LSD	0.0007	0.0205	0.6139
PCP	0.3573	0.3518	0.1458
Ecstasy	0.0416	0.8771	0.9495
Inhalants²	--	--	--
Methamphetamine	0.4256	0.3853	0.2774
Misuse of Prescription Psychotherapeutics	0.1503	0.0808	0.4822
Pain Relievers	0.9934	0.5948	0.1762
Prescription Opioids	0.8442	0.9038	0.3989
Stimulants	0.0462	0.0036	0.0733
Tranquilizers or Sedatives	0.9456	0.6189	0.9516
Tranquilizers	0.8167	0.4955	0.8005
Sedatives	0.9322	0.8944	0.4511
Benzodiazepines	--	--	--
Opioids^1,3	0.8475	0.8993	0.3751
Central Nervous System Stimulants	0.0076	0.0003	0.2296
Illicit Drugs Other than Marijuana^1,24	--	--	--
TOBACCO PRODUCTS	0.0000	0.1309	0.0297
Cigarettes	0.0002	0.0452	0.0596
Daily Cigarettes	0.0000	0.0003	0.0013
Smokeless Tobacco	0.2507	0.0003	0.0482
Cigars	0.0852	0.2971	0.2255
Pipe Tobacco	0.2929	0.3009	0.2577
ALCOHOL	0.0012	0.0062	0.0397
Binge Alcohol Use	0.0010	0.0021	0.0242
Heavy Alcohol Use⁵	0.0263	0.0010	0.0363
SUBSTANCE USE
Illicit Drugs, Tobacco Products, or Alcohol¹	0.0011	0.0206	0.0106
Illicit Drugs or Alcohol¹	0.0023	0.0114	0.0199
Tobacco Products or Alcohol	0.0001	0.0044	0.0099
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates that are used in these comparisons may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.15C – Types of Illicit Drug, Tobacco Product, and Alcohol Use in Past Month: Among People Aged 26 or Older; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
ILLICIT DRUGS¹	769	784	750	791
Marijuana	740	719	714	742
Cocaine	158	173	167	147
Crack	98	97	104	93
Heroin	102	103	65	67
Hallucinogens	186	162	143	168
LSD	82	56	40	56
PCP	71	50	9	21
Ecstasy	88	54	60	64
Inhalants²	--	--	--	88
Methamphetamine	196	176	167	147
Misuse of Prescription Psychotherapeutics	245	240	220	245
Pain Relievers	203	182	170	182
Prescription Opioids	198	174	165	178
Stimulants	98	110	95	111
Tranquilizers or Sedatives	144	132	119	142
Tranquilizers	136	122	107	128
Sedatives	53	56	71	60
Benzodiazepines	--	--	--	--
Opioids^1,3	211	197	173	186
Central Nervous System Stimulants	258	255	244	215
Illicit Drugs Other than Marijuana^1,2,4	--	--	--	357
TOBACCO PRODUCTS	1,018	943	823	814
Cigarettes	958	864	777	751
Daily Cigarettes	763	704	627	631
Smokeless Tobacco	375	293	324	294
Cigars	416	360	377	348
Pipe Tobacco	175	170	170	166
ALCOHOL	1,167	1,119	1,127	1,097
Binge Alcohol Use	891	804	809	794
Heavy Alcohol Use⁵	534	430	438	443
SUBSTANCE USE
Illicit Drugs, Tobacco Products, or Alcohol¹	1,187	1,077	1,069	1,080
Illicit Drugs or Alcohol¹	1,191	1,108	1,117	1,115
Tobacco Products or Alcohol	1,167	1,084	1,071	1,083
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.15D – Types of Illicit Drug, Tobacco Product, and Alcohol Use in Past Month: Among People Aged 26 or Older; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
ILLICIT DRUGS¹	0.35	0.35	0.34	0.35
Marijuana	0.34	0.32	0.32	0.33
Cocaine	0.07	0.08	0.07	0.06
Crack	0.04	0.04	0.05	0.04
Heroin	0.05	0.05	0.03	0.03
Hallucinogens	0.08	0.07	0.06	0.07
LSD	0.04	0.03	0.02	0.02
PCP	0.03	0.02	<0.01	0.01
Ecstasy	0.04	0.02	0.03	0.03
Inhalants²	--	--	--	0.04
Methamphetamine	0.09	0.08	0.07	0.06
Misuse of Prescription Psychotherapeutics	0.11	0.11	0.10	0.11
Pain Relievers	0.09	0.08	0.08	0.08
Prescription Opioids	0.09	0.08	0.07	0.08
Stimulants	0.04	0.05	0.04	0.05
Tranquilizers or Sedatives	0.07	0.06	0.05	0.06
Tranquilizers	0.06	0.06	0.05	0.06
Sedatives	0.02	0.03	0.03	0.03
Benzodiazepines	--	--	--	--
Opioids^1,3	0.10	0.09	0.08	0.08
Central Nervous System Stimulants	0.12	0.12	0.11	0.09
Illicit Drugs Other than Marijuana^1,2,4	--	--	--	0.16
TOBACCO PRODUCTS	0.46	0.43	0.37	0.36
Cigarettes	0.43	0.39	0.35	0.33
Daily Cigarettes	0.35	0.32	0.28	0.28
Smokeless Tobacco	0.17	0.13	0.15	0.13
Cigars	0.19	0.16	0.17	0.15
Pipe Tobacco	0.08	0.08	0.08	0.07
ALCOHOL	0.53	0.51	0.50	0.48
Binge Alcohol Use	0.40	0.36	0.36	0.35
Heavy Alcohol Use⁵	0.24	0.19	0.20	0.20
SUBSTANCE USE
Illicit Drugs, Tobacco Products, or Alcohol¹	0.54	0.49	0.48	0.48
Illicit Drugs or Alcohol¹	0.54	0.50	0.50	0.49
Tobacco Products or Alcohol	0.53	0.49	0.48	0.48
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.15P – Types of Illicit Drug, Tobacco Product, and Alcohol Use in Past Month: Among People Aged 26 or Older; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
ILLICIT DRUGS¹	0.0000	0.2782	0.8987
Marijuana	0.0000	0.0872	0.8621
Cocaine	0.6895	0.3578	0.4512
Crack	0.3643	0.1285	0.3576
Heroin	0.0082	0.0002	0.1979
Hallucinogens	0.0704	0.0450	0.3463
LSD	0.1266	0.3094	0.6415
PCP	0.5500	0.3802	0.3861
Ecstasy	0.9907	0.1042	0.4794
Inhalants²	--	--	--
Methamphetamine	0.3043	0.1108	0.2891
Misuse of Prescription Psychotherapeutics	0.9368	0.3799	0.5307
Pain Relievers	0.1763	0.1105	0.5971
Prescription Opioids	0.1185	0.1346	0.5926
Stimulants	0.1068	0.8371	0.2855
Tranquilizers or Sedatives	0.5769	0.7549	0.2176
Tranquilizers	0.6164	0.8250	0.2157
Sedatives	0.7136	0.6564	0.6412
Benzodiazepines	--	--	--
Opioids^1,3	0.0213	0.0072	0.3537
Central Nervous System Stimulants	0.7347	0.2751	0.4721
Illicit Drugs Other than Marijuana^1,2,4	--	--	--
TOBACCO PRODUCTS	0.0000	0.0027	0.0434
Cigarettes	0.0000	0.0008	0.2449
Daily Cigarettes	0.0000	0.0272	0.4920
Smokeless Tobacco	0.0100	0.9262	0.0984
Cigars	0.0600	0.0497	0.0089
Pipe Tobacco	0.8903	0.8077	0.5524
ALCOHOL	0.4799	0.0008	0.1691
Binge Alcohol Use	0.0041	0.0010	0.0007
Heavy Alcohol Use⁵	0.0189	0.0227	0.0033
SUBSTANCE USE
Illicit Drugs, Tobacco Products, or Alcohol¹	0.2036	0.0012	0.1839
Illicit Drugs or Alcohol¹	0.2868	0.0085	0.3735
Tobacco Products or Alcohol	0.0108	0.0002	0.1954
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates that are used in these comparisons may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.16C – Alcohol Use in Lifetime, Past Year, and Past Month: Among People Aged 12 to 20; by Sex, Standard Errors of Numbers in Thousands, 2021-2024
Sex/Alcohol Use	2021	2022	2023	2024
TOTAL
Lifetime	413	350	347	310
Past Year	366	302	321	282
Past Month	246	204	219	190
Binge Alcohol Use	181	152	162	136
Heavy Alcohol Use¹	71	70	65	56
MALE
Lifetime	252	213	210	209
Past Year	233	193	193	190
Past Month	171	134	140	124
Binge Alcohol Use	117	99	103	89
Heavy Alcohol Use¹	55	52	45	39
FEMALE
Lifetime	272	218	211	196
Past Year	234	186	197	180
Past Month	170	137	140	123
Binge Alcohol Use	126	102	103	91
Heavy Alcohol Use¹	39	41	46	35
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Tables among people aged 12-20 and aged 21+ are included because they are the underage and legal age groups for alcohol. ¹ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.16D – Alcohol Use in Lifetime, Past Year, and Past Month: Among People Aged 12 to 20; by Sex, Standard Errors of Percentages, 2021-2024
Sex/Alcohol Use	2021	2022	2023	2024
TOTAL
Lifetime	0.66	0.60	0.63	0.59
Past Year	0.61	0.55	0.62	0.57
Past Month	0.50	0.45	0.49	0.44
Binge Alcohol Use	0.40	0.36	0.38	0.33
Heavy Alcohol Use¹	0.17	0.18	0.17	0.14
MALE
Lifetime	0.87	0.78	0.78	0.80
Past Year	0.86	0.74	0.76	0.76
Past Month	0.72	0.61	0.63	0.57
Binge Alcohol Use	0.52	0.47	0.49	0.42
Heavy Alcohol Use¹	0.26	0.26	0.23	0.19
FEMALE
Lifetime	0.98	0.82	0.85	0.80
Past Year	0.87	0.74	0.83	0.77
Past Month	0.75	0.63	0.66	0.60
Binge Alcohol Use	0.60	0.51	0.51	0.46
Heavy Alcohol Use¹	0.20	0.22	0.24	0.19
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Tables among people aged 12-20 and aged 21+ are included because they are the underage and legal age groups for alcohol. ¹ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.16P – Alcohol Use in Lifetime, Past Year, and Past Month: Among People Aged 12 to 20; by Sex, P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Sex/Alcohol Use	2021	2022	2023
TOTAL
Lifetime	0.0037	0.1109	0.7414
Past Year	0.0053	0.1109	0.3049
Past Month	0.0005	0.0070	0.0413
Binge Alcohol Use	0.0478	0.3037	0.0449
Heavy Alcohol Use¹	0.7230	0.4484	0.2630
MALE
Lifetime	0.2310	0.4140	0.8221
Past Year	0.2152	0.3292	0.7762
Past Month	0.0179	0.0990	0.1069
Binge Alcohol Use	0.3460	0.4682	0.0942
Heavy Alcohol Use¹	0.8481	0.4224	0.9535
FEMALE
Lifetime	0.0023	0.1048	0.4535
Past Year	0.0042	0.1530	0.2005
Past Month	0.0095	0.0139	0.1450
Binge Alcohol Use	0.0568	0.3947	0.1713
Heavy Alcohol Use¹	0.7169	0.7782	0.1048
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Tables among people aged 12-20 and aged 21+ are included because they are the underage and legal age groups for alcohol. ¹ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.17C – Alcohol Use in Lifetime, Past Year, and Past Month: Among People Aged 21 or Older; by Sex, Standard Errors of Numbers in Thousands, 2021-2024
Sex/Alcohol Use	2021	2022	2023	2024
TOTAL
Lifetime	3,404	3,095	3,041	3,085
Past Year	2,822	2,590	2,482	2,561
Past Month	2,273	2,212	2,055	2,079
Binge Alcohol Use	1,339	1,203	1,089	1,091
Heavy Alcohol Use¹	608	506	476	487
MALE
Lifetime	2,025	1,897	1,784	1,833
Past Year	1,703	1,639	1,479	1,534
Past Month	1,411	1,430	1,281	1,309
Binge Alcohol Use	900	883	771	762
Heavy Alcohol Use¹	453	433	389	379
FEMALE
Lifetime	1,940	1,740	1,703	1,705
Past Year	1,630	1,447	1,390	1,449
Past Month	1,320	1,231	1,143	1,164
Binge Alcohol Use	775	640	632	601
Heavy Alcohol Use¹	348	257	271	272
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Tables among people aged 12-20 and aged 21+ are included because they are the underage and legal age groups for alcohol. ¹ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.17D – Alcohol Use in Lifetime, Past Year, and Past Month: Among People Aged 21 or Older; by Sex, Standard Errors of Percentages, 2021-2024
Sex/Alcohol Use	2021	2022	2023	2024
TOTAL
Lifetime	0.36	0.34	0.32	0.32
Past Year	0.49	0.45	0.45	0.43
Past Month	0.50	0.47	0.47	0.45
Binge Alcohol Use	0.39	0.34	0.34	0.33
Heavy Alcohol Use¹	0.23	0.18	0.18	0.18
MALE
Lifetime	0.44	0.42	0.42	0.40
Past Year	0.68	0.60	0.58	0.60
Past Month	0.67	0.62	0.62	0.64
Binge Alcohol Use	0.59	0.55	0.51	0.50
Heavy Alcohol Use¹	0.36	0.32	0.31	0.30
FEMALE
Lifetime	0.50	0.48	0.44	0.44
Past Year	0.63	0.59	0.59	0.55
Past Month	0.67	0.61	0.61	0.56
Binge Alcohol Use	0.49	0.41	0.42	0.39
Heavy Alcohol Use¹	0.26	0.20	0.21	0.20
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Tables among people aged 12-20 and aged 21+ are included because they are the underage and legal age groups for alcohol. ¹ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.17P – Alcohol Use in Lifetime, Past Year, and Past Month: Among People Aged 21 or Older; by Sex, P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Sex/Alcohol Use	2021	2022	2023
TOTAL
Lifetime	0.1197	0.0586	0.7684
Past Year	0.7297	0.1689	0.3561
Past Month	0.2603	0.0003	0.1425
Binge Alcohol Use	0.0005	0.0001	0.0003
Heavy Alcohol Use¹	0.0049	0.0034	0.0010
MALE
Lifetime	0.5958	0.1029	0.4346
Past Year	0.1596	0.0138	0.0672
Past Month	0.2379	0.0017	0.2043
Binge Alcohol Use	0.1239	0.0135	0.0257
Heavy Alcohol Use¹	0.0574	0.0088	0.0540
FEMALE
Lifetime	0.0813	0.2208	0.7671
Past Year	0.3645	0.7009	0.6469
Past Month	0.6071	0.0183	0.3703
Binge Alcohol Use	0.0002	0.0009	0.0015
Heavy Alcohol Use¹	0.0202	0.1482	0.0042
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Tables among people aged 12-20 and aged 21+ are included because they are the underage and legal age groups for alcohol. ¹ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.18D – Average Number of Days Used Specific Substances in Past Year: Among Past Year Users of Specific Substances Aged 12 or Older; Standard Errors of Averages, 2021-2024
Substance	2021	2022	2023	2024
Marijuana	2.30	2.12	2.05	2.06
Cocaine	5.28	3.87	4.43	4.12
Crack	16.37	11.35	12.48	14.45
Heroin	15.74	12.78	18.13	22.52
Hallucinogens	1.70	1.21	1.47	1.19
Inhalants¹	--	--	--	3.00
Methamphetamine	12.12	10.42	10.28	11.32
Alcohol	1.11	1.01	0.96	1.02
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.18P – Average Number of Days Used Specific Substances in Past Year: Among Past Year Users of Specific Substances Aged 12 or Older; P Values from Tests of Differences of Averages, 2024 Versus 2021-2023
Substance	2021	2022	2023
Marijuana	0.2851	0.0449	0.2664
Cocaine	0.2610	0.8153	0.5841
Crack	0.4290	0.5575	0.9902
Heroin	0.6053	0.9566	0.0906
Hallucinogens	0.6176	0.6494	0.4174
Inhalants¹	--	--	--
Methamphetamine	0.5236	0.3341	0.7747
Alcohol	0.0000	0.0001	0.0650
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.19D – Average Number of Days Used Specific Substances in Past Month: Among Past Month Users of Specific Substances Aged 12 or Older; Standard Errors of Averages, 2021-2024
Substance	2021	2022	2023	2024
Marijuana	0.24	0.20	0.20	0.20
Cocaine	0.85	0.68	0.77	0.79
Crack	1.90	1.82	2.11	2.11
Heroin	2.18	1.44	2.04	1.41
Hallucinogens	0.36	0.23	0.31	0.27
Inhalants¹	--	--	--	0.57
Methamphetamine	1.35	1.09	1.04	0.91
Misuse of Prescription Pain Relievers	0.77	0.55	0.87	0.84
Misuse of Prescription Stimulants	0.48	0.56	0.46	0.59
Misuse of Prescription Tranquilizers	1.15	0.73	0.66	1.13
Misuse of Prescription Sedatives	2.56	2.33	2.25	1.31
Cigarettes	0.22	0.24	0.22	0.23
Smokeless Tobacco	0.56	0.61	0.54	0.53
Cigars	0.44	0.38	0.45	0.39
Alcohol	0.11	0.10	0.09	0.10
Binge Alcohol Use	0.12	0.09	0.09	0.11
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.19P – Average Number of Days Used Specific Substances in Past Month: Among Past Month Users of Specific Substances Aged 12 or Older; P Values from Tests of Differences of Averages, 2024 Versus 2021-2023
Substance	2021	2022	2023
Marijuana	0.1743	0.2292	0.2482
Cocaine	0.9507	0.3734	0.6765
Crack	0.8691	0.6757	0.7364
Heroin	0.0318	0.2054	0.0183
Hallucinogens	0.8096	0.6091	0.9900
Inhalants¹	--	--	--
Methamphetamine	0.3877	0.5308	0.5302
Misuse of Prescription Pain Relievers	0.3381	0.3413	0.6605
Misuse of Prescription Stimulants	0.7609	0.8566	0.2548
Misuse of Prescription Tranquilizers	0.6297	0.2180	0.3727
Misuse of Prescription Sedatives	0.4210	0.2996	0.8776
Cigarettes	0.0024	0.8265	0.9721
Smokeless Tobacco	0.5633	0.7774	0.2622
Cigars	0.9177	0.5643	0.0229
Alcohol	0.0000	0.0538	0.0031
Binge Alcohol Use	0.3731	0.2307	0.8486
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.20C – Daily or Almost Daily Use of Specific Substances in Past Year: Among People Aged 12 or Older and among Past Year Users of Specific Substances Aged 12 or Older; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
DAILY/ALMOST DAILY USE IN PAST YEAR AMONG TOTAL POPULATION
Marijuana	452	466	466	489
Cocaine	71	34	41	25
Crack	55	19	20	22
Heroin	59	53	41	47
Hallucinogens	17	12	25	19
Inhalants¹	--	--	--	24
Methamphetamine	121	91	118	105
Alcohol	477	456	445	498
DAILY/ALMOST DAILY USE IN PAST YEAR AMONG PAST YEAR USERS
Marijuana	495	510	507	543
Cocaine	71	34	41	25
Crack	*	19	20	22
Heroin	59	53	41	47
Hallucinogens	17	12	25	19
Inhalants¹	--	--	--	24
Methamphetamine	121	92	119	105
Alcohol	499	487	462	512
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.20D – Daily or Almost Daily Use of Specific Substances in Past Year: Among People Aged 12 or Older and among Past Year Users of Specific Substances Aged 12 or Older; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
DAILY/ALMOST DAILY USE IN PAST YEAR AMONG TOTAL POPULATION
Marijuana	0.16	0.17	0.16	0.17
Cocaine	0.03	0.01	0.01	0.01
Crack	0.02	0.01	0.01	0.01
Heroin	0.02	0.02	0.01	0.02
Hallucinogens	0.01	<0.01	0.01	0.01
Inhalants¹	--	--	--	0.01
Methamphetamine	0.04	0.03	0.04	0.04
Alcohol	0.17	0.16	0.16	0.17
DAILY/ALMOST DAILY USE IN PAST YEAR AMONG PAST YEAR USERS
Marijuana	0.69	0.64	0.63	0.63
Cocaine	1.43	0.64	0.81	0.59
Crack	*	2.10	2.01	2.91
Heroin	5.37	4.56	5.65	6.30
Hallucinogens	0.22	0.14	0.28	0.18
Inhalants¹	--	--	--	0.74
Methamphetamine	3.98	3.21	3.80	3.74
Alcohol	0.27	0.25	0.25	0.28
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.20P – Daily or Almost Daily Use of Specific Substances in Past Year: Among People Aged 12 or Older and among Past Year Users of Specific Substances Aged 12 or Older; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
DAILY/ALMOST DAILY USE IN PAST YEAR AMONG TOTAL POPULATION
Marijuana	0.0000	0.0242	0.1668
Cocaine	0.0385	0.5187	0.5647
Crack	0.1725	0.9035	0.8351
Heroin	0.3252	0.1252	0.8808
Hallucinogens	0.8699	0.5210	0.9745
Inhalants¹	--	--	--
Methamphetamine	0.9575	0.8795	0.8151
Alcohol	0.0687	0.2639	0.5316
DAILY/ALMOST DAILY USE IN PAST YEAR AMONG PAST YEAR USERS
Marijuana	0.1473	0.0238	0.2988
Cocaine	0.0538	0.9418	0.8380
Crack	*	0.7371	0.4550
Heroin	0.3369	0.5921	0.4283
Hallucinogens	0.7169	0.8152	0.8393
Inhalants¹	--	--	--
Methamphetamine	0.4986	0.3712	0.7907
Alcohol	0.0787	0.3536	0.6272
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.21C – Daily or Almost Daily Use of Specific Substances in Past Year: Among People Aged 12 to 17 and among Past Year Users of Specific Substances Aged 12 to 17; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
DAILY/ALMOST DAILY USE IN PAST YEAR AMONG TOTAL POPULATION
Marijuana	45	34	34	34
Cocaine	3	1	7	*
Crack	*	*	*	*
Heroin	*	*	*	*
Hallucinogens	6	6	2	1
Inhalants¹	--	--	--	4
Methamphetamine	2	1	*	<1
Alcohol	3	5	7	3
DAILY/ALMOST DAILY USE IN PAST YEAR AMONG PAST YEAR USERS
Marijuana	46	34	35	35
Cocaine	*	*	*	*
Crack	*	*	*	*
Heroin	*	*	*	*
Hallucinogens	*	*	2	1
Inhalants¹	--	--	--	4
Methamphetamine	*	*	*	*
Alcohol	3	5	7	3
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.21D – Daily or Almost Daily Use of Specific Substances in Past Year: Among People Aged 12 to 17 and among Past Year Users of Specific Substances Aged 12 to 17; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
DAILY/ALMOST DAILY USE IN PAST YEAR AMONG TOTAL POPULATION
Marijuana	0.17	0.13	0.13	0.13
Cocaine	0.01	<0.01	0.03	*
Crack	*	*	*	*
Heroin	*	*	*	*
Hallucinogens	0.02	0.02	0.01	<0.01
Inhalants¹	--	--	--	0.01
Methamphetamine	0.01	<0.01	*	<0.01
Alcohol	0.01	0.02	0.03	0.01
DAILY/ALMOST DAILY USE IN PAST YEAR AMONG PAST YEAR USERS
Marijuana	1.49	1.09	1.14	1.19
Cocaine	*	*	*	*
Crack	*	*	*	*
Heroin	*	*	*	*
Hallucinogens	*	*	0.50	0.27
Inhalants¹	--	--	--	0.37
Methamphetamine	*	*	*	*
Alcohol	0.07	0.11	0.16	0.07
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.21P – Daily or Almost Daily Use of Specific Substances in Past Year: Among People Aged 12 to 17 and among Past Year Users of Specific Substances Aged 12 to 17; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
DAILY/ALMOST DAILY USE IN PAST YEAR AMONG TOTAL POPULATION
Marijuana	0.3862	0.4142	0.3033
Cocaine	*	*	*
Crack	*	*	*
Heroin	*	*	*
Hallucinogens	0.2695	0.4068	0.5034
Inhalants¹	--	--	--
Methamphetamine	0.2648	0.2288	*
Alcohol	0.0812	0.1645	0.4261
DAILY/ALMOST DAILY USE IN PAST YEAR AMONG PAST YEAR USERS
Marijuana	0.2251	0.1274	0.1169
Cocaine	*	*	*
Crack	*	*	*
Heroin	*	*	*
Hallucinogens	*	*	0.4836
Inhalants¹	--	--	--
Methamphetamine	*	*	*
Alcohol	0.1305	0.1741	0.4427
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.22C – Daily or Almost Daily Use of Specific Substances in Past Year: Among People Aged 18 or Older and among Past Year Users of Specific Substances Aged 18 or Older; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
DAILY/ALMOST DAILY USE IN PAST YEAR AMONG TOTAL POPULATION
Marijuana	447	463	466	487
Cocaine	71	34	41	26
Crack	55	19	20	22
Heroin	59	53	41	47
Hallucinogens	16	11	25	19
Inhalants¹	--	--	--	23
Methamphetamine	121	92	118	105
Alcohol	476	455	444	498
DAILY/ALMOST DAILY USE IN PAST YEAR AMONG PAST YEAR USERS
Marijuana	490	506	503	541
Cocaine	71	34	41	25
Crack	*	19	20	22
Heroin	59	53	41	*
Hallucinogens	16	11	25	19
Inhalants¹	--	--	--	23
Methamphetamine	121	92	119	105
Alcohol	499	486	462	512
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.22D – Daily or Almost Daily Use of Specific Substances in Past Year: Among People Aged 18 or Older and among Past Year Users of Specific Substances Aged 18 or Older; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
DAILY/ALMOST DAILY USE IN PAST YEAR AMONG TOTAL POPULATION
Marijuana	0.18	0.18	0.18	0.19
Cocaine	0.03	0.01	0.02	0.01
Crack	0.02	0.01	0.01	0.01
Heroin	0.02	0.02	0.02	0.02
Hallucinogens	0.01	<0.01	0.01	0.01
Inhalants¹	--	--	--	0.01
Methamphetamine	0.05	0.04	0.05	0.04
Alcohol	0.19	0.18	0.17	0.19
DAILY/ALMOST DAILY USE IN PAST YEAR AMONG PAST YEAR USERS
Marijuana	0.72	0.67	0.66	0.66
Cocaine	1.44	0.64	0.81	0.60
Crack	*	2.10	2.02	2.95
Heroin	5.37	4.57	5.68	*
Hallucinogens	0.22	0.13	0.29	0.19
Inhalants¹	--	--	--	1.06
Methamphetamine	4.03	3.23	3.84	3.82
Alcohol	0.28	0.26	0.25	0.28
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.22P – Daily or Almost Daily Use of Specific Substances in Past Year: Among People Aged 18 or Older and among Past Year Users of Specific Substances Aged 18 or Older; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
DAILY/ALMOST DAILY USE IN PAST YEAR AMONG TOTAL POPULATION
Marijuana	0.0000	0.0289	0.1999
Cocaine	0.0430	0.5316	0.6656
Crack	0.1715	0.9014	0.8374
Heroin	0.3211	0.1241	0.8838
Hallucinogens	0.6675	0.3464	0.9334
Inhalants¹	--	--	--
Methamphetamine	0.9563	0.8764	0.8088
Alcohol	0.0623	0.2585	0.5202
DAILY/ALMOST DAILY USE IN PAST YEAR AMONG PAST YEAR USERS
Marijuana	0.2512	0.0394	0.4111
Cocaine	0.0627	0.9769	0.9607
Crack	*	0.7233	0.4490
Heroin	*	*	*
Hallucinogens	0.9446	0.5687	0.8845
Inhalants¹	--	--	--
Methamphetamine	0.4581	0.3224	0.7592
Alcohol	0.0701	0.3545	0.6211
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.23C – Daily or Almost Daily Use of Specific Substances in Past Year: Among People Aged 18 to 25 and among Past Year Users of Specific Substances Aged 18 to 25; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
DAILY/ALMOST DAILY USE IN PAST YEAR AMONG TOTAL POPULATION
Marijuana	139	141	117	123
Cocaine	15	4	2	3
Crack	9	<1	1	3
Heroin	13	4	4	4
Hallucinogens	7	6	5	5
Inhalants¹	--	--	--	6
Methamphetamine	10	7	8	7
Alcohol	65	56	43	42
DAILY/ALMOST DAILY USE IN PAST YEAR AMONG PAST YEAR USERS
Marijuana	148	157	129	134
Cocaine	15	4	2	3
Crack	*	*	*	*
Heroin	*	*	*	*
Hallucinogens	7	6	5	5
Inhalants¹	--	--	--	6
Methamphetamine	*	*	*	*
Alcohol	65	57	44	41
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.23D – Daily or Almost Daily Use of Specific Substances in Past Year: Among People Aged 18 to 25 and among Past Year Users of Specific Substances Aged 18 to 25; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
DAILY/ALMOST DAILY USE IN PAST YEAR AMONG TOTAL POPULATION
Marijuana	0.42	0.40	0.34	0.35
Cocaine	0.04	0.01	<0.01	0.01
Crack	0.03	<0.01	<0.01	0.01
Heroin	0.04	0.01	0.01	0.01
Hallucinogens	0.02	0.02	0.02	0.02
Inhalants¹	--	--	--	0.02
Methamphetamine	0.03	0.02	0.02	0.02
Alcohol	0.19	0.16	0.13	0.12
DAILY/ALMOST DAILY USE IN PAST YEAR AMONG PAST YEAR USERS
Marijuana	1.03	0.92	0.85	0.93
Cocaine	1.18	0.28	0.15	0.42
Crack	*	*	*	*
Heroin	*	*	*	*
Hallucinogens	0.27	0.22	0.24	0.22
Inhalants¹	--	--	--	0.82
Methamphetamine	*	*	*	*
Alcohol	0.28	0.24	0.19	0.18
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.23P – Daily or Almost Daily Use of Specific Substances in Past Year: Among People Aged 18 to 25 and among Past Year Users of Specific Substances Aged 18 to 25; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
DAILY/ALMOST DAILY USE IN PAST YEAR AMONG TOTAL POPULATION
Marijuana	0.5250	0.0563	0.3833
Cocaine	0.2306	0.9097	0.2911
Crack	0.5458	0.1852	0.4965
Heroin	0.5754	0.4595	0.8719
Hallucinogens	0.7983	0.9753	0.8504
Inhalants¹	--	--	--
Methamphetamine	0.5627	0.8898	0.9959
Alcohol	0.0006	0.0125	0.3863
DAILY/ALMOST DAILY USE IN PAST YEAR AMONG PAST YEAR USERS
Marijuana	0.1868	0.7034	0.9418
Cocaine	0.3427	0.6199	0.2093
Crack	*	*	*
Heroin	*	*	*
Hallucinogens	0.8589	0.9283	0.8579
Inhalants¹	--	--	--
Methamphetamine	*	*	*
Alcohol	0.0010	0.0154	0.4556
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.24C – Daily or Almost Daily Use of Specific Substances in Past Year: Among People Aged 26 or Older and among Past Year Users of Specific Substances Aged 26 or Older; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
DAILY/ALMOST DAILY USE IN PAST YEAR AMONG TOTAL POPULATION
Marijuana	427	427	441	472
Cocaine	70	33	41	25
Crack	54	19	20	21
Heroin	58	52	41	47
Hallucinogens	14	9	24	18
Inhalants¹	--	--	--	23
Methamphetamine	120	91	118	105
Alcohol	472	453	440	493
DAILY/ALMOST DAILY USE IN PAST YEAR AMONG PAST YEAR USERS
Marijuana	456	461	469	518
Cocaine	70	34	41	25
Crack	*	19	20	21
Heroin	58	52	41	*
Hallucinogens	14	9	24	18
Inhalants¹	--	--	--	23
Methamphetamine	121	91	119	105
Alcohol	496	483	459	508
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.24D – Daily or Almost Daily Use of Specific Substances in Past Year: Among People Aged 26 or Older and among Past Year Users of Specific Substances Aged 26 or Older; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
DAILY/ALMOST DAILY USE IN PAST YEAR AMONG TOTAL POPULATION
Marijuana	0.19	0.19	0.20	0.21
Cocaine	0.03	0.02	0.02	0.01
Crack	0.02	0.01	0.01	0.01
Heroin	0.03	0.02	0.02	0.02
Hallucinogens	0.01	<0.01	0.01	0.01
Inhalants¹	--	--	--	0.01
Methamphetamine	0.05	0.04	0.05	0.05
Alcohol	0.21	0.20	0.20	0.22
DAILY/ALMOST DAILY USE IN PAST YEAR AMONG PAST YEAR USERS
Marijuana	0.92	0.81	0.81	0.79
Cocaine	1.91	0.85	1.02	0.74
Crack	*	2.20	2.17	3.12
Heroin	5.66	4.76	5.91	*
Hallucinogens	0.30	0.16	0.40	0.24
Inhalants¹	--	--	--	1.49
Methamphetamine	4.30	3.41	4.00	4.10
Alcohol	0.32	0.30	0.29	0.32
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.24P – Daily or Almost Daily Use of Specific Substances in Past Year: Among People Aged 26 or Older and among Past Year Users of Specific Substances Aged 26 or Older; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
DAILY/ALMOST DAILY USE IN PAST YEAR AMONG TOTAL POPULATION
Marijuana	0.0000	0.0039	0.1189
Cocaine	0.0713	0.5367	0.6071
Crack	0.1994	0.7944	0.8938
Heroin	0.3647	0.1066	0.8920
Hallucinogens	0.5829	0.3990	0.9688
Inhalants¹	--	--	--
Methamphetamine	0.9154	0.8924	0.8124
Alcohol	0.1431	0.3624	0.5793
DAILY/ALMOST DAILY USE IN PAST YEAR AMONG PAST YEAR USERS
Marijuana	0.5253	0.0256	0.3938
Cocaine	0.0746	0.8322	0.8422
Crack	*	0.8008	0.5143
Heroin	*	*	*
Hallucinogens	0.9281	0.6962	0.8245
Inhalants¹	--	--	--
Methamphetamine	0.4411	0.3147	0.6702
Alcohol	0.1480	0.4739	0.6654
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.25C – Daily or Almost Daily Use of Specific Substances in Past Year: Among People Aged 12 to 20 and among Past Year Users of Specific Substances Aged 12 to 20; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
DAILY/ALMOST DAILY USE IN PAST YEAR AMONG TOTAL POPULATION
Marijuana	90	82	90	69
Cocaine	11	1	7	3
Crack	<1	<1	*	3
Heroin	13	*	*	*
Hallucinogens	6	6	2	1
Inhalants¹	--	--	--	4
Methamphetamine	2	1	2	1
Alcohol	27	30	20	13
DAILY/ALMOST DAILY USE IN PAST YEAR AMONG PAST YEAR USERS
Marijuana	90	82	90	69
Cocaine	*	1	*	*
Crack	*	*	*	*
Heroin	*	*	*	*
Hallucinogens	6	6	2	1
Inhalants¹	--	--	--	4
Methamphetamine	*	*	*	*
Alcohol	27	30	20	13
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Tables among people aged 12-20 and aged 21+ are included because they are the underage and legal age groups for alcohol. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.25D – Daily or Almost Daily Use of Specific Substances in Past Year: Among People Aged 12 to 20 and among Past Year Users of Specific Substances Aged 12 to 20; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
DAILY/ALMOST DAILY USE IN PAST YEAR AMONG TOTAL POPULATION
Marijuana	0.22	0.20	0.22	0.18
Cocaine	0.03	<0.01	0.02	0.01
Crack	<0.01	<0.01	*	0.01
Heroin	0.03	*	*	*
Hallucinogens	0.02	0.01	0.01	<0.01
Inhalants¹	--	--	--	0.01
Methamphetamine	0.01	<0.01	0.01	<0.01
Alcohol	0.07	0.08	0.05	0.03
DAILY/ALMOST DAILY USE IN PAST YEAR AMONG PAST YEAR USERS
Marijuana	1.09	0.97	1.09	1.00
Cocaine	*	0.36	*	*
Crack	*	*	*	*
Heroin	*	*	*	*
Hallucinogens	0.51	0.49	0.18	0.10
Inhalants¹	--	--	--	0.28
Methamphetamine	*	*	*	*
Alcohol	0.23	0.27	0.19	0.13
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Tables among people aged 12-20 and aged 21+ are included because they are the underage and legal age groups for alcohol. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.25P – Daily or Almost Daily Use of Specific Substances in Past Year: Among People Aged 12 to 20 and among Past Year Users of Specific Substances Aged 12 to 20; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
DAILY/ALMOST DAILY USE IN PAST YEAR AMONG TOTAL POPULATION
Marijuana	0.6194	0.2442	0.1953
Cocaine	0.2892	0.6668	0.5301
Crack	0.3336	0.3361	*
Heroin	*	*	*
Hallucinogens	0.1461	0.4091	0.4980
Inhalants¹	--	--	--
Methamphetamine	0.3395	0.7388	0.2626
Alcohol	0.1502	0.0141	0.3753
DAILY/ALMOST DAILY USE IN PAST YEAR AMONG PAST YEAR USERS
Marijuana	0.1919	0.6662	0.7505
Cocaine	*	*	*
Crack	*	*	*
Heroin	*	*	*
Hallucinogens	0.1532	0.4203	0.4956
Inhalants¹	--	--	--
Methamphetamine	*	*	*
Alcohol	0.1986	0.0174	0.4118
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Tables among people aged 12-20 and aged 21+ are included because they are the underage and legal age groups for alcohol. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.26C – Daily or Almost Daily Use of Specific Substances in Past Year: Among People Aged 21 or Older and among Past Year Users of Specific Substances Aged 21 or Older; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
DAILY/ALMOST DAILY USE IN PAST YEAR AMONG TOTAL POPULATION
Marijuana	476	489	487	537
Cocaine	70	34	41	25
Crack	55	19	20	21
Heroin	58	53	41	47
Hallucinogens	16	11	25	19
Inhalants¹	--	--	--	23
Methamphetamine	121	92	119	105
Alcohol	498	485	462	511
DAILY/ALMOST DAILY USE IN PAST YEAR AMONG PAST YEAR USERS
Marijuana	476	489	487	537
Cocaine	70	34	41	25
Crack	*	19	20	21
Heroin	58	53	41	*
Hallucinogens	16	11	25	19
Inhalants¹	--	--	--	23
Methamphetamine	121	92	119	105
Alcohol	498	485	462	511
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Tables among people aged 12-20 and aged 21+ are included because they are the underage and legal age groups for alcohol. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.26D – Daily or Almost Daily Use of Specific Substances in Past Year: Among People Aged 21 or Older and among Past Year Users of Specific Substances Aged 21 or Older; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
DAILY/ALMOST DAILY USE IN PAST YEAR AMONG TOTAL POPULATION
Marijuana	0.18	0.19	0.18	0.19
Cocaine	0.03	0.01	0.02	0.01
Crack	0.02	0.01	0.01	0.01
Heroin	0.02	0.02	0.02	0.02
Hallucinogens	0.01	<0.01	0.01	0.01
Inhalants¹	--	--	--	0.01
Methamphetamine	0.05	0.04	0.05	0.04
Alcohol	0.20	0.19	0.18	0.20
DAILY/ALMOST DAILY USE IN PAST YEAR AMONG PAST YEAR USERS
Marijuana	0.78	0.71	0.69	0.70
Cocaine	1.50	0.67	0.85	0.63
Crack	*	2.11	2.06	2.97
Heroin	5.36	4.64	5.79	*
Hallucinogens	0.25	0.15	0.32	0.21
Inhalants¹	--	--	--	1.22
Methamphetamine	4.11	3.27	3.90	3.87
Alcohol	0.29	0.27	0.26	0.29
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Tables among people aged 12-20 and aged 21+ are included because they are the underage and legal age groups for alcohol. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.26P – Daily or Almost Daily Use of Specific Substances in Past Year: Among People Aged 21 or Older and among Past Year Users of Specific Substances Aged 21 or Older; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
DAILY/ALMOST DAILY USE IN PAST YEAR AMONG TOTAL POPULATION
Marijuana	0.0000	0.0146	0.1032
Cocaine	0.0526	0.4954	0.6294
Crack	0.1578	0.8317	0.9025
Heroin	0.3984	0.1223	0.8823
Hallucinogens	0.6006	0.3491	0.9325
Inhalants¹	--	--	--
Methamphetamine	0.9669	0.8898	0.8265
Alcohol	0.0612	0.2860	0.5419
DAILY/ALMOST DAILY USE IN PAST YEAR AMONG PAST YEAR USERS
Marijuana	0.3834	0.0437	0.3254
Cocaine	0.0749	0.9188	0.8973
Crack	*	0.7723	0.5073
Heroin	*	*	*
Hallucinogens	0.9720	0.6190	0.8697
Inhalants¹	--	--	--
Methamphetamine	0.4820	0.3284	0.7529
Alcohol	0.0676	0.3833	0.6279
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Tables among people aged 12-20 and aged 21+ are included because they are the underage and legal age groups for alcohol. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.27C – Daily or Almost Daily Use of Specific Substances in Past Month: Among People Aged 12 or Older and among Past Month Users of Specific Substances Aged 12 or Older; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
DAILY/ALMOST DAILY USE IN PAST MONTH AMONG TOTAL POPULATION
Marijuana	551	520	552	554
Cocaine	86	49	65	77
Crack	63	47	54	69
Heroin	84	89	43	52
Hallucinogens	22	17	32	27
Inhalants¹	--	--	--	28
Methamphetamine	158	132	147	115
Misuse of Prescription Pain Relievers	81	57	83	73
Misuse of Prescription Stimulants	17	29	17	35
Misuse of Prescription Tranquilizers	42	38	27	58
Misuse of Prescription Sedatives	42	28	25	7
Daily Cigarette Use²	792	714	634	643
Smokeless Tobacco	312	240	266	226
Cigars	204	174	219	166
Alcohol	658	605	604	583
Binge Alcohol Use	273	198	232	236
DAILY/ALMOST DAILY USE IN PAST MONTH AMONG PAST MONTH USERS
Marijuana	610	587	618	625
Cocaine	86	49	65	77
Crack	*	*	*	*
Heroin	*	*	*	52
Hallucinogens	22	17	32	28
Inhalants¹	--	--	--	28
Methamphetamine	160	132	148	116
Misuse of Prescription Pain Relievers	82	56	83	73
Misuse of Prescription Stimulants	17	29	17	35
Misuse of Prescription Tranquilizers	*	38	27	58
Misuse of Prescription Sedatives	*	*	*	*
Daily Cigarette Use²	904	777	724	700
Smokeless Tobacco	321	241	270	232
Cigars	207	176	221	168
Alcohol	748	677	641	644
Binge Alcohol Use	278	202	234	239
SMOKED 1+ PACKS OF CIGARETTES PER DAY AMONG DAILY CIGARETTE USERS³	582	473	426	414
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ² Daily cigarette use includes only respondents who smoked cigarettes on each of the past 30 days. ³ Respondents with unknown data for number of cigarettes smoked per day were excluded from the analysis. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.27D – Daily or Almost Daily Use of Specific Substances in Past Month: Among People Aged 12 or Older and among Past Month Users of Specific Substances Aged 12 or Older; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
DAILY/ALMOST DAILY USE IN PAST MONTH AMONG TOTAL POPULATION
Marijuana	0.20	0.18	0.19	0.19
Cocaine	0.03	0.02	0.02	0.03
Crack	0.02	0.02	0.02	0.02
Heroin	0.03	0.03	0.02	0.02
Hallucinogens	0.01	0.01	0.01	0.01
Inhalants¹	--	--	--	0.01
Methamphetamine	0.06	0.05	0.05	0.04
Misuse of Prescription Pain Relievers	0.03	0.02	0.03	0.03
Misuse of Prescription Stimulants	0.01	0.01	0.01	0.01
Misuse of Prescription Tranquilizers	0.02	0.01	0.01	0.02
Misuse of Prescription Sedatives	0.02	0.01	0.01	<0.01
Daily Cigarette Use²	0.28	0.25	0.22	0.22
Smokeless Tobacco	0.11	0.09	0.09	0.08
Cigars	0.07	0.06	0.08	0.06
Alcohol	0.23	0.21	0.21	0.20
Binge Alcohol Use	0.10	0.07	0.08	0.08
DAILY/ALMOST DAILY USE IN PAST MONTH AMONG PAST MONTH USERS
Marijuana	1.01	0.85	0.86	0.85
Cocaine	3.88	2.33	3.28	4.00
Crack	*	*	*	*
Heroin	*	*	*	5.53
Hallucinogens	0.94	0.74	1.18	0.97
Inhalants¹	--	--	--	2.38
Methamphetamine	6.06	5.62	4.52	4.51
Misuse of Prescription Pain Relievers	3.10	2.22	3.37	3.18
Misuse of Prescription Stimulants	1.54	2.07	1.47	2.63
Misuse of Prescription Tranquilizers	*	2.80	2.50	4.23
Misuse of Prescription Sedatives	*	*	*	*
Daily Cigarette Use²	1.02	1.01	0.98	1.02
Smokeless Tobacco	2.43	2.47	2.17	2.20
Cigars	1.65	1.49	1.74	1.48
Alcohol	0.46	0.42	0.42	0.41
Binge Alcohol Use	0.44	0.32	0.37	0.40
SMOKED 1+ PACKS OF CIGARETTES PER DAY AMONG DAILY CIGARETTE USERS³	1.46	1.33	1.33	1.35
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ² Daily cigarette use includes only respondents who smoked cigarettes on each of the past 30 days. ³ Respondents with unknown data for number of cigarettes smoked per day were excluded from the analysis. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.27P – Daily or Almost Daily Use of Specific Substances in Past Month: Among People Aged 12 or Older and among Past Month Users of Specific Substances Aged 12 or Older; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
DAILY/ALMOST DAILY USE IN PAST MONTH AMONG TOTAL POPULATION
Marijuana	0.0000	0.3736	0.6887
Cocaine	0.4705	0.4295	0.9481
Crack	0.9559	0.8891	0.9250
Heroin	0.1136	0.0150	0.9334
Hallucinogens	0.2985	0.2794	0.8501
Inhalants¹	--	--	--
Methamphetamine	0.7587	0.3357	0.2324
Misuse of Prescription Pain Relievers	0.3814	0.3788	0.9079
Misuse of Prescription Stimulants	0.2413	0.9133	0.1403
Misuse of Prescription Tranquilizers	0.1485	0.4752	0.1527
Misuse of Prescription Sedatives	0.2914	0.1910	0.6115
Daily Cigarette Use²	0.0000	0.0143	0.3201
Smokeless Tobacco	0.0293	0.6609	0.0874
Cigars	0.2756	0.3316	0.0021
Alcohol	0.0000	0.0124	0.0070
Binge Alcohol Use	0.0713	0.4205	0.6136
DAILY/ALMOST DAILY USE IN PAST MONTH AMONG PAST MONTH USERS
Marijuana	0.4153	0.7115	0.4946
Cocaine	0.6604	0.1532	0.8172
Crack	*	*	*
Heroin	*	*	*
Hallucinogens	0.4635	0.4623	0.8997
Inhalants¹	--	--	--
Methamphetamine	0.4646	0.9635	0.2974
Misuse of Prescription Pain Relievers	0.1297	0.1168	0.7617
Misuse of Prescription Stimulants	0.2816	0.7130	0.1434
Misuse of Prescription Tranquilizers	*	0.3734	0.2195
Misuse of Prescription Sedatives	*	*	*
Daily Cigarette Use²	0.0897	0.8587	0.9457
Smokeless Tobacco	0.4359	0.5998	0.1238
Cigars	0.9569	0.9410	0.0265
Alcohol	0.0000	0.1198	0.0198
Binge Alcohol Use	0.2677	0.1112	0.8277
SMOKED 1+ PACKS OF CIGARETTES PER DAY AMONG DAILY CIGARETTE USERS³	0.0201	0.2792	0.3222
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ² Daily cigarette use includes only respondents who smoked cigarettes on each of the past 30 days. ³ Respondents with unknown data for number of cigarettes smoked per day were excluded from the analysis. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.28C – Daily or Almost Daily Use of Specific Substances in Past Month: Among People Aged 12 to 17 and among Past Month Users of Specific Substances Aged 12 to 17; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
DAILY/ALMOST DAILY USE IN PAST MONTH AMONG TOTAL POPULATION
Marijuana	59	44	42	42
Cocaine	3	*	1	1
Crack	*	*	*	*
Heroin	*	*	*	1
Hallucinogens	6	2	<1	10
Inhalants¹	--	--	--	10
Methamphetamine	7	1	14	3
Misuse of Prescription Pain Relievers	1	2	7	4
Misuse of Prescription Stimulants	7	<1	1	1
Misuse of Prescription Tranquilizers	*	<1	3	*
Misuse of Prescription Sedatives	1	*	3	1
Daily Cigarette Use²	35	4	10	4
Smokeless Tobacco	9	5	5	7
Cigars	7	10	6	10
Alcohol	27	7	6	12
Binge Alcohol Use	27	2	2	5
DAILY/ALMOST DAILY USE IN PAST MONTH AMONG PAST MONTH USERS
Marijuana	60	45	43	43
Cocaine	*	*	*	*
Crack	*	*	*	*
Heroin	*	*	*	*
Hallucinogens	*	*	<1	*
Inhalants¹	--	--	--	*
Methamphetamine	*	*	*	*
Misuse of Prescription Pain Relievers	1	2	*	*
Misuse of Prescription Stimulants	*	*	*	*
Misuse of Prescription Tranquilizers	*	*	*	*
Misuse of Prescription Sedatives	*	*	*	*
Daily Cigarette Use²	*	4	*	4
Smokeless Tobacco	*	*	*	*
Cigars	7	10	*	*
Alcohol	27	7	6	12
Binge Alcohol Use	*	2	2	5
SMOKED 1+ PACKS OF CIGARETTES PER DAY AMONG DAILY CIGARETTE USERS³	*	*	*	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ² Daily cigarette use includes only respondents who smoked cigarettes on each of the past 30 days. ³ Respondents with unknown data for number of cigarettes smoked per day were excluded from the analysis. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.28D – Daily or Almost Daily Use of Specific Substances in Past Month: Among People Aged 12 to 17 and among Past Month Users of Specific Substances Aged 12 to 17; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
DAILY/ALMOST DAILY USE IN PAST MONTH AMONG TOTAL POPULATION
Marijuana	0.23	0.17	0.16	0.16
Cocaine	0.01	*	<0.01	<0.01
Crack	*	*	*	*
Heroin	*	*	*	<0.01
Hallucinogens	0.02	0.01	<0.01	0.04
Inhalants¹	--	--	--	0.04
Methamphetamine	0.03	<0.01	0.05	0.01
Misuse of Prescription Pain Relievers	<0.01	0.01	0.03	0.01
Misuse of Prescription Stimulants	0.03	<0.01	<0.01	<0.01
Misuse of Prescription Tranquilizers	*	<0.01	0.01	*
Misuse of Prescription Sedatives	<0.01	*	0.01	<0.01
Daily Cigarette Use²	0.13	0.02	0.04	0.02
Smokeless Tobacco	0.03	0.02	0.02	0.03
Cigars	0.03	0.04	0.02	0.04
Alcohol	0.10	0.03	0.02	0.05
Binge Alcohol Use	0.10	0.01	0.01	0.02
DAILY/ALMOST DAILY USE IN PAST MONTH AMONG PAST MONTH USERS
Marijuana	3.03	2.12	2.23	2.39
Cocaine	*	*	*	*
Crack	*	*	*	*
Heroin	*	*	*	*
Hallucinogens	*	*	0.37	*
Inhalants¹	--	--	--	*
Methamphetamine	*	*	*	*
Misuse of Prescription Pain Relievers	0.42	1.63	*	*
Misuse of Prescription Stimulants	*	*	*	*
Misuse of Prescription Tranquilizers	*	*	*	*
Misuse of Prescription Sedatives	*	*	*	*
Daily Cigarette Use²	*	1.30	*	1.37
Smokeless Tobacco	*	*	*	*
Cigars	3.96	5.17	*	*
Alcohol	1.38	0.41	0.31	0.71
Binge Alcohol Use	*	0.30	0.21	0.50
SMOKED 1+ PACKS OF CIGARETTES PER DAY AMONG DAILY CIGARETTE USERS³	*	*	*	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ² Daily cigarette use includes only respondents who smoked cigarettes on each of the past 30 days. ³ Respondents with unknown data for number of cigarettes smoked per day were excluded from the analysis. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.28P – Daily or Almost Daily Use of Specific Substances in Past Month: Among People Aged 12 to 17 and among Past Month Users of Specific Substances Aged 12 to 17; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
DAILY/ALMOST DAILY USE IN PAST MONTH AMONG TOTAL POPULATION
Marijuana	0.8316	0.7338	0.2355
Cocaine	0.3250	*	0.7655
Crack	*	*	*
Heroin	*	*	*
Hallucinogens	0.8236	0.4005	0.3143
Inhalants¹	--	--	--
Methamphetamine	0.7014	0.2044	0.3283
Misuse of Prescription Pain Relievers	0.1267	0.3911	0.4489
Misuse of Prescription Stimulants	0.2944	0.2944	0.9118
Misuse of Prescription Tranquilizers	*	*	*
Misuse of Prescription Sedatives	0.4470	*	0.6329
Daily Cigarette Use²	0.0983	0.7242	0.4838
Smokeless Tobacco	0.4112	0.7100	0.4108
Cigars	0.8526	0.5599	0.5441
Alcohol	0.6330	0.8328	0.4004
Binge Alcohol Use	0.2814	0.5788	0.7030
DAILY/ALMOST DAILY USE IN PAST MONTH AMONG PAST MONTH USERS
Marijuana	0.6875	0.8232	0.1420
Cocaine	*	*	*
Crack	*	*	*
Heroin	*	*	*
Hallucinogens	*	*	*
Inhalants¹	--	--	--
Methamphetamine	*	*	*
Misuse of Prescription Pain Relievers	*	*	*
Misuse of Prescription Stimulants	*	*	*
Misuse of Prescription Tranquilizers	*	*	*
Misuse of Prescription Sedatives	*	*	*
Daily Cigarette Use²	*	0.7144	*
Smokeless Tobacco	*	*	*
Cigars	*	*	*
Alcohol	0.6894	0.8003	0.3679
Binge Alcohol Use	*	0.6134	0.6285
SMOKED 1+ PACKS OF CIGARETTES PER DAY AMONG DAILY CIGARETTE USERS³	*	*	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ² Daily cigarette use includes only respondents who smoked cigarettes on each of the past 30 days. ³ Respondents with unknown data for number of cigarettes smoked per day were excluded from the analysis. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.29C – Daily or Almost Daily Use of Specific Substances in Past Month: Among People Aged 18 or Older and among Past Month Users of Specific Substances Aged 18 or Older; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
DAILY/ALMOST DAILY USE IN PAST MONTH AMONG TOTAL POPULATION
Marijuana	546	517	550	553
Cocaine	86	49	65	77
Crack	63	47	54	69
Heroin	84	89	43	52
Hallucinogens	21	17	32	25
Inhalants¹	--	--	--	26
Methamphetamine	158	132	146	115
Misuse of Prescription Pain Relievers	81	57	82	73
Misuse of Prescription Stimulants	15	29	17	35
Misuse of Prescription Tranquilizers	42	38	27	58
Misuse of Prescription Sedatives	42	28	25	7
Daily Cigarette Use²	787	711	634	639
Smokeless Tobacco	312	239	265	225
Cigars	203	173	219	165
Alcohol	658	603	603	580
Binge Alcohol Use	273	199	232	236
DAILY/ALMOST DAILY USE IN PAST MONTH AMONG PAST MONTH USERS
Marijuana	603	584	611	622
Cocaine	86	49	65	77
Crack	*	*	*	*
Heroin	*	*	*	52
Hallucinogens	21	17	32	26
Inhalants¹	--	--	--	26
Methamphetamine	159	132	147	116
Misuse of Prescription Pain Relievers	82	56	82	73
Misuse of Prescription Stimulants	15	29	17	35
Misuse of Prescription Tranquilizers	*	38	27	58
Misuse of Prescription Sedatives	*	*	*	*
Daily Cigarette Use²	900	777	724	699
Smokeless Tobacco	321	241	270	232
Cigars	206	176	221	167
Alcohol	748	678	641	644
Binge Alcohol Use	278	202	234	239
SMOKED 1+ PACKS OF CIGARETTES PER DAY AMONG DAILY CIGARETTE USERS³	582	473	426	414
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ² Daily cigarette use includes only respondents who smoked cigarettes on each of the past 30 days. ³ Respondents with unknown data for number of cigarettes smoked per day were excluded from the analysis. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.29D – Daily or Almost Daily Use of Specific Substances in Past Month: Among People Aged 18 or Older and among Past Month Users of Specific Substances Aged 18 or Older; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
DAILY/ALMOST DAILY USE IN PAST MONTH AMONG TOTAL POPULATION
Marijuana	0.22	0.20	0.21	0.21
Cocaine	0.03	0.02	0.03	0.03
Crack	0.02	0.02	0.02	0.03
Heroin	0.03	0.03	0.02	0.02
Hallucinogens	0.01	0.01	0.01	0.01
Inhalants¹	--	--	--	0.01
Methamphetamine	0.06	0.05	0.06	0.04
Misuse of Prescription Pain Relievers	0.03	0.02	0.03	0.03
Misuse of Prescription Stimulants	0.01	0.01	0.01	0.01
Misuse of Prescription Tranquilizers	0.02	0.01	0.01	0.02
Misuse of Prescription Sedatives	0.02	0.01	0.01	<0.01
Daily Cigarette Use²	0.31	0.28	0.25	0.24
Smokeless Tobacco	0.12	0.09	0.10	0.09
Cigars	0.08	0.07	0.08	0.06
Alcohol	0.26	0.24	0.23	0.22
Binge Alcohol Use	0.11	0.08	0.09	0.09
DAILY/ALMOST DAILY USE IN PAST MONTH AMONG PAST MONTH USERS
Marijuana	1.05	0.88	0.90	0.88
Cocaine	3.90	2.34	3.32	4.03
Crack	*	*	*	*
Heroin	*	*	*	5.55
Hallucinogens	0.95	0.76	1.23	0.95
Inhalants¹	--	--	--	2.95
Methamphetamine	6.11	5.63	4.56	4.51
Misuse of Prescription Pain Relievers	3.27	2.34	3.57	3.36
Misuse of Prescription Stimulants	1.48	2.12	1.51	2.70
Misuse of Prescription Tranquilizers	*	2.88	2.59	4.32
Misuse of Prescription Sedatives	*	*	*	*
Daily Cigarette Use²	1.02	1.01	0.98	1.02
Smokeless Tobacco	2.47	2.51	2.19	2.23
Cigars	1.67	1.51	1.75	1.49
Alcohol	0.47	0.42	0.43	0.41
Binge Alcohol Use	0.45	0.32	0.37	0.40
SMOKED 1+ PACKS OF CIGARETTES PER DAY AMONG DAILY CIGARETTE USERS³	1.46	1.33	1.33	1.35
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ² Daily cigarette use includes only respondents who smoked cigarettes on each of the past 30 days. ³ Respondents with unknown data for number of cigarettes smoked per day were excluded from the analysis. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.29P – Daily or Almost Daily Use of Specific Substances in Past Month: Among People Aged 18 or Older and among Past Month Users of Specific Substances Aged 18 or Older; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
DAILY/ALMOST DAILY USE IN PAST MONTH AMONG TOTAL POPULATION
Marijuana	0.0000	0.3716	0.7825
Cocaine	0.4838	0.4365	0.9484
Crack	0.9606	0.8912	0.9273
Heroin	0.1106	0.0146	0.9432
Hallucinogens	0.3041	0.3913	0.9747
Inhalants¹	--	--	--
Methamphetamine	0.7600	0.3220	0.2591
Misuse of Prescription Pain Relievers	0.4168	0.4020	0.8650
Misuse of Prescription Stimulants	0.1606	0.9349	0.1417
Misuse of Prescription Tranquilizers	0.1500	0.4734	0.1369
Misuse of Prescription Sedatives	0.2800	0.1715	0.6574
Daily Cigarette Use²	0.0000	0.0127	0.3042
Smokeless Tobacco	0.0288	0.6775	0.0807
Cigars	0.2607	0.3425	0.0018
Alcohol	0.0000	0.0109	0.0057
Binge Alcohol Use	0.0804	0.4334	0.5997
DAILY/ALMOST DAILY USE IN PAST MONTH AMONG PAST MONTH USERS
Marijuana	0.5100	0.7718	0.5975
Cocaine	0.6948	0.1524	0.8253
Crack	*	*	*
Heroin	*	*	*
Hallucinogens	0.4483	0.6084	0.9273
Inhalants¹	--	--	--
Methamphetamine	0.3845	0.8435	0.3890
Misuse of Prescription Pain Relievers	0.1473	0.1230	0.7530
Misuse of Prescription Stimulants	0.2097	0.7290	0.1440
Misuse of Prescription Tranquilizers	*	0.3751	0.2035
Misuse of Prescription Sedatives	*	*	*
Daily Cigarette Use²	0.0946	0.8393	0.9479
Smokeless Tobacco	0.4210	0.6913	0.1505
Cigars	0.9055	0.9357	0.0255
Alcohol	0.0000	0.1192	0.0181
Binge Alcohol Use	0.2979	0.1096	0.8403
SMOKED 1+ PACKS OF CIGARETTES PER DAY AMONG DAILY CIGARETTE USERS³	0.0186	0.2807	0.3201
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ² Daily cigarette use includes only respondents who smoked cigarettes on each of the past 30 days. ³ Respondents with unknown data for number of cigarettes smoked per day were excluded from the analysis. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.30C – Daily or Almost Daily Use of Specific Substances in Past Month: Among People Aged 18 to 25 and among Past Month Users of Specific Substances Aged 18 to 25; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
DAILY/ALMOST DAILY USE IN PAST MONTH AMONG TOTAL POPULATION
Marijuana	158	163	143	141
Cocaine	15	3	2	3
Crack	<1	3	1	2
Heroin	13	4	4	4
Hallucinogens	7	*	6	8
Inhalants¹	--	--	--	11
Methamphetamine	13	9	10	11
Misuse of Prescription Pain Relievers	14	6	13	19
Misuse of Prescription Stimulants	5	11	9	10
Misuse of Prescription Tranquilizers	5	8	1	17
Misuse of Prescription Sedatives	<1	<1	<1	1
Daily Cigarette Use²	82	76	70	57
Smokeless Tobacco	51	38	46	43
Cigars	53	46	44	39
Alcohol	98	77	76	73
Binge Alcohol Use	36	38	34	29
DAILY/ALMOST DAILY USE IN PAST MONTH AMONG PAST MONTH USERS
Marijuana	179	188	166	161
Cocaine	*	3	2	3
Crack	*	*	*	*
Heroin	*	*	*	*
Hallucinogens	*	*	*	8
Inhalants¹	--	--	--	*
Methamphetamine	*	*	*	*
Misuse of Prescription Pain Relievers	*	6	*	*
Misuse of Prescription Stimulants	5	11	*	*
Misuse of Prescription Tranquilizers	*	*	*	*
Misuse of Prescription Sedatives	*	*	*	*
Daily Cigarette Use²	81	78	72	58
Smokeless Tobacco	51	38	47	44
Cigars	54	47	44	39
Alcohol	102	79	79	74
Binge Alcohol Use	37	39	35	29
SMOKED 1+ PACKS OF CIGARETTES PER DAY AMONG DAILY CIGARETTE USERS³	32	28	29	21
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ² Daily cigarette use includes only respondents who smoked cigarettes on each of the past 30 days. ³ Respondents with unknown data for number of cigarettes smoked per day were excluded from the analysis. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.30D – Daily or Almost Daily Use of Specific Substances in Past Month: Among People Aged 18 to 25 and among Past Month Users of Specific Substances Aged 18 to 25; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
DAILY/ALMOST DAILY USE IN PAST MONTH AMONG TOTAL POPULATION
Marijuana	0.47	0.47	0.42	0.40
Cocaine	0.04	0.01	<0.01	0.01
Crack	<0.01	0.01	<0.01	<0.01
Heroin	0.04	0.01	0.01	0.01
Hallucinogens	0.02	*	0.02	0.02
Inhalants¹	--	--	--	0.03
Methamphetamine	0.04	0.03	0.03	0.03
Misuse of Prescription Pain Relievers	0.04	0.02	0.04	0.05
Misuse of Prescription Stimulants	0.01	0.03	0.03	0.03
Misuse of Prescription Tranquilizers	0.01	0.02	<0.01	0.05
Misuse of Prescription Sedatives	<0.01	<0.01	<0.01	<0.01
Daily Cigarette Use²	0.24	0.22	0.21	0.16
Smokeless Tobacco	0.15	0.11	0.14	0.12
Cigars	0.16	0.13	0.13	0.11
Alcohol	0.29	0.22	0.22	0.21
Binge Alcohol Use	0.11	0.11	0.10	0.08
DAILY/ALMOST DAILY USE IN PAST MONTH AMONG PAST MONTH USERS
Marijuana	1.54	1.31	1.26	1.29
Cocaine	*	0.86	0.72	1.38
Crack	*	*	*	*
Heroin	*	*	*	*
Hallucinogens	*	*	*	1.55
Inhalants¹	--	--	--	*
Methamphetamine	*	*	*	*
Misuse of Prescription Pain Relievers	*	2.56	*	*
Misuse of Prescription Stimulants	1.50	2.87	*	*
Misuse of Prescription Tranquilizers	*	*	*	*
Misuse of Prescription Sedatives	*	*	*	*
Daily Cigarette Use²	1.76	1.75	1.64	1.52
Smokeless Tobacco	3.77	3.79	3.75	2.95
Cigars	2.57	2.25	2.23	2.06
Alcohol	0.57	0.42	0.44	0.43
Binge Alcohol Use	0.36	0.37	0.34	0.31
SMOKED 1+ PACKS OF CIGARETTES PER DAY AMONG DAILY CIGARETTE USERS³	2.74	2.62	2.64	2.93
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ² Daily cigarette use includes only respondents who smoked cigarettes on each of the past 30 days. ³ Respondents with unknown data for number of cigarettes smoked per day were excluded from the analysis. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.30P – Daily or Almost Daily Use of Specific Substances in Past Month: Among People Aged 18 to 25 and among Past Month Users of Specific Substances Aged 18 to 25; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
DAILY/ALMOST DAILY USE IN PAST MONTH AMONG TOTAL POPULATION
Marijuana	0.4207	0.0377	0.1608
Cocaine	0.1359	0.9185	0.2800
Crack	0.1812	0.7398	0.7088
Heroin	0.5022	0.3916	0.7460
Hallucinogens	0.4821	*	0.2756
Inhalants¹	--	--	--
Methamphetamine	0.9490	0.9121	0.6440
Misuse of Prescription Pain Relievers	0.4210	0.1057	0.6460
Misuse of Prescription Stimulants	0.2835	0.8317	0.7544
Misuse of Prescription Tranquilizers	0.2780	0.4876	0.1301
Misuse of Prescription Sedatives	0.4661	0.6493	0.5532
Daily Cigarette Use²	0.0000	0.0003	0.0013
Smokeless Tobacco	0.7779	0.0014	0.2311
Cigars	0.6680	0.2669	0.4872
Alcohol	0.0039	0.0423	0.0237
Binge Alcohol Use	0.2450	0.5344	0.1451
DAILY/ALMOST DAILY USE IN PAST MONTH AMONG PAST MONTH USERS
Marijuana	0.1550	0.3423	0.4778
Cocaine	*	0.4165	0.2802
Crack	*	*	*
Heroin	*	*	*
Hallucinogens	*	*	*
Inhalants¹	--	--	--
Methamphetamine	*	*	*
Misuse of Prescription Pain Relievers	*	*	*
Misuse of Prescription Stimulants	*	*	*
Misuse of Prescription Tranquilizers	*	*	*
Misuse of Prescription Sedatives	*	*	*
Daily Cigarette Use²	0.0016	0.0022	0.0073
Smokeless Tobacco	0.1717	0.2485	0.9765
Cigars	0.2096	0.5226	0.8706
Alcohol	0.0181	0.1176	0.0576
Binge Alcohol Use	0.5183	0.8362	0.2550
SMOKED 1+ PACKS OF CIGARETTES PER DAY AMONG DAILY CIGARETTE USERS³	0.1132	0.8558	0.0951
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ² Daily cigarette use includes only respondents who smoked cigarettes on each of the past 30 days. ³ Respondents with unknown data for number of cigarettes smoked per day were excluded from the analysis. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.31C – Daily or Almost Daily Use of Specific Substances in Past Month: Among People Aged 26 or Older and among Past Month Users of Specific Substances Aged 26 or Older; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
DAILY/ALMOST DAILY USE IN PAST MONTH AMONG TOTAL POPULATION
Marijuana	507	479	503	526
Cocaine	84	49	65	77
Crack	63	47	54	69
Heroin	83	89	43	52
Hallucinogens	20	17	31	24
Inhalants¹	--	--	--	24
Methamphetamine	157	132	146	114
Misuse of Prescription Pain Relievers	80	56	81	70
Misuse of Prescription Stimulants	15	27	15	34
Misuse of Prescription Tranquilizers	42	37	27	56
Misuse of Prescription Sedatives	42	28	25	7
Daily Cigarette Use²	763	704	627	631
Smokeless Tobacco	308	236	260	220
Cigars	193	172	213	160
Alcohol	645	596	594	574
Binge Alcohol Use	269	193	230	235
DAILY/ALMOST DAILY USE IN PAST MONTH AMONG PAST MONTH USERS
Marijuana	546	533	548	582
Cocaine	85	49	65	77
Crack	*	*	*	*
Heroin	*	*	*	52
Hallucinogens	20	17	31	24
Inhalants¹	--	--	--	24
Methamphetamine	*	131	147	114
Misuse of Prescription Pain Relievers	80	56	81	70
Misuse of Prescription Stimulants	15	27	15	34
Misuse of Prescription Tranquilizers	*	37	27	56
Misuse of Prescription Sedatives	*	*	*	*
Daily Cigarette Use²	881	768	717	689
Smokeless Tobacco	315	238	263	225
Cigars	196	174	214	162
Alcohol	732	671	636	638
Binge Alcohol Use	273	197	233	239
SMOKED 1+ PACKS OF CIGARETTES PER DAY AMONG DAILY CIGARETTE USERS³	578	471	425	413
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ² Daily cigarette use includes only respondents who smoked cigarettes on each of the past 30 days. ³ Respondents with unknown data for number of cigarettes smoked per day were excluded from the analysis. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.31D – Daily or Almost Daily Use of Specific Substances in Past Month: Among People Aged 26 or Older and among Past Month Users of Specific Substances Aged 26 or Older; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
DAILY/ALMOST DAILY USE IN PAST MONTH AMONG TOTAL POPULATION
Marijuana	0.23	0.22	0.22	0.23
Cocaine	0.04	0.02	0.03	0.03
Crack	0.03	0.02	0.02	0.03
Heroin	0.04	0.04	0.02	0.02
Hallucinogens	0.01	0.01	0.01	0.01
Inhalants¹	--	--	--	0.01
Methamphetamine	0.07	0.06	0.07	0.05
Misuse of Prescription Pain Relievers	0.04	0.03	0.04	0.03
Misuse of Prescription Stimulants	0.01	0.01	0.01	0.01
Misuse of Prescription Tranquilizers	0.02	0.02	0.01	0.02
Misuse of Prescription Sedatives	0.02	0.01	0.01	<0.01
Daily Cigarette Use²	0.35	0.32	0.28	0.28
Smokeless Tobacco	0.14	0.11	0.12	0.10
Cigars	0.09	0.08	0.10	0.07
Alcohol	0.29	0.27	0.27	0.25
Binge Alcohol Use	0.12	0.09	0.10	0.10
DAILY/ALMOST DAILY USE IN PAST MONTH AMONG PAST MONTH USERS
Marijuana	1.30	1.07	1.05	1.03
Cocaine	4.73	2.92	3.77	4.57
Crack	*	*	*	*
Heroin	*	*	*	5.70
Hallucinogens	1.19	1.03	1.58	1.11
Inhalants¹	--	--	--	3.51
Methamphetamine	*	5.80	4.68	4.68
Misuse of Prescription Pain Relievers	3.58	2.56	3.83	3.71
Misuse of Prescription Stimulants	2.01	2.80	1.79	3.21
Misuse of Prescription Tranquilizers	*	3.18	2.99	4.62
Misuse of Prescription Sedatives	*	*	*	*
Daily Cigarette Use²	1.09	1.10	1.03	1.10
Smokeless Tobacco	2.80	2.81	2.45	2.61
Cigars	1.96	1.84	2.02	1.79
Alcohol	0.52	0.48	0.48	0.46
Binge Alcohol Use	0.53	0.38	0.44	0.48
SMOKED 1+ PACKS OF CIGARETTES PER DAY AMONG DAILY CIGARETTE USERS³	1.51	1.37	1.38	1.39
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ² Daily cigarette use includes only respondents who smoked cigarettes on each of the past 30 days. ³ Respondents with unknown data for number of cigarettes smoked per day were excluded from the analysis. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.31P – Daily or Almost Daily Use of Specific Substances in Past Month: Among People Aged 26 or Older and among Past Month Users of Specific Substances Aged 26 or Older; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
DAILY/ALMOST DAILY USE IN PAST MONTH AMONG TOTAL POPULATION
Marijuana	0.0000	0.1037	0.5048
Cocaine	0.6158	0.4421	0.9220
Crack	0.9774	0.8837	0.9332
Heroin	0.1292	0.0123	0.9606
Hallucinogens	0.3958	0.7538	0.7918
Inhalants¹	--	--	--
Methamphetamine	0.7666	0.3087	0.2413
Misuse of Prescription Pain Relievers	0.5105	0.6105	0.9381
Misuse of Prescription Stimulants	0.2675	0.8687	0.1472
Misuse of Prescription Tranquilizers	0.2262	0.5848	0.2680
Misuse of Prescription Sedatives	0.2752	0.1674	0.6466
Daily Cigarette Use²	0.0000	0.0272	0.4920
Smokeless Tobacco	0.0301	0.8775	0.0476
Cigars	0.1952	0.5041	0.0019
Alcohol	0.0000	0.0183	0.0132
Binge Alcohol Use	0.1082	0.3784	0.7454
DAILY/ALMOST DAILY USE IN PAST MONTH AMONG PAST MONTH USERS
Marijuana	0.8912	0.5489	0.4352
Cocaine	0.6762	0.2188	0.8291
Crack	*	*	*
Heroin	*	*	*
Hallucinogens	0.6224	0.8466	0.6685
Inhalants¹	--	--	--
Methamphetamine	*	0.7465	0.4526
Misuse of Prescription Pain Relievers	0.1928	0.2009	0.7294
Misuse of Prescription Stimulants	0.4912	0.9145	0.2079
Misuse of Prescription Tranquilizers	*	0.5090	0.4304
Misuse of Prescription Sedatives	*	*	*
Daily Cigarette Use²	0.2154	0.5460	0.7433
Smokeless Tobacco	0.7804	0.7173	0.2512
Cigars	0.6256	0.8070	0.0234
Alcohol	0.0000	0.1516	0.0296
Binge Alcohol Use	0.3190	0.1061	0.7073
SMOKED 1+ PACKS OF CIGARETTES PER DAY AMONG DAILY CIGARETTE USERS³	0.0189	0.2272	0.3239
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ² Daily cigarette use includes only respondents who smoked cigarettes on each of the past 30 days. ³ Respondents with unknown data for number of cigarettes smoked per day were excluded from the analysis. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.32C – Daily or Almost Daily Use of Specific Substances in Past Month: Among People Aged 12 to 20 and among Past Month Users of Specific Substances Aged 12 to 20; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
DAILY/ALMOST DAILY USE IN PAST MONTH AMONG TOTAL POPULATION
Marijuana	111	100	107	88
Cocaine	12	<1	1	1
Crack	*	<1	*	*
Heroin	13	<1	*	1
Hallucinogens	6	2	1	11
Inhalants¹	--	--	--	13
Methamphetamine	7	3	14	3
Misuse of Prescription Pain Relievers	13	3	9	4
Misuse of Prescription Stimulants	7	<1	7	3
Misuse of Prescription Tranquilizers	*	1	3	*
Misuse of Prescription Sedatives	1	*	3	1
Daily Cigarette Use²	49	34	26	22
Smokeless Tobacco	22	16	15	21
Cigars	18	26	27	18
Alcohol	42	32	25	29
Binge Alcohol Use	34	23	15	13
DAILY/ALMOST DAILY USE IN PAST MONTH AMONG PAST MONTH USERS
Marijuana	111	100	107	88
Cocaine	*	*	*	*
Crack	*	*	*	*
Heroin	*	*	*	*
Hallucinogens	*	*	1	*
Inhalants¹	--	--	--	*
Methamphetamine	*	*	*	*
Misuse of Prescription Pain Relievers	*	3	*	*
Misuse of Prescription Stimulants	*	<1	*	*
Misuse of Prescription Tranquilizers	*	*	*	*
Misuse of Prescription Sedatives	*	*	*	*
Daily Cigarette Use²	49	34	26	22
Smokeless Tobacco	22	16	15	21
Cigars	18	26	27	18
Alcohol	42	32	25	29
Binge Alcohol Use	34	23	15	13
SMOKED 1+ PACKS OF CIGARETTES PER DAY AMONG DAILY CIGARETTE USERS³	9	*	8	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Tables among people aged 12-20 and aged 21+ are included because they are the underage and legal age groups for alcohol and tobacco. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ² Daily cigarette use includes only respondents who smoked cigarettes on each of the past 30 days. ³ Respondents with unknown data for number of cigarettes smoked per day were excluded from the analysis. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.32D – Daily or Almost Daily Use of Specific Substances in Past Month: Among People Aged 12 to 20 and among Past Month Users of Specific Substances Aged 12 to 20; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
DAILY/ALMOST DAILY USE IN PAST MONTH AMONG TOTAL POPULATION
Marijuana	0.27	0.25	0.26	0.22
Cocaine	0.03	<0.01	<0.01	<0.01
Crack	*	<0.01	*	*
Heroin	0.03	<0.01	*	<0.01
Hallucinogens	0.02	0.01	<0.01	0.03
Inhalants¹	--	--	--	0.03
Methamphetamine	0.02	0.01	0.04	0.01
Misuse of Prescription Pain Relievers	0.03	0.01	0.02	0.01
Misuse of Prescription Stimulants	0.02	<0.01	0.02	0.01
Misuse of Prescription Tranquilizers	*	<0.01	0.01	*
Misuse of Prescription Sedatives	<0.01	*	0.01	<0.01
Daily Cigarette Use²	0.12	0.09	0.07	0.06
Smokeless Tobacco	0.06	0.04	0.04	0.05
Cigars	0.05	0.07	0.07	0.05
Alcohol	0.11	0.08	0.06	0.08
Binge Alcohol Use	0.09	0.06	0.04	0.03
DAILY/ALMOST DAILY USE IN PAST MONTH AMONG PAST MONTH USERS
Marijuana	2.00	1.61	1.76	1.68
Cocaine	*	*	*	*
Crack	*	*	*	*
Heroin	*	*	*	*
Hallucinogens	*	*	0.24	*
Inhalants¹	--	--	--	*
Methamphetamine	*	*	*	*
Misuse of Prescription Pain Relievers	*	1.31	*	*
Misuse of Prescription Stimulants	*	0.25	*	*
Misuse of Prescription Tranquilizers	*	*	*	*
Misuse of Prescription Sedatives	*	*	*	*
Daily Cigarette Use²	3.05	2.67	1.96	1.84
Smokeless Tobacco	5.21	4.64	4.73	4.91
Cigars	2.39	3.19	4.06	3.36
Alcohol	0.67	0.53	0.43	0.56
Binge Alcohol Use	0.99	0.73	0.47	0.43
SMOKED 1+ PACKS OF CIGARETTES PER DAY AMONG DAILY CIGARETTE USERS³	3.43	*	4.41	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Tables among people aged 12-20 and aged 21+ are included because they are the underage and legal age groups for alcohol and tobacco. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ² Daily cigarette use includes only respondents who smoked cigarettes on each of the past 30 days. ³ Respondents with unknown data for number of cigarettes smoked per day were excluded from the analysis. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.32P – Daily or Almost Daily Use of Specific Substances in Past Month: Among People Aged 12 to 20 and among Past Month Users of Specific Substances Aged 12 to 20; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
DAILY/ALMOST DAILY USE IN PAST MONTH AMONG TOTAL POPULATION
Marijuana	0.5838	0.0563	0.2339
Cocaine	0.1100	0.3346	0.7607
Crack	*	*	*
Heroin	0.2972	0.4018	*
Hallucinogens	0.5029	0.1419	0.1174
Inhalants¹	--	--	--
Methamphetamine	0.8749	0.5000	0.3824
Misuse of Prescription Pain Relievers	0.6048	0.7874	0.2014
Misuse of Prescription Stimulants	0.5271	0.2368	0.5826
Misuse of Prescription Tranquilizers	*	*	*
Misuse of Prescription Sedatives	0.5100	*	0.6288
Daily Cigarette Use²	0.0084	0.0868	0.1601
Smokeless Tobacco	0.8594	0.1315	0.1379
Cigars	0.6209	0.0394	0.5357
Alcohol	0.6566	0.8576	0.3340
Binge Alcohol Use	0.1856	0.5056	0.7215
DAILY/ALMOST DAILY USE IN PAST MONTH AMONG PAST MONTH USERS
Marijuana	0.2811	0.6236	0.7373
Cocaine	*	*	*
Crack	*	*	*
Heroin	*	*	*
Hallucinogens	*	*	*
Inhalants¹	--	--	--
Methamphetamine	*	*	*
Misuse of Prescription Pain Relievers	*	*	*
Misuse of Prescription Stimulants	*	*	*
Misuse of Prescription Tranquilizers	*	*	*
Misuse of Prescription Sedatives	*	*	*
Daily Cigarette Use²	0.0201	0.0924	0.2636
Smokeless Tobacco	0.7424	0.2374	0.2449
Cigars	0.0980	0.4584	0.8068
Alcohol	0.9066	0.4890	0.1812
Binge Alcohol Use	0.2492	0.5837	0.9434
SMOKED 1+ PACKS OF CIGARETTES PER DAY AMONG DAILY CIGARETTE USERS³	*	*	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Tables among people aged 12-20 and aged 21+ are included because they are the underage and legal age groups for alcohol and tobacco. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ² Daily cigarette use includes only respondents who smoked cigarettes on each of the past 30 days. ³ Respondents with unknown data for number of cigarettes smoked per day were excluded from the analysis. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.33C – Daily or Almost Daily Use of Specific Substances in Past Month: Among People Aged 21 or Older and among Past Month Users of Specific Substances Aged 21 or Older; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
DAILY/ALMOST DAILY USE IN PAST MONTH AMONG TOTAL POPULATION
Marijuana	584	561	589	611
Cocaine	85	49	65	77
Crack	63	47	54	69
Heroin	83	89	43	52
Hallucinogens	21	17	32	25
Inhalants¹	--	--	--	25
Methamphetamine	159	132	147	115
Misuse of Prescription Pain Relievers	81	56	82	73
Misuse of Prescription Stimulants	15	29	16	35
Misuse of Prescription Tranquilizers	42	38	27	58
Misuse of Prescription Sedatives	42	28	25	7
Daily Cigarette Use²	897	775	721	695
Smokeless Tobacco	320	241	268	230
Cigars	204	176	219	166
Alcohol	746	677	639	641
Binge Alcohol Use	276	199	234	238
DAILY/ALMOST DAILY USE IN PAST MONTH AMONG PAST MONTH USERS
Marijuana	584	561	589	611
Cocaine	85	49	65	77
Crack	*	*	*	*
Heroin	*	*	*	52
Hallucinogens	21	17	32	25
Inhalants¹	--	--	--	25
Methamphetamine	159	132	147	115
Misuse of Prescription Pain Relievers	81	56	82	73
Misuse of Prescription Stimulants	15	29	16	35
Misuse of Prescription Tranquilizers	*	38	27	58
Misuse of Prescription Sedatives	*	*	*	*
Daily Cigarette Use²	897	775	721	695
Smokeless Tobacco	320	241	268	230
Cigars	204	176	219	166
Alcohol	746	677	639	641
Binge Alcohol Use	276	199	234	238
SMOKED 1+ PACKS OF CIGARETTES PER DAY AMONG DAILY CIGARETTE USERS³	582	474	426	414
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Tables among people aged 12-20 and aged 21+ are included because they are the underage and legal age groups for alcohol and tobacco. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ² Daily cigarette use includes only respondents who smoked cigarettes on each of the past 30 days. ³ Respondents with unknown data for number of cigarettes smoked per day were excluded from the analysis. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.33D – Daily or Almost Daily Use of Specific Substances in Past Month: Among People Aged 21 or Older and among Past Month Users of Specific Substances Aged 21 or Older; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
DAILY/ALMOST DAILY USE IN PAST MONTH AMONG TOTAL POPULATION
Marijuana	0.22	0.21	0.22	0.22
Cocaine	0.04	0.02	0.03	0.03
Crack	0.03	0.02	0.02	0.03
Heroin	0.03	0.04	0.02	0.02
Hallucinogens	0.01	0.01	0.01	0.01
Inhalants¹	--	--	--	0.01
Methamphetamine	0.07	0.05	0.06	0.05
Misuse of Prescription Pain Relievers	0.03	0.02	0.03	0.03
Misuse of Prescription Stimulants	0.01	0.01	0.01	0.01
Misuse of Prescription Tranquilizers	0.02	0.02	0.01	0.02
Misuse of Prescription Sedatives	0.02	0.01	0.01	<0.01
Daily Cigarette Use²	0.32	0.29	0.26	0.25
Smokeless Tobacco	0.13	0.10	0.11	0.09
Cigars	0.08	0.07	0.09	0.07
Alcohol	0.27	0.25	0.24	0.23
Binge Alcohol Use	0.11	0.08	0.09	0.09
DAILY/ALMOST DAILY USE IN PAST MONTH AMONG PAST MONTH USERS
Marijuana	1.13	0.92	0.94	0.92
Cocaine	4.03	2.42	3.41	4.11
Crack	*	*	*	*
Heroin	*	*	*	5.56
Hallucinogens	1.00	0.83	1.32	0.97
Inhalants¹	--	--	--	3.08
Methamphetamine	6.13	5.67	4.58	4.53
Misuse of Prescription Pain Relievers	3.34	2.42	3.65	3.47
Misuse of Prescription Stimulants	1.60	2.35	1.47	2.93
Misuse of Prescription Tranquilizers	*	2.92	2.70	4.41
Misuse of Prescription Sedatives	*	*	*	*
Daily Cigarette Use²	1.04	1.04	1.00	1.03
Smokeless Tobacco	2.53	2.60	2.26	2.30
Cigars	1.75	1.62	1.81	1.56
Alcohol	0.48	0.43	0.44	0.42
Binge Alcohol Use	0.46	0.33	0.39	0.42
SMOKED 1+ PACKS OF CIGARETTES PER DAY AMONG DAILY CIGARETTE USERS³	1.47	1.34	1.34	1.36
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Tables among people aged 12-20 and aged 21+ are included because they are the underage and legal age groups for alcohol and tobacco. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ² Daily cigarette use includes only respondents who smoked cigarettes on each of the past 30 days. ³ Respondents with unknown data for number of cigarettes smoked per day were excluded from the analysis. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.33P – Daily or Almost Daily Use of Specific Substances in Past Month: Among People Aged 21 or Older and among Past Month Users of Specific Substances Aged 21 or Older; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
DAILY/ALMOST DAILY USE IN PAST MONTH AMONG TOTAL POPULATION
Marijuana	0.0000	0.2258	0.5371
Cocaine	0.5616	0.4401	0.9501
Crack	0.9661	0.8951	0.9261
Heroin	0.1397	0.0143	0.9416
Hallucinogens	0.3906	0.5562	0.8401
Inhalants¹	--	--	--
Methamphetamine	0.7415	0.3168	0.2571
Misuse of Prescription Pain Relievers	0.3541	0.3923	0.8233
Misuse of Prescription Stimulants	0.1831	0.9844	0.1051
Misuse of Prescription Tranquilizers	0.1517	0.4641	0.1366
Misuse of Prescription Sedatives	0.2810	0.1709	0.6577
Daily Cigarette Use²	0.0000	0.0131	0.3333
Smokeless Tobacco	0.0249	0.7757	0.0667
Cigars	0.2322	0.4648	0.0023
Alcohol	0.0000	0.0088	0.0052
Binge Alcohol Use	0.0815	0.4025	0.6219
DAILY/ALMOST DAILY USE IN PAST MONTH AMONG PAST MONTH USERS
Marijuana	0.6815	0.7272	0.4832
Cocaine	0.7782	0.1586	0.8382
Crack	*	*	*
Heroin	*	*	*
Hallucinogens	0.5575	0.8433	0.7587
Inhalants¹	--	--	--
Methamphetamine	0.3736	0.8397	0.3747
Misuse of Prescription Pain Relievers	0.1129	0.1182	0.6884
Misuse of Prescription Stimulants	0.2520	0.8102	0.1091
Misuse of Prescription Tranquilizers	*	0.3536	0.2178
Misuse of Prescription Sedatives	*	*	*
Daily Cigarette Use²	0.1208	0.7317	0.9227
Smokeless Tobacco	0.4349	0.5371	0.1192
Cigars	0.7541	0.8731	0.0270
Alcohol	0.0000	0.0918	0.0131
Binge Alcohol Use	0.3019	0.0992	0.8381
SMOKED 1+ PACKS OF CIGARETTES PER DAY AMONG DAILY CIGARETTE USERS³	0.0171	0.2702	0.3198
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Tables among people aged 12-20 and aged 21+ are included because they are the underage and legal age groups for alcohol and tobacco. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ² Daily cigarette use includes only respondents who smoked cigarettes on each of the past 30 days. ³ Respondents with unknown data for number of cigarettes smoked per day were excluded from the analysis. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.34C – Past Year Initiation of Substance Use: Among People Aged 12 or Older; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
ILLICIT DRUGS	nr	nr	nr	nr
Marijuana	172	186	162	155
Cocaine	80	70	63	58
Crack	23	12	27	23
Heroin	9	24	11	10
Hallucinogens	111	108	95	126
LSD	82	61	47	40
PCP	71	7	17	20
Ecstasy	73	50	68	51
Inhalants	--	--	--	68
Methamphetamine	21	63	23	29
Misuse of Prescription Psychotherapeutics	nr	nr	nr	nr
Pain Relievers	198	120	122	128
Stimulants	94	81	77	70
Tranquilizers or Sedatives	nr	nr	nr	nr
Tranquilizers	130	94	67	83
Sedatives	47	29	65	50
Benzodiazepines	--	--	--	--
Opioids	--	--	--	--
Illicit Drugs Other than Marijuana¹	nr	nr	nr	nr
TOBACCO PRODUCTS²	nr	nr	nr	nr
Cigarettes	106	94	95	93
Daily Cigarettes	71	39	56	40
Smokeless Tobacco	71	57	94	85
Cigars	99	132	153	106
ALCOHOL	177	157	165	164
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Methodological limitations preclude the estimation of past year initiates for aggregate substance use categories having at least one prescription psychotherapeutic, including categories for overall illicit drugs, misuse of prescription psychotherapeutics, tranquilizers or sedatives, opioids, and illicit drugs other than marijuana (see Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions). NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ² Because respondents were not asked initiation questions for pipe tobacco, initiation of the aggregate tobacco products measure cannot be determined (see Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.34D – Past Year Initiation of Substance Use: Among People Aged 12 or Older; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
ILLICIT DRUGS	nr	nr	nr	nr
Marijuana	0.06	0.07	0.06	0.05
Cocaine	0.03	0.02	0.02	0.02
Crack	0.01	<0.01	0.01	0.01
Heroin	<0.01	0.01	<0.01	<0.01
Hallucinogens	0.04	0.04	0.03	0.04
LSD	0.03	0.02	0.02	0.01
PCP	0.03	<0.01	0.01	0.01
Ecstasy	0.03	0.02	0.02	0.02
Inhalants	--	--	--	0.02
Methamphetamine	0.01	0.02	0.01	0.01
Misuse of Prescription Psychotherapeutics	nr	nr	nr	nr
Pain Relievers	0.07	0.04	0.04	0.04
Stimulants	0.03	0.03	0.03	0.02
Tranquilizers or Sedatives	nr	nr	nr	nr
Tranquilizers	0.05	0.03	0.02	0.03
Sedatives	0.02	0.01	0.02	0.02
Benzodiazepines	--	--	--	--
Opioids	--	--	--	--
Illicit Drugs Other than Marijuana¹	nr	nr	nr	nr
TOBACCO PRODUCTS²	nr	nr	nr	nr
Cigarettes	0.04	0.03	0.03	0.03
Daily Cigarettes	0.03	0.01	0.02	0.01
Smokeless Tobacco	0.03	0.02	0.03	0.03
Cigars	0.04	0.05	0.05	0.04
ALCOHOL	0.06	0.06	0.06	0.06
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Methodological limitations preclude the estimation of past year initiates for aggregate substance use categories having at least one prescription psychotherapeutic, including categories for overall illicit drugs, misuse of prescription psychotherapeutics, tranquilizers or sedatives, opioids, and illicit drugs other than marijuana (see Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions). NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ² Because respondents were not asked initiation questions for pipe tobacco, initiation of the aggregate tobacco products measure cannot be determined (see Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.34P – Past Year Initiation of Substance Use: Among People Aged 12 or Older; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
ILLICIT DRUGS	nr	nr	nr
Marijuana	0.4815	0.0003	0.0084
Cocaine	0.5329	0.3195	0.5473
Crack	0.7459	0.1903	0.6313
Heroin	0.7234	0.0871	0.9043
Hallucinogens	0.1271	0.2518	0.5468
LSD	0.0000	0.0022	0.1823
PCP	0.4022	0.2389	0.5608
Ecstasy	0.0428	0.8749	0.1023
Inhalants	--	--	--
Methamphetamine	0.9349	0.2885	0.5231
Misuse of Prescription Psychotherapeutics	nr	nr	nr
Pain Relievers	0.1668	0.3385	0.5162
Stimulants	0.0782	0.0749	0.3055
Tranquilizers or Sedatives	nr	nr	nr
Tranquilizers	0.1513	0.6328	0.1229
Sedatives	0.7313	0.3241	0.5409
Benzodiazepines	--	--	--
Opioids	--	--	--
Illicit Drugs Other than Marijuana¹	nr	nr	nr
TOBACCO PRODUCTS²	nr	nr	nr
Cigarettes	0.1485	0.4510	0.7514
Daily Cigarettes	0.2762	0.4526	0.1890
Smokeless Tobacco	0.0000	0.0000	0.1517
Cigars	0.4685	0.8206	0.0189
ALCOHOL	0.7368	0.6745	0.7764
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Methodological limitations preclude the estimation of past year initiates for aggregate substance use categories having at least one prescription psychotherapeutic, including categories for overall illicit drugs, misuse of prescription psychotherapeutics, tranquilizers or sedatives, opioids, and illicit drugs other than marijuana (see Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions). NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ² Because respondents were not asked initiation questions for pipe tobacco, initiation of the aggregate tobacco products measure cannot be determined (see Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.35C – Past Year Initiation of Substance Use: Among People Aged 12 to 17; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
ILLICIT DRUGS	nr	nr	nr	nr
Marijuana	74	72	73	66
Cocaine	7	12	7	10
Crack	2	<1	4	4
Heroin	1	*	4	6
Hallucinogens	37	30	32	33
LSD	35	22	20	22
PCP	8	6	6	1
Ecstasy	17	15	15	8
Inhalants	--	--	--	35
Methamphetamine	12	5	9	5
Misuse of Prescription Psychotherapeutics	nr	nr	nr	nr
Pain Relievers	36	27	26	26
Stimulants	32	22	19	14
Tranquilizers or Sedatives	nr	nr	nr	nr
Tranquilizers	20	13	11	15
Sedatives	8	9	16	6
Benzodiazepines	--	--	--	--
Opioids	--	--	--	--
Illicit Drugs Other than Marijuana¹	nr	nr	nr	nr
TOBACCO PRODUCTS²	nr	nr	nr	nr
Cigarettes	58	47	47	34
Daily Cigarettes	14	11	7	10
Smokeless Tobacco	25	21	20	28
Cigars	49	29	36	30
ALCOHOL	100	90	91	84
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Methodological limitations preclude the estimation of past year initiates for aggregate substance use categories having at least one prescription psychotherapeutic, including categories for overall illicit drugs, misuse of prescription psychotherapeutics, tranquilizers or sedatives, opioids, and illicit drugs other than marijuana (see Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions). NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ² Because respondents were not asked initiation questions for pipe tobacco, initiation of the aggregate tobacco products measure cannot be determined (see Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.35D – Past Year Initiation of Substance Use: Among People Aged 12 to 17; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
ILLICIT DRUGS	nr	nr	nr	nr
Marijuana	0.28	0.28	0.28	0.26
Cocaine	0.03	0.05	0.03	0.04
Crack	0.01	<0.01	0.02	0.02
Heroin	<0.01	*	0.02	0.02
Hallucinogens	0.14	0.12	0.12	0.13
LSD	0.13	0.08	0.08	0.08
PCP	0.03	0.02	0.02	<0.01
Ecstasy	0.06	0.06	0.06	0.03
Inhalants	--	--	--	0.13
Methamphetamine	0.04	0.02	0.03	0.02
Misuse of Prescription Psychotherapeutics	nr	nr	nr	nr
Pain Relievers	0.14	0.10	0.10	0.10
Stimulants	0.12	0.09	0.07	0.05
Tranquilizers or Sedatives	nr	nr	nr	nr
Tranquilizers	0.08	0.05	0.04	0.06
Sedatives	0.03	0.04	0.06	0.02
Benzodiazepines	--	--	--	--
Opioids	--	--	--	--
Illicit Drugs Other than Marijuana¹	nr	nr	nr	nr
TOBACCO PRODUCTS²	nr	nr	nr	nr
Cigarettes	0.22	0.18	0.18	0.13
Daily Cigarettes	0.05	0.04	0.03	0.04
Smokeless Tobacco	0.10	0.08	0.08	0.11
Cigars	0.19	0.11	0.14	0.12
ALCOHOL	0.38	0.35	0.35	0.32
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Methodological limitations preclude the estimation of past year initiates for aggregate substance use categories having at least one prescription psychotherapeutic, including categories for overall illicit drugs, misuse of prescription psychotherapeutics, tranquilizers or sedatives, opioids, and illicit drugs other than marijuana (see Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions). NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ² Because respondents were not asked initiation questions for pipe tobacco, initiation of the aggregate tobacco products measure cannot be determined (see Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.35P – Past Year Initiation of Substance Use: Among People Aged 12 to 17; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
ILLICIT DRUGS	nr	nr	nr
Marijuana	0.9941	0.0010	0.0084
Cocaine	0.1465	0.8242	0.3755
Crack	0.4993	0.1879	0.7174
Heroin	0.1249	*	0.4344
Hallucinogens	0.4675	0.7277	0.8105
LSD	0.1146	0.1973	0.6422
PCP	0.1212	0.2447	0.2018
Ecstasy	0.1031	0.3918	0.0388
Inhalants	--	--	--
Methamphetamine	0.3589	0.5036	0.9746
Misuse of Prescription Psychotherapeutics	nr	nr	nr
Pain Relievers	0.8974	0.2915	0.1197
Stimulants	0.0082	0.0696	0.1897
Tranquilizers or Sedatives	nr	nr	nr
Tranquilizers	0.4921	0.8470	0.4431
Sedatives	0.8528	0.7928	0.0993
Benzodiazepines	--	--	--
Opioids	--	--	--
Illicit Drugs Other than Marijuana¹	nr	nr	nr
TOBACCO PRODUCTS²	nr	nr	nr
Cigarettes	0.4576	0.0816	0.0594
Daily Cigarettes	0.9449	0.6150	0.2901
Smokeless Tobacco	0.2279	0.0499	0.0837
Cigars	0.2312	0.7093	0.6574
ALCOHOL	0.1586	0.1882	0.1679
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Methodological limitations preclude the estimation of past year initiates for aggregate substance use categories having at least one prescription psychotherapeutic, including categories for overall illicit drugs, misuse of prescription psychotherapeutics, tranquilizers or sedatives, opioids, and illicit drugs other than marijuana (see Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions). NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ² Because respondents were not asked initiation questions for pipe tobacco, initiation of the aggregate tobacco products measure cannot be determined (see Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.36C – Past Year Initiation of Substance Use: Among People Aged 18 or Older; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
ILLICIT DRUGS	nr	nr	nr	nr
Marijuana	156	173	144	138
Cocaine	80	67	62	58
Crack	23	12	27	23
Heroin	9	24	10	8
Hallucinogens	103	107	92	123
LSD	72	59	43	36
PCP	71	4	16	20
Ecstasy	73	48	66	51
Inhalants	--	--	--	59
Methamphetamine	17	63	22	29
Misuse of Prescription Psychotherapeutics	nr	nr	nr	nr
Pain Relievers	195	118	121	126
Stimulants	89	78	76	68
Tranquilizers or Sedatives	nr	nr	nr	nr
Tranquilizers	124	93	66	82
Sedatives	47	28	63	50
Benzodiazepines	--	--	--	--
Opioids	--	--	--	--
Illicit Drugs Other than Marijuana¹	nr	nr	nr	nr
TOBACCO PRODUCTS²	nr	nr	nr	nr
Cigarettes	87	83	82	86
Daily Cigarettes	70	37	55	39
Smokeless Tobacco	67	54	92	80
Cigars	90	129	148	102
ALCOHOL	144	121	128	131
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Methodological limitations preclude the estimation of past year initiates for aggregate substance use categories having at least one prescription psychotherapeutic, including categories for overall illicit drugs, misuse of prescription psychotherapeutics, tranquilizers or sedatives, opioids, and illicit drugs other than marijuana (see Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions). NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ² Because respondents were not asked initiation questions for pipe tobacco, initiation of the aggregate tobacco products measure cannot be determined (see Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.36D – Past Year Initiation of Substance Use: Among People Aged 18 or Older; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
ILLICIT DRUGS	nr	nr	nr	nr
Marijuana	0.06	0.07	0.06	0.05
Cocaine	0.03	0.03	0.02	0.02
Crack	0.01	<0.01	0.01	0.01
Heroin	<0.01	0.01	<0.01	<0.01
Hallucinogens	0.04	0.04	0.04	0.05
LSD	0.03	0.02	0.02	0.01
PCP	0.03	<0.01	0.01	0.01
Ecstasy	0.03	0.02	0.03	0.02
Inhalants	--	--	--	0.02
Methamphetamine	0.01	0.02	0.01	0.01
Misuse of Prescription Psychotherapeutics	nr	nr	nr	nr
Pain Relievers	0.08	0.05	0.05	0.05
Stimulants	0.04	0.03	0.03	0.03
Tranquilizers or Sedatives	nr	nr	nr	nr
Tranquilizers	0.05	0.04	0.03	0.03
Sedatives	0.02	0.01	0.02	0.02
Benzodiazepines	--	--	--	--
Opioids	--	--	--	--
Illicit Drugs Other than Marijuana¹	nr	nr	nr	nr
TOBACCO PRODUCTS²	nr	nr	nr	nr
Cigarettes	0.03	0.03	0.03	0.03
Daily Cigarettes	0.03	0.01	0.02	0.01
Smokeless Tobacco	0.03	0.02	0.04	0.03
Cigars	0.04	0.05	0.06	0.04
ALCOHOL	0.06	0.05	0.05	0.05
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Methodological limitations preclude the estimation of past year initiates for aggregate substance use categories having at least one prescription psychotherapeutic, including categories for overall illicit drugs, misuse of prescription psychotherapeutics, tranquilizers or sedatives, opioids, and illicit drugs other than marijuana (see Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions). NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ² Because respondents were not asked initiation questions for pipe tobacco, initiation of the aggregate tobacco products measure cannot be determined (see Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.36P – Past Year Initiation of Substance Use: Among People Aged 18 or Older; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
ILLICIT DRUGS	nr	nr	nr
Marijuana	0.3707	0.0170	0.1265
Cocaine	0.4151	0.2809	0.4660
Crack	0.8228	0.2689	0.5840
Heroin	0.7148	0.0330	0.7697
Hallucinogens	0.1649	0.2794	0.4898
LSD	0.0000	0.0078	0.2310
PCP	0.5019	0.1104	0.3709
Ecstasy	0.0904	0.9650	0.2109
Inhalants	--	--	--
Methamphetamine	0.6504	0.2546	0.4993
Misuse of Prescription Psychotherapeutics	nr	nr	nr
Pain Relievers	0.1518	0.2337	0.3299
Stimulants	0.3365	0.1620	0.4591
Tranquilizers or Sedatives	nr	nr	nr
Tranquilizers	0.1707	0.6022	0.1561
Sedatives	0.7089	0.2911	0.7803
Benzodiazepines	--	--	--
Opioids	--	--	--
Illicit Drugs Other than Marijuana¹	nr	nr	nr
TOBACCO PRODUCTS²	nr	nr	nr
Cigarettes	0.0291	0.0917	0.5447
Daily Cigarettes	0.2609	0.3530	0.1252
Smokeless Tobacco	0.0000	0.0000	0.3067
Cigars	0.1799	0.8947	0.0203
ALCOHOL	0.4240	0.6242	0.4884
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Methodological limitations preclude the estimation of past year initiates for aggregate substance use categories having at least one prescription psychotherapeutic, including categories for overall illicit drugs, misuse of prescription psychotherapeutics, tranquilizers or sedatives, opioids, and illicit drugs other than marijuana (see Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions). NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ² Because respondents were not asked initiation questions for pipe tobacco, initiation of the aggregate tobacco products measure cannot be determined (see Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.37C – Past Year Initiation of Substance Use: Among People Aged 18 to 25; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
ILLICIT DRUGS	nr	nr	nr	nr
Marijuana	95	82	80	72
Cocaine	50	51	36	42
Crack	11	7	17	3
Heroin	7	11	4	8
Hallucinogens	75	61	54	58
LSD	51	37	26	26
PCP	8	3	*	3
Ecstasy	46	29	47	33
Inhalants	--	--	--	43
Methamphetamine	8	23	5	13
Misuse of Prescription Psychotherapeutics	nr	nr	nr	nr
Pain Relievers	44	42	28	42
Stimulants	53	41	44	36
Tranquilizers or Sedatives	nr	nr	nr	nr
Tranquilizers	36	32	23	23
Sedatives	16	12	8	10
Benzodiazepines	--	--	--	--
Opioids	--	--	--	--
Illicit Drugs Other than Marijuana¹	nr	nr	nr	nr
TOBACCO PRODUCTS²	nr	nr	nr	nr
Cigarettes	77	67	73	75
Daily Cigarettes	29	30	31	35
Smokeless Tobacco	48	37	66	52
Cigars	79	66	79	69
ALCOHOL	119	105	116	116
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Methodological limitations preclude the estimation of past year initiates for aggregate substance use categories having at least one prescription psychotherapeutic, including categories for overall illicit drugs, misuse of prescription psychotherapeutics, tranquilizers or sedatives, opioids, and illicit drugs other than marijuana (see Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions). NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ² Because respondents were not asked initiation questions for pipe tobacco, initiation of the aggregate tobacco products measure cannot be determined (see Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.37D – Past Year Initiation of Substance Use: Among People Aged 18 to 25; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
ILLICIT DRUGS	nr	nr	nr	nr
Marijuana	0.28	0.24	0.23	0.21
Cocaine	0.15	0.15	0.11	0.12
Crack	0.03	0.02	0.05	0.01
Heroin	0.02	0.03	0.01	0.02
Hallucinogens	0.22	0.18	0.16	0.16
LSD	0.15	0.11	0.08	0.07
PCP	0.02	0.01	*	0.01
Ecstasy	0.14	0.08	0.14	0.10
Inhalants	--	--	--	0.12
Methamphetamine	0.02	0.07	0.01	0.04
Misuse of Prescription Psychotherapeutics	nr	nr	nr	nr
Pain Relievers	0.13	0.12	0.08	0.12
Stimulants	0.16	0.12	0.13	0.10
Tranquilizers or Sedatives	nr	nr	nr	nr
Tranquilizers	0.11	0.09	0.07	0.07
Sedatives	0.05	0.03	0.02	0.03
Benzodiazepines	--	--	--	--
Opioids	--	--	--	--
Illicit Drugs Other than Marijuana¹	nr	nr	nr	nr
TOBACCO PRODUCTS²	nr	nr	nr	nr
Cigarettes	0.23	0.19	0.22	0.21
Daily Cigarettes	0.09	0.09	0.09	0.10
Smokeless Tobacco	0.14	0.11	0.19	0.15
Cigars	0.23	0.19	0.23	0.20
ALCOHOL	0.36	0.30	0.34	0.33
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Methodological limitations preclude the estimation of past year initiates for aggregate substance use categories having at least one prescription psychotherapeutic, including categories for overall illicit drugs, misuse of prescription psychotherapeutics, tranquilizers or sedatives, opioids, and illicit drugs other than marijuana (see Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions). NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ² Because respondents were not asked initiation questions for pipe tobacco, initiation of the aggregate tobacco products measure cannot be determined (see Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.37P – Past Year Initiation of Substance Use: Among People Aged 18 to 25; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
ILLICIT DRUGS	nr	nr	nr
Marijuana	0.1046	0.0961	0.0735
Cocaine	0.7745	0.1387	0.9113
Crack	0.3456	0.6667	0.1596
Heroin	0.3769	0.5530	0.1305
Hallucinogens	0.0448	0.1414	0.3832
LSD	0.0000	0.0214	0.4228
PCP	0.2316	0.7909	*
Ecstasy	0.0079	0.5120	0.0969
Inhalants	--	--	--
Methamphetamine	0.9071	0.2011	0.4877
Misuse of Prescription Psychotherapeutics	nr	nr	nr
Pain Relievers	0.6410	0.6943	0.3788
Stimulants	0.1320	0.3468	0.4890
Tranquilizers or Sedatives	nr	nr	nr
Tranquilizers	0.0075	0.1080	0.6102
Sedatives	0.0632	0.1096	0.4401
Benzodiazepines	--	--	--
Opioids	--	--	--
Illicit Drugs Other than Marijuana¹	nr	nr	nr
TOBACCO PRODUCTS²	nr	nr	nr
Cigarettes	0.0349	0.0403	0.7669
Daily Cigarettes	0.7562	0.8215	0.3704
Smokeless Tobacco	0.0001	0.0001	0.8453
Cigars	0.7973	0.6793	0.0343
ALCOHOL	0.2882	0.5289	0.9493
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Methodological limitations preclude the estimation of past year initiates for aggregate substance use categories having at least one prescription psychotherapeutic, including categories for overall illicit drugs, misuse of prescription psychotherapeutics, tranquilizers or sedatives, opioids, and illicit drugs other than marijuana (see Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions). NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ² Because respondents were not asked initiation questions for pipe tobacco, initiation of the aggregate tobacco products measure cannot be determined (see Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.38C – Past Year Initiation of Substance Use: Among People Aged 26 or Older; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
ILLICIT DRUGS	nr	nr	nr	nr
Marijuana	111	153	127	113
Cocaine	50	40	51	38
Crack	20	9	21	23
Heroin	6	21	9	*
Hallucinogens	68	78	75	107
LSD	51	46	35	26
PCP	71	2	16	19
Ecstasy	56	39	47	38
Inhalants	--	--	--	40
Methamphetamine	16	59	21	26
Misuse of Prescription Psychotherapeutics	nr	nr	nr	nr
Pain Relievers	190	110	119	121
Stimulants	68	66	59	59
Tranquilizers or Sedatives	nr	nr	nr	nr
Tranquilizers	118	87	63	78
Sedatives	44	25	63	49
Benzodiazepines	--	--	--	--
Opioids	--	--	--	--
Illicit Drugs Other than Marijuana¹	nr	nr	nr	nr
TOBACCO PRODUCTS²	nr	nr	nr	nr
Cigarettes	37	44	29	38
Daily Cigarettes	63	22	43	16
Smokeless Tobacco	45	38	64	56
Cigars	58	113	126	69
ALCOHOL	75	43	38	52
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Methodological limitations preclude the estimation of past year initiates for aggregate substance use categories having at least one prescription psychotherapeutic, including categories for overall illicit drugs, misuse of prescription psychotherapeutics, tranquilizers or sedatives, opioids, and illicit drugs other than marijuana (see Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions). NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ² Because respondents were not asked initiation questions for pipe tobacco, initiation of the aggregate tobacco products measure cannot be determined (see Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.38D – Past Year Initiation of Substance Use: Among People Aged 26 or Older; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
ILLICIT DRUGS	nr	nr	nr	nr
Marijuana	0.05	0.07	0.06	0.05
Cocaine	0.02	0.02	0.02	0.02
Crack	0.01	<0.01	0.01	0.01
Heroin	<0.01	0.01	<0.01	*
Hallucinogens	0.03	0.04	0.03	0.05
LSD	0.02	0.02	0.02	0.01
PCP	0.03	<0.01	0.01	0.01
Ecstasy	0.03	0.02	0.02	0.02
Inhalants	--	--	--	0.02
Methamphetamine	0.01	0.03	0.01	0.01
Misuse of Prescription Psychotherapeutics	nr	nr	nr	nr
Pain Relievers	0.09	0.05	0.05	0.05
Stimulants	0.03	0.03	0.03	0.03
Tranquilizers or Sedatives	nr	nr	nr	nr
Tranquilizers	0.05	0.04	0.03	0.03
Sedatives	0.02	0.01	0.03	0.02
Benzodiazepines	--	--	--	--
Opioids	--	--	--	--
Illicit Drugs Other than Marijuana¹	nr	nr	nr	nr
TOBACCO PRODUCTS²	nr	nr	nr	nr
Cigarettes	0.02	0.02	0.01	0.02
Daily Cigarettes	0.03	0.01	0.02	0.01
Smokeless Tobacco	0.02	0.02	0.03	0.02
Cigars	0.03	0.05	0.06	0.03
ALCOHOL	0.03	0.02	0.02	0.02
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Methodological limitations preclude the estimation of past year initiates for aggregate substance use categories having at least one prescription psychotherapeutic, including categories for overall illicit drugs, misuse of prescription psychotherapeutics, tranquilizers or sedatives, opioids, and illicit drugs other than marijuana (see Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions). NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ² Because respondents were not asked initiation questions for pipe tobacco, initiation of the aggregate tobacco products measure cannot be determined (see Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.38P – Past Year Initiation of Substance Use: Among People Aged 26 or Older; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
ILLICIT DRUGS	nr	nr	nr
Marijuana	0.0199	0.0813	0.5204
Cocaine	0.3130	0.8989	0.2758
Crack	0.5412	0.1933	0.8502
Heroin	*	*	*
Hallucinogens	0.0017	0.0213	0.1871
LSD	0.0719	0.1364	0.3428
PCP	0.5867	0.1145	0.4744
Ecstasy	0.9513	0.5300	0.8497
Inhalants	--	--	--
Methamphetamine	0.5835	0.4848	0.6566
Misuse of Prescription Psychotherapeutics	nr	nr	nr
Pain Relievers	0.1712	0.1643	0.4581
Stimulants	0.8579	0.2894	0.6699
Tranquilizers or Sedatives	nr	nr	nr
Tranquilizers	0.5416	0.9818	0.1051
Sedatives	0.3591	0.1208	0.8703
Benzodiazepines	--	--	--
Opioids	--	--	--
Illicit Drugs Other than Marijuana¹	nr	nr	nr
TOBACCO PRODUCTS²	nr	nr	nr
Cigarettes	0.5916	0.8355	0.4930
Daily Cigarettes	0.1105	0.1793	0.1759
Smokeless Tobacco	0.0096	0.0008	0.2267
Cigars	0.1153	0.7228	0.1470
ALCOHOL	0.6429	0.6335	0.1249
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Methodological limitations preclude the estimation of past year initiates for aggregate substance use categories having at least one prescription psychotherapeutic, including categories for overall illicit drugs, misuse of prescription psychotherapeutics, tranquilizers or sedatives, opioids, and illicit drugs other than marijuana (see Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions). NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ² Because respondents were not asked initiation questions for pipe tobacco, initiation of the aggregate tobacco products measure cannot be determined (see Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.39D – Mean Age at First Substance Use: Among Past Year Initiates Aged 12 to 49; Standard Errors of Averages, 2021-2024
Substance	2021	2022	2023	2024
ILLICIT DRUGS	nr	nr	nr	nr
Marijuana	0.47	0.50	0.39	0.51
Cocaine	1.59	0.41	0.93	0.61
Crack	1.45	2.85	4.06	3.38
Heroin	2.10	2.82	4.31	1.26
Hallucinogens	0.59	0.61	0.66	0.72
LSD	0.67	0.93	1.08	1.33
PCP	1.85	2.40	*	*
Ecstasy	1.53	1.13	1.26	1.23
Inhalants	--	--	--	0.85
Methamphetamine	1.73	1.10	2.06	3.29
Misuse of Prescription Psychotherapeutics	nr	nr	nr	nr
Pain Relievers	1.18	1.04	1.06	1.13
Stimulants	1.33	1.03	0.80	1.43
Tranquilizers or Sedatives	nr	nr	nr	nr
Tranquilizers	1.31	1.06	1.40	1.37
Sedatives	1.29	2.50	2.05	2.06
Benzodiazepines	--	--	--	--
Opioids	--	--	--	--
Illicit Drugs Other Than Marijuana¹	nr	nr	nr	nr
TOBACCO PRODUCTS²	nr	nr	nr	nr
Cigarettes	0.72	0.53	0.30	0.52
Daily Cigarettes	1.18	0.74	0.85	0.88
Smokeless Tobacco	1.43	0.99	1.01	0.64
Cigars	0.50	1.05	0.54	0.55
ALCOHOL	0.40	0.16	0.15	0.21
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Methodological limitations preclude the estimation of past year initiates for aggregate substance use categories having at least one prescription psychotherapeutic, including categories for overall illicit drugs, misuse of prescription psychotherapeutics, tranquilizers or sedatives, opioids, and illicit drugs other than marijuana (see Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions). NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ² Because respondents were not asked initiation questions for pipe tobacco, initiation of the aggregate tobacco products measure cannot be determined (see Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.39P – Mean Age at First Substance Use: Among Past Year Initiates Aged 12 to 49; P Values from Tests of Differences of Averages, 2024 Versus 2021-2023
Substance	2021	2022	2023
ILLICIT DRUGS	nr	nr	nr
Marijuana	0.0488	0.8792	0.2663
Cocaine	0.1262	0.9832	0.0448
Crack	0.1813	0.7485	0.5300
Heroin	0.0060	0.0085	0.0312
Hallucinogens	0.0007	0.0166	0.3726
LSD	0.3642	0.7797	0.8637
PCP	*	*	*
Ecstasy	0.2469	0.3238	0.1753
Inhalants	--	--	--
Methamphetamine	0.0624	0.1948	0.1274
Misuse of Prescription Psychotherapeutics	nr	nr	nr
Pain Relievers	0.8241	0.0722	0.3791
Stimulants	0.2916	0.3971	0.1785
Tranquilizers or Sedatives	nr	nr	nr
Tranquilizers	0.3081	0.2918	0.9196
Sedatives	0.0025	0.0524	0.0504
Benzodiazepines	--	--	--
Opioids	--	--	--
Illicit Drugs Other Than Marijuana¹	nr	nr	nr
TOBACCO PRODUCTS²	nr	nr	nr
Cigarettes	0.5255	0.4831	0.4650
Daily Cigarettes	0.2817	0.9834	0.8264
Smokeless Tobacco	0.4340	0.4386	0.5728
Cigars	0.0320	0.8280	0.4822
ALCOHOL	0.5660	0.0234	0.0189
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Methodological limitations preclude the estimation of past year initiates for aggregate substance use categories having at least one prescription psychotherapeutic, including categories for overall illicit drugs, misuse of prescription psychotherapeutics, tranquilizers or sedatives, opioids, and illicit drugs other than marijuana (see Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions). NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ² Because respondents were not asked initiation questions for pipe tobacco, initiation of the aggregate tobacco products measure cannot be determined (see Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.40C – Substance Use Disorder for Specific Substances in Past Year: Among People Aged 12 or Older; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
SUBSTANCE USE DISORDER	847	774	768	805
DRUGS	620	634	615	655
Marijuana	499	474	504	540
Cocaine	157	149	124	125
Heroin	142	115	94	78
Hallucinogens	82	82	60	64
Inhalants	63	64	52	57
Methamphetamine	177	184	179	154
Prescription Psychotherapeutics	330	363	332	345
Pain Relievers	280	318	299	294
Prescription Opioids	267	308	276	281
Stimulants	125	128	129	125
Tranquilizers or Sedatives	186	186	167	169
Tranquilizers	162	169	145	135
Sedatives	139	100	105	108
Opioids¹	284	327	285	286
Central Nervous System Stimulants	262	252	243	224
ALCOHOL	717	620	579	582
BOTH DRUGS AND ALCOHOL	339	320	298	306
DRUGS ONLY (NO ALCOHOL USE DISORDER)	502	517	505	537
ALCOHOL ONLY (NO DRUG USE DISORDER)	634	565	514	521
NO SUBSTANCE USE DISORDER	847	774	768	805
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ¹ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.40D – Substance Use Disorder for Specific Substances in Past Year: Among People Aged 12 or Older; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
SUBSTANCE USE DISORDER	0.30	0.27	0.27	0.28
DRUGS	0.22	0.22	0.22	0.23
Marijuana	0.18	0.17	0.18	0.19
Cocaine	0.06	0.05	0.04	0.04
Heroin	0.05	0.04	0.03	0.03
Hallucinogens	0.03	0.03	0.02	0.02
Inhalants	0.02	0.02	0.02	0.02
Methamphetamine	0.06	0.07	0.06	0.05
Prescription Psychotherapeutics	0.12	0.13	0.12	0.12
Pain Relievers	0.10	0.11	0.11	0.10
Prescription Opioids	0.10	0.11	0.10	0.10
Stimulants	0.04	0.05	0.05	0.04
Tranquilizers or Sedatives	0.07	0.07	0.06	0.06
Tranquilizers	0.06	0.06	0.05	0.05
Sedatives	0.05	0.04	0.04	0.04
Opioids¹	0.10	0.12	0.10	0.10
Central Nervous System Stimulants	0.09	0.09	0.09	0.08
ALCOHOL	0.26	0.22	0.20	0.20
BOTH DRUGS AND ALCOHOL	0.12	0.11	0.11	0.11
DRUGS ONLY (NO ALCOHOL USE DISORDER)	0.18	0.18	0.18	0.19
ALCOHOL ONLY (NO DRUG USE DISORDER)	0.23	0.20	0.18	0.18
NO SUBSTANCE USE DISORDER	0.30	0.27	0.27	0.28
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ¹ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.40P – Substance Use Disorder for Specific Substances in Past Year: Among People Aged 12 or Older; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
SUBSTANCE USE DISORDER	0.8945	0.1959	0.4042
DRUGS	0.0010	0.7002	0.5217
Marijuana	0.0000	0.0952	0.1268
Cocaine	0.1817	0.1847	0.7003
Heroin	0.0020	0.0024	0.3968
Hallucinogens	0.4002	0.1087	0.9776
Inhalants	0.8830	0.8758	0.6099
Methamphetamine	0.6528	0.2270	0.2763
Prescription Psychotherapeutics	0.9352	0.1224	0.4133
Pain Relievers	0.6074	0.0880	0.2543
Prescription Opioids	0.6381	0.0928	0.6326
Stimulants	0.1496	0.8981	0.5867
Tranquilizers or Sedatives	0.3875	0.2263	0.3940
Tranquilizers	0.2113	0.1165	0.1472
Sedatives	0.3938	0.7910	0.6350
Opioids¹	0.1944	0.0192	0.4561
Central Nervous System Stimulants	0.8303	0.3018	0.6849
ALCOHOL	0.0035	0.0069	0.0715
BOTH DRUGS AND ALCOHOL	0.8081	0.2754	0.8675
DRUGS ONLY (NO ALCOHOL USE DISORDER)	0.0002	0.2706	0.4946
ALCOHOL ONLY (NO DRUG USE DISORDER)	0.0005	0.0180	0.0349
NO SUBSTANCE USE DISORDER	0.8945	0.1959	0.4042
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ¹ Some 2021-2023 estimates that are used in these comparisons may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.41C – Substance Use Disorder for Specific Substances in Past Year: Among People Aged 12 to 17; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
SUBSTANCE USE DISORDER	126	99	97	91
DRUGS	110	90	88	85
Marijuana	99	75	74	73
Cocaine	4	3	16	6
Heroin	1	2	*	6
Hallucinogens	16	17	13	21
Inhalants	24	21	17	21
Methamphetamine	10	4	10	8
Prescription Psychotherapeutics	59	47	49	49
Pain Relievers	39	32	36	34
Prescription Opioids	38	29	27	33
Stimulants	45	30	34	31
Tranquilizers or Sedatives	25	26	22	23
Tranquilizers	24	16	18	20
Sedatives	16	20	16	13
Opioids¹	38	29	27	34
Central Nervous System Stimulants	45	31	35	32
ALCOHOL	80	57	59	59
BOTH DRUGS AND ALCOHOL	53	39	35	46
DRUGS ONLY (NO ALCOHOL USE DISORDER)	97	89	82	72
ALCOHOL ONLY (NO DRUG USE DISORDER)	63	42	47	36
NO SUBSTANCE USE DISORDER	126	99	97	91
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ¹ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.41D – Substance Use Disorder for Specific Substances in Past Year: Among People Aged 12 to 17; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
SUBSTANCE USE DISORDER	0.48	0.39	0.37	0.35
DRUGS	0.42	0.35	0.34	0.33
Marijuana	0.38	0.29	0.28	0.28
Cocaine	0.02	0.01	0.06	0.02
Heroin	<0.01	0.01	*	0.02
Hallucinogens	0.06	0.07	0.05	0.08
Inhalants	0.09	0.08	0.07	0.08
Methamphetamine	0.04	0.01	0.04	0.03
Prescription Psychotherapeutics	0.22	0.18	0.19	0.19
Pain Relievers	0.15	0.12	0.14	0.13
Prescription Opioids	0.14	0.11	0.10	0.13
Stimulants	0.17	0.12	0.13	0.12
Tranquilizers or Sedatives	0.10	0.10	0.09	0.09
Tranquilizers	0.09	0.06	0.07	0.08
Sedatives	0.06	0.08	0.06	0.05
Opioids¹	0.14	0.11	0.10	0.13
Central Nervous System Stimulants	0.17	0.12	0.14	0.12
ALCOHOL	0.31	0.22	0.23	0.23
BOTH DRUGS AND ALCOHOL	0.21	0.15	0.14	0.18
DRUGS ONLY (NO ALCOHOL USE DISORDER)	0.37	0.34	0.32	0.28
ALCOHOL ONLY (NO DRUG USE DISORDER)	0.24	0.16	0.18	0.14
NO SUBSTANCE USE DISORDER	0.48	0.39	0.37	0.35
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ¹ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.41P – Substance Use Disorder for Specific Substances in Past Year: Among People Aged 12 to 17; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
SUBSTANCE USE DISORDER	0.0150	0.0948	0.2155
DRUGS	0.1722	0.3108	0.5438
Marijuana	0.2996	0.3388	0.9622
Cocaine	0.3504	0.2539	0.0657
Heroin	0.2034	0.2555	*
Hallucinogens	0.2106	0.8879	0.3484
Inhalants	0.7237	0.6474	0.8227
Methamphetamine	0.2960	0.8525	0.2843
Prescription Psychotherapeutics	0.4258	0.7548	0.2683
Pain Relievers	0.8059	0.6955	0.5346
Prescription Opioids	0.6104	0.4040	0.4500
Stimulants	0.1414	0.1050	0.2399
Tranquilizers or Sedatives	0.5906	0.6500	0.5052
Tranquilizers	0.5465	0.8243	0.8568
Sedatives	0.5570	0.3906	0.1708
Opioids¹	0.5506	0.3557	0.3981
Central Nervous System Stimulants	0.1942	0.1765	0.2094
ALCOHOL	0.0555	0.8551	0.8354
BOTH DRUGS AND ALCOHOL	1.0000	0.0497	0.0600
DRUGS ONLY (NO ALCOHOL USE DISORDER)	0.1209	0.0359	0.0917
ALCOHOL ONLY (NO DRUG USE DISORDER)	0.0108	0.0789	0.1154
NO SUBSTANCE USE DISORDER	0.0150	0.0948	0.2155
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ¹ Some 2021-2023 estimates that are used in these comparisons may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.42C – Substance Use Disorder for Specific Substances in Past Year: Among People Aged 18 or Older; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
SUBSTANCE USE DISORDER	833	763	756	795
DRUGS	595	623	601	640
Marijuana	481	469	494	529
Cocaine	157	149	123	124
Heroin	142	115	94	78
Hallucinogens	80	82	58	60
Inhalants	59	57	50	53
Methamphetamine	177	184	179	153
Prescription Psychotherapeutics	323	359	326	338
Pain Relievers	275	318	296	292
Prescription Opioids	263	307	273	279
Stimulants	115	124	122	120
Tranquilizers or Sedatives	183	185	164	167
Tranquilizers	158	168	143	134
Sedatives	138	99	104	107
Opioids¹	281	325	281	283
Central Nervous System Stimulants	256	249	238	221
ALCOHOL	712	618	574	578
BOTH DRUGS AND ALCOHOL	331	318	295	298
DRUGS ONLY (NO ALCOHOL USE DISORDER)	479	507	494	531
ALCOHOL ONLY (NO DRUG USE DISORDER)	630	562	509	520
NO SUBSTANCE USE DISORDER	833	763	756	795
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ¹ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.42D – Substance Use Disorder for Specific Substances in Past Year: Among People Aged 18 or Older; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
SUBSTANCE USE DISORDER	0.33	0.30	0.29	0.30
DRUGS	0.23	0.24	0.23	0.24
Marijuana	0.19	0.18	0.19	0.20
Cocaine	0.06	0.06	0.05	0.05
Heroin	0.06	0.04	0.04	0.03
Hallucinogens	0.03	0.03	0.02	0.02
Inhalants	0.02	0.02	0.02	0.02
Methamphetamine	0.07	0.07	0.07	0.06
Prescription Psychotherapeutics	0.13	0.14	0.13	0.13
Pain Relievers	0.11	0.12	0.11	0.11
Prescription Opioids	0.10	0.12	0.11	0.11
Stimulants	0.05	0.05	0.05	0.05
Tranquilizers or Sedatives	0.07	0.07	0.06	0.06
Tranquilizers	0.06	0.07	0.06	0.05
Sedatives	0.05	0.04	0.04	0.04
Opioids¹	0.11	0.13	0.11	0.11
Central Nervous System Stimulants	0.10	0.10	0.09	0.08
ALCOHOL	0.28	0.24	0.22	0.22
BOTH DRUGS AND ALCOHOL	0.13	0.12	0.11	0.11
DRUGS ONLY (NO ALCOHOL USE DISORDER)	0.19	0.20	0.19	0.20
ALCOHOL ONLY (NO DRUG USE DISORDER)	0.25	0.22	0.20	0.20
NO SUBSTANCE USE DISORDER	0.33	0.30	0.29	0.30
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ¹ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.42P – Substance Use Disorder for Specific Substances in Past Year: Among People Aged 18 or Older; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
SUBSTANCE USE DISORDER	0.6970	0.2587	0.4690
DRUGS	0.0004	0.6056	0.4621
Marijuana	0.0000	0.0682	0.1185
Cocaine	0.1643	0.1686	0.8278
Heroin	0.0016	0.0020	0.3511
Hallucinogens	0.2381	0.0902	0.7590
Inhalants	0.9848	0.9929	0.6356
Methamphetamine	0.6806	0.2202	0.3018
Prescription Psychotherapeutics	0.9740	0.1283	0.4985
Pain Relievers	0.5688	0.0789	0.2780
Prescription Opioids	0.5775	0.0737	0.5654
Stimulants	0.0412	0.7702	0.3850
Tranquilizers or Sedatives	0.4177	0.2469	0.4385
Tranquilizers	0.2355	0.1071	0.1501
Sedatives	0.4276	0.8959	0.7680
Opioids¹	0.1590	0.0137	0.3926
Central Nervous System Stimulants	0.9842	0.3832	0.8177
ALCOHOL	0.0052	0.0059	0.0609
BOTH DRUGS AND ALCOHOL	0.8178	0.1666	0.9084
DRUGS ONLY (NO ALCOHOL USE DISORDER)	0.0001	0.1536	0.3422
ALCOHOL ONLY (NO DRUG USE DISORDER)	0.0009	0.0234	0.0433
NO SUBSTANCE USE DISORDER	0.6970	0.2587	0.4690
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ¹ Some 2021-2023 estimates that are used in these comparisons may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.43C – Substance Use Disorder for Specific Substances in Past Year: Among People Aged 18 to 25; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
SUBSTANCE USE DISORDER	226	229	199	191
DRUGS	191	186	176	175
Marijuana	187	179	169	169
Cocaine	46	40	28	40
Heroin	19	10	7	10
Hallucinogens	37	40	24	22
Inhalants	31	26	10	21
Methamphetamine	34	15	16	21
Prescription Psychotherapeutics	77	71	59	59
Pain Relievers	56	47	46	42
Prescription Opioids	54	45	43	39
Stimulants	47	57	37	45
Tranquilizers or Sedatives	45	36	33	31
Tranquilizers	42	31	29	28
Sedatives	26	20	18	20
Opioids¹	54	45	43	41
Central Nervous System Stimulants	65	68	45	62
ALCOHOL	182	180	164	149
BOTH DRUGS AND ALCOHOL	110	116	103	107
DRUGS ONLY (NO ALCOHOL USE DISORDER)	159	150	147	140
ALCOHOL ONLY (NO DRUG USE DISORDER)	155	142	125	122
NO SUBSTANCE USE DISORDER	226	229	199	191
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ¹ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.43D – Substance Use Disorder for Specific Substances in Past Year: Among People Aged 18 to 25; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
SUBSTANCE USE DISORDER	0.68	0.66	0.59	0.55
DRUGS	0.57	0.54	0.52	0.50
Marijuana	0.56	0.52	0.50	0.48
Cocaine	0.14	0.11	0.08	0.11
Heroin	0.06	0.03	0.02	0.03
Hallucinogens	0.11	0.11	0.07	0.06
Inhalants	0.09	0.08	0.03	0.06
Methamphetamine	0.10	0.04	0.05	0.06
Prescription Psychotherapeutics	0.23	0.20	0.17	0.17
Pain Relievers	0.17	0.13	0.14	0.12
Prescription Opioids	0.16	0.13	0.13	0.11
Stimulants	0.14	0.16	0.11	0.13
Tranquilizers or Sedatives	0.14	0.10	0.10	0.09
Tranquilizers	0.12	0.09	0.09	0.08
Sedatives	0.08	0.06	0.05	0.06
Opioids¹	0.16	0.13	0.13	0.12
Central Nervous System Stimulants	0.19	0.20	0.13	0.18
ALCOHOL	0.54	0.52	0.48	0.43
BOTH DRUGS AND ALCOHOL	0.33	0.33	0.30	0.31
DRUGS ONLY (NO ALCOHOL USE DISORDER)	0.47	0.43	0.43	0.40
ALCOHOL ONLY (NO DRUG USE DISORDER)	0.46	0.41	0.37	0.35
NO SUBSTANCE USE DISORDER	0.68	0.66	0.59	0.55
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ¹ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.43P – Substance Use Disorder for Specific Substances in Past Year: Among People Aged 18 to 25; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
SUBSTANCE USE DISORDER	0.7548	0.0286	0.1214
DRUGS	0.1331	0.2280	0.7846
Marijuana	0.1191	0.3387	0.2845
Cocaine	0.9943	0.8427	0.0802
Heroin	0.0897	0.9036	0.1950
Hallucinogens	0.0150	0.0050	0.3035
Inhalants	0.7460	0.7858	0.0806
Methamphetamine	0.4606	0.6575	0.3852
Prescription Psychotherapeutics	0.1549	0.1118	0.8550
Pain Relievers	0.1947	0.2642	0.3076
Prescription Opioids	0.2250	0.3838	0.4864
Stimulants	0.9567	0.3497	0.1428
Tranquilizers or Sedatives	0.1437	0.2734	0.8099
Tranquilizers	0.1861	0.3106	0.5120
Sedatives	0.4990	0.7579	0.6922
Opioids¹	0.1946	0.4554	0.6976
Central Nervous System Stimulants	0.6140	0.6916	0.0175
ALCOHOL	0.1191	0.0035	0.2900
BOTH DRUGS AND ALCOHOL	0.4875	0.0362	0.4139
DRUGS ONLY (NO ALCOHOL USE DISORDER)	0.1843	0.8895	0.3435
ALCOHOL ONLY (NO DRUG USE DISORDER)	0.0176	0.0591	0.0411
NO SUBSTANCE USE DISORDER	0.7548	0.0286	0.1214
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ¹ Some 2021-2023 estimates that are used in these comparisons may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.44C – Substance Use Disorder for Specific Substances in Past Year: Among People Aged 26 or Older; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
SUBSTANCE USE DISORDER	779	716	702	756
DRUGS	563	588	548	603
Marijuana	442	426	440	486
Cocaine	150	144	119	117
Heroin	140	114	94	78
Hallucinogens	71	72	48	56
Inhalants	50	51	49	48
Methamphetamine	169	183	178	151
Prescription Psychotherapeutics	318	353	319	334
Pain Relievers	274	314	289	289
Prescription Opioids	263	304	266	277
Stimulants	105	116	114	110
Tranquilizers or Sedatives	176	182	160	165
Tranquilizers	150	165	139	133
Sedatives	136	97	102	105
Opioids¹	280	322	273	281
Central Nervous System Stimulants	248	243	233	210
ALCOHOL	666	595	543	555
BOTH DRUGS AND ALCOHOL	303	293	274	277
DRUGS ONLY (NO ALCOHOL USE DISORDER)	451	483	451	504
ALCOHOL ONLY (NO DRUG USE DISORDER)	601	545	487	504
NO SUBSTANCE USE DISORDER	779	716	702	756
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ¹ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.44D – Substance Use Disorder for Specific Substances in Past Year: Among People Aged 26 or Older; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
SUBSTANCE USE DISORDER	0.35	0.32	0.31	0.33
DRUGS	0.26	0.27	0.25	0.27
Marijuana	0.20	0.19	0.20	0.21
Cocaine	0.07	0.06	0.05	0.05
Heroin	0.06	0.05	0.04	0.03
Hallucinogens	0.03	0.03	0.02	0.02
Inhalants	0.02	0.02	0.02	0.02
Methamphetamine	0.08	0.08	0.08	0.07
Prescription Psychotherapeutics	0.14	0.16	0.14	0.15
Pain Relievers	0.12	0.14	0.13	0.13
Prescription Opioids	0.12	0.14	0.12	0.12
Stimulants	0.05	0.05	0.05	0.05
Tranquilizers or Sedatives	0.08	0.08	0.07	0.07
Tranquilizers	0.07	0.07	0.06	0.06
Sedatives	0.06	0.04	0.05	0.05
Opioids¹	0.13	0.15	0.12	0.12
Central Nervous System Stimulants	0.11	0.11	0.10	0.09
ALCOHOL	0.30	0.27	0.24	0.24
BOTH DRUGS AND ALCOHOL	0.14	0.13	0.12	0.12
DRUGS ONLY (NO ALCOHOL USE DISORDER)	0.20	0.22	0.20	0.22
ALCOHOL ONLY (NO DRUG USE DISORDER)	0.27	0.25	0.22	0.22
NO SUBSTANCE USE DISORDER	0.35	0.32	0.31	0.33
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ¹ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.44P – Substance Use Disorder for Specific Substances in Past Year: Among People Aged 26 or Older; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
SUBSTANCE USE DISORDER	0.6384	0.6172	0.6943
DRUGS	0.0011	0.3324	0.4000
Marijuana	0.0000	0.0161	0.0416
Cocaine	0.1427	0.1362	0.4491
Heroin	0.0030	0.0019	0.2872
Hallucinogens	0.8737	0.6253	0.9286
Inhalants	0.8396	0.8753	0.9655
Methamphetamine	0.7742	0.1937	0.2529
Prescription Psychotherapeutics	0.7357	0.2053	0.4692
Pain Relievers	0.7329	0.0997	0.3431
Prescription Opioids	0.7318	0.0870	0.6331
Stimulants	0.0299	0.4391	0.6872
Tranquilizers or Sedatives	0.6211	0.3287	0.4002
Tranquilizers	0.3807	0.1461	0.1071
Sedatives	0.4984	0.8441	0.7113
Opioids¹	0.2346	0.0156	0.4203
Central Nervous System Stimulants	0.8677	0.4460	0.3991
ALCOHOL	0.0103	0.0481	0.0957
BOTH DRUGS AND ALCOHOL	0.9591	0.5413	0.6358
DRUGS ONLY (NO ALCOHOL USE DISORDER)	0.0001	0.1361	0.2050
ALCOHOL ONLY (NO DRUG USE DISORDER)	0.0045	0.0662	0.1151
NO SUBSTANCE USE DISORDER	0.6384	0.6172	0.6943
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. ¹ Some 2021-2023 estimates that are used in these comparisons may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.45C – Any Mental Illness in Past Year: Among People Aged 18 or Older; by Detailed Age Category, Standard Errors of Numbers in Thousands, 2021-2024
Age Category	2021	2022	2023	2024
TOTAL	951	883	845	814
18-25	249	231	219	234
18-20	206	184	161	155
21-25	290	274	251	253
26 or Older	890	834	797	756
26-49	528	520	478	500
26-29	262	280	262	256
30-34	317	317	270	291
35-39	304	299	286	280
40-44	279	240	219	236
45-49	263	219	209	226
50 or Older	655	599	574	598
50-54	362	272	290	334
55-59	334	269	271	319
60-64	285	308	285	283
65 or Older	383	349	381	356
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Any mental illness (AMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic criteria. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.45D – Any Mental Illness in Past Year: Among People Aged 18 or Older; by Detailed Age Category, Standard Errors of Percentages, 2021-2024
Age Category	2021	2022	2023	2024
TOTAL	0.37	0.34	0.33	0.31
18-25	0.74	0.66	0.64	0.67
18-20	1.12	1.03	1.01	1.06
21-25	0.96	0.83	0.80	0.80
26 or Older	0.40	0.38	0.36	0.33
26-49	0.52	0.51	0.46	0.47
26-29	1.18	1.24	1.13	1.10
30-34	1.06	0.96	0.93	0.90
35-39	1.12	1.08	0.96	1.00
40-44	1.15	1.03	0.92	0.97
45-49	1.18	0.97	0.96	1.02
50 or Older	0.55	0.50	0.48	0.49
50-54	1.59	1.26	1.39	1.46
55-59	1.40	1.23	1.15	1.45
60-64	1.20	1.24	1.16	1.12
65 or Older	0.70	0.62	0.66	0.60
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Any mental illness (AMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic criteria. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.45P – Any Mental Illness in Past Year: Among People Aged 18 or Older; by Detailed Age Category, P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Age Category	2021	2022	2023
TOTAL	0.3894	0.4896	0.1292
18-25	0.2311	0.0017	0.5034
18-20	0.0696	0.0042	0.8552
21-25	0.7402	0.0511	0.4765
26 or Older	0.2088	0.0795	0.0725
26-49	0.0814	0.6491	0.4421
26-29	0.3620	0.5687	0.8407
30-34	0.4636	0.9088	0.3170
35-39	0.4633	0.5712	0.7852
40-44	0.9083	0.6224	0.4570
45-49	0.0732	0.0673	0.0194
50 or Older	0.8690	0.0791	0.1148
50-54	0.7099	0.2468	0.4873
55-59	0.1135	0.0889	0.0436
60-64	0.8384	0.9285	0.6425
65 or Older	0.7065	0.2993	0.7191
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Any mental illness (AMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Mental illness estimates that are used in these comparisons are based on a predictive model and are not direct measures of diagnostic criteria. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.46C – Serious Mental Illness in Past Year: Among People Aged 18 or Older; by Detailed Age Category, Standard Errors of Numbers in Thousands, 2021-2024
Age Category	2021	2022	2023	2024
TOTAL	457	447	422	422
18-25	163	152	133	133
18-20	121	92	81	75
21-25	150	139	123	122
26 or Older	412	414	393	401
26-49	278	284	272	278
26-29	136	126	141	133
30-34	142	145	145	148
35-39	154	139	130	114
40-44	110	114	103	117
45-49	132	111	90	112
50 or Older	291	292	267	300
50-54	166	164	134	205
55-59	154	131	112	150
60-64	141	138	124	97
65 or Older	155	153	148	121
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Serious mental illness (SMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. SMI is a subset of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic criteria. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.46D – Serious Mental Illness in Past Year: Among People Aged 18 or Older; by Detailed Age Category, Standard Errors of Percentages, 2021-2024
Age Category	2021	2022	2023	2024
TOTAL	0.18	0.17	0.16	0.16
18-25	0.49	0.44	0.39	0.38
18-20	0.82	0.67	0.63	0.57
21-25	0.63	0.55	0.50	0.48
26 or Older	0.19	0.19	0.18	0.18
26-49	0.27	0.28	0.26	0.26
26-29	0.72	0.71	0.72	0.71
30-34	0.59	0.60	0.60	0.59
35-39	0.65	0.60	0.52	0.48
40-44	0.51	0.54	0.48	0.52
45-49	0.65	0.56	0.48	0.58
50 or Older	0.25	0.25	0.22	0.25
50-54	0.83	0.82	0.70	1.00
55-59	0.70	0.63	0.53	0.76
60-64	0.62	0.60	0.53	0.42
65 or Older	0.28	0.27	0.25	0.20
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Serious mental illness (SMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. SMI is a subset of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic criteria. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.46P – Serious Mental Illness in Past Year: Among People Aged 18 or Older; by Detailed Age Category, P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Age Category	2021	2022	2023
TOTAL	0.5237	0.0698	0.6520
18-25	0.0000	0.0002	0.0878
18-20	0.0003	0.0033	0.2889
21-25	0.0137	0.0073	0.1752
26 or Older	0.4296	0.5899	0.9367
26-49	0.5741	0.7590	0.2433
26-29	0.9154	0.5054	0.2756
30-34	0.2215	0.4534	0.1682
35-39	0.0363	0.2025	0.3179
40-44	0.1034	0.8805	0.9025
45-49	0.4099	0.4493	0.2412
50 or Older	0.5975	0.6165	0.2348
50-54	0.1348	0.2545	0.0653
55-59	0.5699	0.9461	0.1981
60-64	0.4878	0.0673	0.5438
65 or Older	0.6997	0.4191	0.5144
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Serious mental illness (SMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. SMI is a subset of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. Mental illness estimates that are used in these comparisons are based on a predictive model and are not direct measures of diagnostic criteria. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.47C – Any Mental Illness in Past Year: Among People Aged 18 or Older; by Demographic Characteristics, Standard Errors of Numbers in Thousands, 2021-2024
Demographic Characteristic	2021	2022	2023	2024
TOTAL	951	883	845	814
SEX
Male	588	576	552	554
Female	711	615	577	591
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	862	794	763	736
AIAN	79	31	39	45
Asian	213	237	223	230
Black or African American	380	322	324	320
NHPI	42	*	*	42
White	1,033	844	816	871
Two or More Races	148	146	166	146
Hispanic or Latino	347	355	304	329
EMPLOYMENT STATUS
Full-Time	726	692	636	671
Part-Time	399	388	289	358
Unemployed	254	208	201	224
Other¹	718	627	660	630
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Any mental illness (AMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic criteria. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.47D – Any Mental Illness in Past Year: Among People Aged 18 or Older; by Demographic Characteristics, Standard Errors of Percentages, 2021-2024
Demographic Characteristic	2021	2022	2023	2024
TOTAL	0.37	0.34	0.33	0.31
SEX
Male	0.48	0.46	0.44	0.43
Female	0.55	0.47	0.44	0.44
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.41	0.37	0.36	0.34
AIAN	4.21	2.31	3.31	3.24
Asian	1.30	1.37	1.28	1.20
Black or African American	0.97	0.85	0.87	0.84
NHPI	4.14	*	*	3.52
White	0.49	0.44	0.41	0.41
Two or More Races	2.43	2.27	2.43	2.11
Hispanic or Latino	0.80	0.80	0.67	0.69
EMPLOYMENT STATUS
Full-Time	0.52	0.46	0.43	0.42
Part-Time	1.05	0.94	0.82	0.86
Unemployed	1.52	1.54	1.47	1.34
Other¹	0.63	0.59	0.57	0.55
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Any mental illness (AMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic criteria. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.47P – Any Mental Illness in Past Year: Among People Aged 18 or Older; by Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Demographic Characteristic	2021	2022	2023
TOTAL	0.3894	0.4896	0.1292
SEX
Male	0.0021	0.5529	0.0863
Female	0.1273	0.6862	0.6022
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.3471	0.2641	0.0970
AIAN	1.0000	0.1241	0.5883
Asian	0.7294	0.8932	0.5447
Black or African American	0.6071	0.3068	0.2198
NHPI	0.4681	*	*
White	0.1919	0.3470	0.0465
Two or More Races	0.9785	0.9261	0.6994
Hispanic or Latino	0.7943	0.5513	0.9206
EMPLOYMENT STATUS
Full-Time	0.0945	0.7323	0.1952
Part-Time	0.1838	0.8073	0.0724
Unemployed	0.9742	0.8240	0.3872
Other¹	0.7644	0.5863	0.8061
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Any mental illness (AMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Mental illness estimates that are used in these comparisons are based on a predictive model and are not direct measures of diagnostic criteria. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.48C – Serious Mental Illness in Past Year: Among People Aged 18 or Older; by Demographic Characteristics, Standard Errors of Numbers in Thousands, 2021-2024
Demographic Characteristic	2021	2022	2023	2024
TOTAL	457	447	422	422
SEX
Male	255	297	261	294
Female	373	319	306	293
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	437	401	373	398
AIAN	50	18	8	12
Asian	92	95	76	99
Black or African American	153	123	118	135
NHPI	23	23	*	*
White	406	384	334	382
Two or More Races	58	83	119	94
Hispanic or Latino	188	180	182	145
EMPLOYMENT STATUS
Full-Time	297	268	287	260
Part-Time	163	187	149	147
Unemployed	119	112	96	112
Other¹	307	288	252	302
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Serious mental illness (SMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. SMI is a subset of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic criteria. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.48D – Serious Mental Illness in Past Year: Among People Aged 18 or Older; by Demographic Characteristics, Standard Errors of Percentages, 2021-2024
Demographic Characteristic	2021	2022	2023	2024
TOTAL	0.18	0.17	0.16	0.16
SEX
Male	0.21	0.24	0.21	0.23
Female	0.29	0.24	0.23	0.22
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.21	0.19	0.18	0.19
AIAN	2.92	1.38	0.69	0.98
Asian	0.62	0.60	0.48	0.58
Black or African American	0.49	0.38	0.37	0.41
NHPI	2.31	1.91	*	*
White	0.24	0.22	0.20	0.22
Two or More Races	1.22	1.52	2.05	1.57
Hispanic or Latino	0.44	0.41	0.40	0.30
EMPLOYMENT STATUS
Full-Time	0.25	0.21	0.23	0.20
Part-Time	0.54	0.53	0.45	0.43
Unemployed	0.86	0.97	0.83	0.81
Other¹	0.31	0.29	0.26	0.30
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Serious mental illness (SMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. SMI is a subset of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic criteria. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.48P – Serious Mental Illness in Past Year: Among People Aged 18 or Older; by Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Demographic Characteristic	2021	2022	2023
TOTAL	0.5237	0.0698	0.6520
SEX
Male	0.0413	0.7581	0.2285
Female	0.0120	0.0213	0.0703
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.9490	0.2522	0.6170
AIAN	0.0833	0.0567	0.5521
Asian	0.4316	0.7688	0.2223
Black or African American	0.7066	0.7600	0.1417
NHPI	*	*	*
White	0.6292	0.2558	0.8896
Two or More Races	0.0218	0.5585	0.7061
Hispanic or Latino	0.0849	0.0633	0.0313
EMPLOYMENT STATUS
Full-Time	0.6863	0.4573	0.1449
Part-Time	0.1117	0.0683	0.4815
Unemployed	0.7399	0.2458	0.8911
Other¹	0.7118	0.4229	0.2772
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Serious mental illness (SMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. SMI is a subset of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. Mental illness estimates that are used in these comparisons are based on a predictive model and are not direct measures of diagnostic criteria. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.49C – Any Mental Illness in Past Year: Among People Aged 18 or Older; by Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2021-2024
Geographic/Socioeconomic Characteristic	2021	2022	2023	2024
TOTAL	951	883	845	814
GEOGRAPHIC REGION
Northeast	458	350	328	335
Midwest	385	380	331	346
South	563	521	544	514
West	467	485	471	428
COUNTY TYPE
Large Metro	1,035	873	866	946
Small Metro	720	694	622	646
Nonmetro	515	451	419	375
Urbanized	297	273	288	261
Less Urbanized	379	369	291	284
Completely Rural	194	170	155	80
POVERTY LEVEL¹
Less Than 100%	485	444	448	471
100-199%	583	490	469	454
200% or More	899	818	774	832
EDUCATION LEVEL
< High School	316	267	241	237
High School Graduate	474	439	434	427
Some College/Associate’s Degree	519	474	481	488
College Graduate	458	453	427	440
HEALTH INSURANCE²
Private	874	792	759	803
Medicaid/CHIP	547	520	544	535
Other³	618	508	558	528
No Coverage	320	315	238	279
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Any mental illness (AMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic criteria. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.49D – Any Mental Illness in Past Year: Among People Aged 18 or Older; by Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2021-2024
Geographic/Socioeconomic Characteristic	2021	2022	2023	2024
TOTAL	0.37	0.34	0.33	0.31
GEOGRAPHIC REGION
Northeast	1.02	0.78	0.73	0.73
Midwest	0.73	0.72	0.63	0.65
South	0.58	0.53	0.55	0.51
West	0.78	0.80	0.77	0.69
COUNTY TYPE
Large Metro	0.53	0.47	0.46	0.44
Small Metro	0.66	0.59	0.55	0.51
Nonmetro	0.86	0.90	0.76	0.77
Urbanized	1.37	1.42	1.21	1.22
Less Urbanized	1.11	1.13	1.06	1.02
Completely Rural	2.84	3.72	2.47	1.97
POVERTY LEVEL¹
Less Than 100%	1.04	0.90	0.87	0.92
100-199%	0.91	0.79	0.80	0.72
200% or More	0.42	0.38	0.36	0.37
EDUCATION LEVEL
< High School	1.12	1.09	0.99	0.98
High School Graduate	0.68	0.63	0.63	0.61
Some College/Associate’s Degree	0.67	0.61	0.62	0.63
College Graduate	0.58	0.53	0.49	0.49
HEALTH INSURANCE²
Private	0.44	0.41	0.39	0.38
Medicaid/CHIP	0.90	0.83	0.80	0.85
Other³	0.71	0.61	0.61	0.60
No Coverage	1.12	1.06	0.96	0.98
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Any mental illness (AMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic criteria. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.49P – Any Mental Illness in Past Year: Among People Aged 18 or Older; by Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Geographic/Socioeconomic Characteristic	2021	2022	2023
TOTAL	0.3894	0.4896	0.1292
GEOGRAPHIC REGION
Northeast	0.3640	0.7807	0.5692
Midwest	0.3831	0.9275	0.0631
South	0.9116	0.2098	0.3527
West	0.7448	0.8035	0.4037
COUNTY TYPE
Large Metro	0.3663	0.1773	0.0645
Small Metro	0.6758	0.5266	1.0000
Nonmetro	0.8161	0.9425	0.8493
Urbanized	0.6395	0.8008	0.9104
Less Urbanized	0.4994	0.5791	0.2871
Completely Rural	0.0877	0.0317	0.0270
POVERTY LEVEL¹
Less Than 100%	0.8495	0.9238	0.9880
100-199%	0.5746	0.4299	0.3544
200% or More	0.1095	0.9302	0.1761
EDUCATION LEVEL
< High School	0.5568	0.5439	0.7441
High School Graduate	0.4616	0.7110	0.9589
Some College/Associate’s Degree	0.8836	0.3155	0.2166
College Graduate	0.7170	0.7686	0.0819
HEALTH INSURANCE²
Private	0.0767	0.8684	0.1747
Medicaid/CHIP	0.8283	0.9886	0.3570
Other³	0.3180	0.0691	0.4022
No Coverage	0.7909	0.7343	0.0458
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Any mental illness (AMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Mental illness estimates that are used in these comparisons are based on a predictive model and are not direct measures of diagnostic criteria. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.50C – Serious Mental Illness in Past Year: Among People Aged 18 or Older; by Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2021-2024
Geographic/Socioeconomic Characteristic	2021	2022	2023	2024
TOTAL	457	447	422	422
GEOGRAPHIC REGION
Northeast	172	176	169	212
Midwest	185	178	139	180
South	295	268	261	240
West	250	244	233	222
COUNTY TYPE
Large Metro	345	352	352	355
Small Metro	298	274	273	269
Nonmetro	200	197	137	156
Urbanized	118	112	90	120
Less Urbanized	148	136	99	102
Completely Rural	55	89	42	25
POVERTY LEVEL¹
Less Than 100%	219	215	191	246
100-199%	243	249	215	182
200% or More	333	331	323	335
EDUCATION LEVEL
< High School	142	146	132	82
High School Graduate	231	243	208	213
Some College/Associate’s Degree	286	252	246	268
College Graduate	204	215	205	225
HEALTH INSURANCE²
Private	318	328	301	312
Medicaid/CHIP	258	274	202	272
Other³	270	243	224	234
No Coverage	142	129	138	119
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Serious mental illness (SMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. SMI is a subset of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic criteria. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.50D – Serious Mental Illness in Past Year: Among People Aged 18 or Older; by Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2021-2024
Geographic/Socioeconomic Characteristic	2021	2022	2023	2024
TOTAL	0.18	0.17	0.16	0.16
GEOGRAPHIC REGION
Northeast	0.39	0.39	0.38	0.46
Midwest	0.35	0.34	0.26	0.34
South	0.31	0.27	0.26	0.24
West	0.42	0.40	0.38	0.36
COUNTY TYPE
Large Metro	0.23	0.23	0.23	0.22
Small Metro	0.35	0.29	0.30	0.28
Nonmetro	0.44	0.49	0.32	0.42
Urbanized	0.64	0.67	0.52	0.77
Less Urbanized	0.64	0.61	0.46	0.50
Completely Rural	1.26	2.83	0.96	0.85
POVERTY LEVEL¹
Less Than 100%	0.57	0.56	0.46	0.57
100-199%	0.45	0.46	0.42	0.35
200% or More	0.19	0.19	0.18	0.18
EDUCATION LEVEL
< High School	0.50	0.60	0.54	0.34
High School Graduate	0.33	0.35	0.30	0.30
Some College/Associate’s Degree	0.37	0.32	0.32	0.34
College Graduate	0.26	0.25	0.24	0.25
HEALTH INSURANCE²
Private	0.20	0.19	0.18	0.18
Medicaid/CHIP	0.52	0.54	0.38	0.54
Other³	0.35	0.31	0.28	0.29
No Coverage	0.57	0.53	0.60	0.48
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Serious mental illness (SMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. SMI is a subset of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic criteria. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.50P – Serious Mental Illness in Past Year: Among People Aged 18 or Older; by Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Geographic/Socioeconomic Characteristic	2021	2022	2023
TOTAL	0.5237	0.0698	0.6520
GEOGRAPHIC REGION
Northeast	0.5465	0.9779	0.5080
Midwest	0.2366	0.8635	0.0163
South	0.1052	0.0355	0.2431
West	0.4603	0.2359	0.5082
COUNTY TYPE
Large Metro	0.9352	0.4465	0.5955
Small Metro	0.2941	0.0511	0.0463
Nonmetro	0.9782	0.6650	0.4068
Urbanized	0.7741	0.9364	0.2846
Less Urbanized	0.7876	0.8069	0.5395
Completely Rural	0.5268	0.0659	0.0700
POVERTY LEVEL¹
Less Than 100%	0.9550	0.9114	0.2738
100-199%	0.3130	0.0633	0.3982
200% or More	0.7239	0.1331	0.3592
EDUCATION LEVEL
< High School	0.3107	0.0231	0.1637
High School Graduate	0.9618	0.0333	0.3008
Some College/Associate’s Degree	0.0996	0.6804	0.8470
College Graduate	0.1693	0.5911	0.2656
HEALTH INSURANCE²
Private	0.8584	0.0428	0.4976
Medicaid/CHIP	0.4040	0.2357	0.4083
Other³	0.5003	0.8893	0.5497
No Coverage	0.6637	0.8907	0.8770
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Serious mental illness (SMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. SMI is a subset of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. Mental illness estimates that are used in these comparisons are based on a predictive model and are not direct measures of diagnostic criteria. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.51C – Co-Occurring Substance Use Disorder and Level of Mental Illness in Past Year: Among People Aged 18 or Older; by Age Group, Standard Errors of Numbers in Thousands, 2021-2024
Co-Occurring Substance Use Disorder and Level of Mental Illness/Age Group	2021	2022	2023	2024
Substance Use Disorder and Any Mental Illness	529	496	509	536
18-25	176	174	165	152
26 or Older	486	475	474	494
26-49	334	368	320	349
50 or Older	358	312	311	330
Substance Use Disorder and Serious Mental Illness	300	297	268	307
18-25	116	107	99	92
26 or Older	277	270	245	294
26-49	194	196	203	195
50 or Older	191	187	133	212
Substance Use Disorder and Any Mental Illness Excluding Serious Mental Illness	443	403	413	441
18-25	139	136	136	128
26 or Older	419	392	385	405
26-49	292	314	258	288
50 or Older	306	247	275	261
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. NOTE: Mental illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Serious mental illness (SMI) is a subset of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic criteria. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.51D – Co-Occurring Substance Use Disorder and Level of Mental Illness in Past Year: Among People Aged 18 or Older; by Age Group, Standard Errors of Percentages, 2021-2024
Co-Occurring Substance Use Disorder and Level of Mental Illness/Age Group	2021	2022	2023	2024
Substance Use Disorder and Any Mental Illness	0.21	0.19	0.20	0.20
18-25	0.53	0.50	0.48	0.44
26 or Older	0.22	0.21	0.21	0.22
26-49	0.33	0.36	0.31	0.33
50 or Older	0.30	0.26	0.26	0.27
Substance Use Disorder and Serious Mental Illness	0.12	0.12	0.10	0.12
18-25	0.35	0.31	0.29	0.26
26 or Older	0.13	0.12	0.11	0.13
26-49	0.19	0.19	0.20	0.18
50 or Older	0.16	0.16	0.11	0.17
Substance Use Disorder and Any Mental Illness Excluding Serious Mental Illness	0.17	0.16	0.16	0.17
18-25	0.42	0.39	0.40	0.37
26 or Older	0.19	0.18	0.17	0.18
26-49	0.29	0.31	0.25	0.27
50 or Older	0.26	0.21	0.23	0.22
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. NOTE: Mental illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Serious mental illness (SMI) is a subset of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic criteria. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.51P – Co-Occurring Substance Use Disorder and Level of Mental Illness in Past Year: Among People Aged 18 or Older; by Age Group, P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Co-Occurring Substance Use Disorder and Level of Mental Illness/Age Group	2021	2022	2023
Substance Use Disorder and Any Mental Illness	0.2615	0.2563	0.5778
18-25	0.4710	0.0048	0.2154
26 or Older	0.1498	0.8446	0.3290
26-49	0.0427	0.8814	0.4139
50 or Older	0.9550	0.8365	0.6039
Substance Use Disorder and Serious Mental Illness	0.8048	0.1033	0.8963
18-25	0.0691	0.0055	0.1834
26 or Older	0.3527	0.4791	0.7533
26-49	0.3108	0.7193	0.2828
50 or Older	0.7461	0.4767	0.1035
Substance Use Disorder and Any Mental Illness Excluding Serious Mental Illness	0.2430	0.8338	0.4405
18-25	0.5939	0.1792	0.6260
26 or Older	0.2922	0.7822	0.3276
26-49	0.0974	0.9540	0.0705
50 or Older	0.8717	0.7796	0.6497
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. NOTE: Mental illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Serious mental illness (SMI) is a subset of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. Mental illness estimates that are used in these comparisons are based on a predictive model and are not direct measures of diagnostic criteria. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.52C – Substance Use in Past Year and Past Month: Among People Aged 18 or Older with Any Mental Illness; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
PAST YEAR USE
Illicit Drugs¹	689	672	597	684
Marijuana	632	632	561	627
Cocaine	198	178	178	168
Crack	111	84	106	95
Heroin	135	84	54	70
Hallucinogens	231	215	203	273
LSD	118	107	86	99
PCP	23	67	27	19
Ecstasy	126	107	114	89
Inhalants²	--	--	--	99
Methamphetamine	161	160	146	126
Misuse of Prescription Psychotherapeutics	382	290	283	312
Pain Relievers	313	224	206	229
Prescription Opioids	307	221	202	223
Stimulants	151	153	153	156
Tranquilizers or Sedatives	212	190	184	184
Tranquilizers	204	171	177	169
Sedatives	70	92	92	79
Benzodiazepines	188	158	160	156
Opioids^1,3	317	229	204	229
Central Nervous System Stimulants	277	253	248	244
Illicit Drugs Other than Marijuana^1,2,4	--	--	--	415
PAST MONTH USE
Alcohol	862	772	710	768
Binge Alcohol Use	582	503	440	456
Heavy Alcohol Use⁵	281	276	233	243
Cigarettes	572	463	433	461
Daily Cigarettes	418	366	330	361
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Any mental illness (AMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic criteria. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.52D – Substance Use in Past Year and Past Month: Among People Aged 18 or Older with Any Mental Illness; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
PAST YEAR USE
Illicit Drugs¹	0.87	0.74	0.70	0.76
Marijuana	0.82	0.73	0.71	0.72
Cocaine	0.33	0.29	0.30	0.27
Crack	0.19	0.14	0.18	0.15
Heroin	0.23	0.14	0.09	0.11
Hallucinogens	0.36	0.34	0.33	0.40
LSD	0.20	0.18	0.14	0.16
PCP	0.04	0.11	0.05	0.03
Ecstasy	0.21	0.18	0.19	0.14
Inhalants²	--	--	--	0.16
Methamphetamine	0.27	0.26	0.24	0.20
Misuse of Prescription Psychotherapeutics	0.61	0.45	0.43	0.47
Pain Relievers	0.52	0.37	0.33	0.36
Prescription Opioids	0.51	0.36	0.32	0.35
Stimulants	0.25	0.26	0.25	0.25
Tranquilizers or Sedatives	0.35	0.31	0.30	0.29
Tranquilizers	0.34	0.28	0.29	0.27
Sedatives	0.12	0.15	0.16	0.13
Benzodiazepines	0.31	0.26	0.26	0.25
Opioids^1,3	0.53	0.37	0.33	0.36
Central Nervous System Stimulants	0.45	0.41	0.39	0.37
Illicit Drugs Other than Marijuana^1,2,4	--	--	--	0.58
PAST MONTH USE
Alcohol	0.86	0.75	0.78	0.75
Binge Alcohol Use	0.75	0.62	0.60	0.58
Heavy Alcohol Use⁵	0.43	0.43	0.37	0.37
Cigarettes	0.78	0.66	0.62	0.67
Daily Cigarettes	0.64	0.56	0.51	0.55
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Any mental illness (AMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic criteria. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.52P – Substance Use in Past Year and Past Month: Among People Aged 18 or Older with Any Mental Illness; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
PAST YEAR USE
Illicit Drugs¹	0.0006	0.8926	0.1037
Marijuana	0.0000	0.8543	0.2242
Cocaine	0.0867	0.0754	0.2384
Crack	0.2191	0.4111	0.4338
Heroin	0.0034	0.0024	0.6303
Hallucinogens	0.0008	0.0126	0.0171
LSD	0.0008	0.0094	0.3986
PCP	0.8081	0.2007	0.4859
Ecstasy	0.0251	0.3452	0.2101
Inhalants²	--	--	--
Methamphetamine	0.3305	0.1324	0.3870
Misuse of Prescription Psychotherapeutics	0.0090	0.0518	0.2365
Pain Relievers	0.0075	0.0378	0.4803
Prescription Opioids	0.0051	0.0246	0.4568
Stimulants	0.9812	0.0946	0.3275
Tranquilizers or Sedatives	0.1306	0.1513	0.3815
Tranquilizers	0.0396	0.3294	0.2189
Sedatives	0.6342	0.0780	0.6386
Benzodiazepines	0.0215	0.2858	0.1619
Opioids^1,3	0.0008	0.0088	0.4468
Central Nervous System Stimulants	0.2886	0.0365	0.1682
Illicit Drugs Other than Marijuana^1,2,4	--	--	--
PAST MONTH USE
Alcohol	0.4235	0.0013	0.4150
Binge Alcohol Use	0.0036	0.0000	0.1391
Heavy Alcohol Use⁵	0.0654	0.0019	0.1735
Cigarettes	0.0000	0.0538	0.7580
Daily Cigarettes	0.0003	0.1164	0.7503
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Any mental illness (AMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Mental illness estimates that are used in these comparisons are based on a predictive model and are not direct measures of diagnostic criteria. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates that are used in these comparisons may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.53C – Substance Use in Past Year and Past Month: Among People Aged 18 to 25 with Any Mental Illness; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
PAST YEAR USE
Illicit Drugs¹	259	254	211	218
Marijuana	251	246	206	205
Cocaine	66	66	61	53
Crack	13	12	8	14
Heroin	18	12	4	13
Hallucinogens	107	102	84	95
LSD	67	55	35	35
PCP	18	3	<1	7
Ecstasy	46	44	45	37
Inhalants²	--	--	--	47
Methamphetamine	27	27	14	24
Misuse of Prescription Psychotherapeutics	111	95	76	87
Pain Relievers	64	62	45	59
Prescription Opioids	63	58	43	58
Stimulants	79	65	59	60
Tranquilizers or Sedatives	67	56	39	48
Tranquilizers	64	54	38	45
Sedatives	26	18	17	18
Benzodiazepines	64	54	38	42
Opioids^1,3	64	58	43	59
Central Nervous System Stimulants	95	91	82	77
Illicit Drugs Other than Marijuana^1,2,4	--	--	--	133
PAST MONTH USE
Alcohol	281	268	220	220
Binge Alcohol Use	199	184	158	154
Heavy Alcohol Use⁵	85	98	81	71
Cigarettes	120	117	92	94
Daily Cigarettes	48	63	44	37
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Any mental illness (AMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic criteria. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.53D – Substance Use in Past Year and Past Month: Among People Aged 18 to 25 with Any Mental Illness; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
PAST YEAR USE
Illicit Drugs¹	1.25	1.16	1.15	1.14
Marijuana	1.27	1.18	1.16	1.15
Cocaine	0.55	0.50	0.50	0.44
Crack	0.12	0.10	0.07	0.12
Heroin	0.15	0.10	0.04	0.11
Hallucinogens	0.80	0.72	0.68	0.78
LSD	0.54	0.42	0.30	0.30
PCP	0.16	0.03	<0.01	0.06
Ecstasy	0.38	0.35	0.38	0.32
Inhalants²	--	--	--	0.40
Methamphetamine	0.23	0.22	0.13	0.21
Misuse of Prescription Psychotherapeutics	0.83	0.68	0.63	0.70
Pain Relievers	0.53	0.48	0.39	0.49
Prescription Opioids	0.53	0.45	0.37	0.49
Stimulants	0.62	0.48	0.50	0.51
Tranquilizers or Sedatives	0.57	0.42	0.34	0.40
Tranquilizers	0.54	0.41	0.32	0.38
Sedatives	0.22	0.14	0.14	0.16
Benzodiazepines	0.54	0.41	0.32	0.36
Opioids^1,3	0.53	0.45	0.37	0.50
Central Nervous System Stimulants	0.72	0.66	0.67	0.63
Illicit Drugs Other than Marijuana^1,2,4	--	--	--	0.99
PAST MONTH USE
Alcohol	1.35	1.17	1.21	1.13
Binge Alcohol Use	1.24	1.06	1.02	1.05
Heavy Alcohol Use⁵	0.66	0.72	0.64	0.58
Cigarettes	0.90	0.84	0.74	0.74
Daily Cigarettes	0.40	0.48	0.38	0.32
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Any mental illness (AMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic criteria. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.53P – Substance Use in Past Year and Past Month: Among People Aged 18 to 25 with Any Mental Illness; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
PAST YEAR USE
Illicit Drugs¹	0.8274	0.0273	0.4740
Marijuana	0.6361	0.0097	0.7150
Cocaine	0.1493	0.0227	0.2708
Crack	0.5853	0.5632	0.3521
Heroin	0.4372	0.7687	0.0251
Hallucinogens	0.6500	0.6119	0.2798
LSD	0.0000	0.0000	0.1276
PCP	0.3269	0.2434	0.0149
Ecstasy	0.0051	0.1001	0.2135
Inhalants²	--	--	--
Methamphetamine	0.9849	0.7893	0.0913
Misuse of Prescription Psychotherapeutics	0.0026	0.0402	0.7250
Pain Relievers	0.1564	0.0664	0.6372
Prescription Opioids	0.1961	0.1222	0.5544
Stimulants	0.2443	0.3956	0.6401
Tranquilizers or Sedatives	0.0034	0.0456	0.9451
Tranquilizers	0.0020	0.0320	0.7490
Sedatives	0.0537	0.9239	0.9864
Benzodiazepines	0.0015	0.0202	0.5307
Opioids^1,3	0.2257	0.1639	0.3887
Central Nervous System Stimulants	0.1608	0.0532	0.9915
Illicit Drugs Other than Marijuana^1,2,4	--	--	--
PAST MONTH USE
Alcohol	0.0657	0.0284	0.9068
Binge Alcohol Use	0.0983	0.0345	0.6346
Heavy Alcohol Use⁵	0.1182	0.0081	0.0715
Cigarettes	0.0810	0.4157	0.7038
Daily Cigarettes	0.0440	0.0534	0.1754
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Any mental illness (AMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Mental illness estimates that are used in these comparisons are based on a predictive model and are not direct measures of diagnostic criteria. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates that are used in these comparisons may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.54C – Substance Use in Past Year and Past Month: Among People Aged 26 or Older with Any Mental Illness; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
PAST YEAR USE
Illicit Drugs¹	612	589	542	610
Marijuana	539	549	507	562
Cocaine	185	163	165	157
Crack	111	83	106	93
Heroin	133	82	54	69
Hallucinogens	192	181	189	257
LSD	91	91	79	93
PCP	15	67	27	18
Ecstasy	117	93	104	81
Inhalants²	--	--	--	88
Methamphetamine	159	157	145	123
Misuse of Prescription Psychotherapeutics	366	270	267	294
Pain Relievers	306	217	200	219
Prescription Opioids	301	214	196	213
Stimulants	122	135	140	141
Tranquilizers or Sedatives	197	183	179	178
Tranquilizers	191	162	171	162
Sedatives	64	90	89	77
Benzodiazepines	173	148	154	149
Opioids^1,3	312	221	198	218
Central Nervous System Stimulants	254	233	235	228
Illicit Drugs Other than Marijuana^1,2,4	--	--	--	389
PAST MONTH USE
Alcohol	771	690	642	702
Binge Alcohol Use	522	456	403	413
Heavy Alcohol Use⁵	260	256	215	230
Cigarettes	555	453	417	438
Daily Cigarettes	410	359	323	356
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Any mental illness (AMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic criteria. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.54D – Substance Use in Past Year and Past Month: Among People Aged 26 or Older with Any Mental Illness; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
PAST YEAR USE
Illicit Drugs¹	1.01	0.85	0.84	0.88
Marijuana	0.93	0.84	0.83	0.84
Cocaine	0.39	0.34	0.34	0.31
Crack	0.24	0.18	0.22	0.19
Heroin	0.28	0.17	0.11	0.14
Hallucinogens	0.39	0.37	0.38	0.47
LSD	0.19	0.19	0.16	0.18
PCP	0.03	0.14	0.06	0.04
Ecstasy	0.24	0.20	0.22	0.16
Inhalants²	--	--	--	0.17
Methamphetamine	0.34	0.33	0.30	0.24
Misuse of Prescription Psychotherapeutics	0.73	0.54	0.51	0.55
Pain Relievers	0.63	0.44	0.40	0.42
Prescription Opioids	0.63	0.44	0.39	0.41
Stimulants	0.26	0.29	0.29	0.28
Tranquilizers or Sedatives	0.41	0.38	0.37	0.35
Tranquilizers	0.39	0.34	0.35	0.32
Sedatives	0.14	0.19	0.19	0.15
Benzodiazepines	0.36	0.31	0.32	0.29
Opioids^1,3	0.65	0.45	0.40	0.42
Central Nervous System Stimulants	0.52	0.47	0.46	0.44
Illicit Drugs Other than Marijuana^1,2,4	--	--	--	0.68
PAST MONTH USE
Alcohol	1.02	0.88	0.91	0.89
Binge Alcohol Use	0.86	0.73	0.70	0.67
Heavy Alcohol Use⁵	0.50	0.50	0.43	0.44
Cigarettes	0.94	0.81	0.74	0.79
Daily Cigarettes	0.78	0.70	0.62	0.67
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Any mental illness (AMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic criteria. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.54P – Substance Use in Past Year and Past Month: Among People Aged 26 or Older with Any Mental Illness; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
PAST YEAR USE
Illicit Drugs¹	0.0001	0.2479	0.1121
Marijuana	0.0000	0.2984	0.1314
Cocaine	0.1957	0.3012	0.3720
Crack	0.1813	0.3134	0.3569
Heroin	0.0040	0.0012	0.9119
Hallucinogens	0.0001	0.0013	0.0335
LSD	0.5098	0.8081	0.8403
PCP	0.5979	0.1562	0.8407
Ecstasy	0.2304	0.8156	0.4229
Inhalants²	--	--	--
Methamphetamine	0.3015	0.0835	0.2381
Misuse of Prescription Psychotherapeutics	0.0591	0.1573	0.1745
Pain Relievers	0.0132	0.0825	0.3824
Prescription Opioids	0.0088	0.0457	0.3470
Stimulants	0.4941	0.1903	0.2250
Tranquilizers or Sedatives	0.5143	0.3278	0.3667
Tranquilizers	0.2409	0.6736	0.2267
Sedatives	0.9068	0.0668	0.6198
Benzodiazepines	0.1726	0.6634	0.1935
Opioids^1,3	0.0013	0.0147	0.3048
Central Nervous System Stimulants	0.5176	0.1319	0.1468
Illicit Drugs Other than Marijuana^1,2,4	--	--	--
PAST MONTH USE
Alcohol	0.7953	0.0080	0.4256
Binge Alcohol Use	0.0134	0.0004	0.1815
Heavy Alcohol Use⁵	0.1456	0.0179	0.4171
Cigarettes	0.0000	0.0422	0.7649
Daily Cigarettes	0.0003	0.0981	0.7969
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Any mental illness (AMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Mental illness estimates that are used in these comparisons are based on a predictive model and are not direct measures of diagnostic criteria. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates that are used in these comparisons may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.55C – Substance Use in Past Year and Past Month: Among People Aged 26 to 49 with Any Mental Illness; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
PAST YEAR USE
Illicit Drugs¹	451	471	409	467
Marijuana	419	443	382	430
Cocaine	132	134	112	118
Crack	67	52	42	38
Heroin	69	71	46	43
Hallucinogens	175	161	163	201
LSD	87	79	67	89
PCP	15	21	2	14
Ecstasy	111	75	93	77
Inhalants²	--	--	--	83
Methamphetamine	117	109	118	90
Misuse of Prescription Psychotherapeutics	236	205	191	198
Pain Relievers	178	168	144	135
Prescription Opioids	175	167	141	132
Stimulants	114	116	114	114
Tranquilizers or Sedatives	148	122	123	124
Tranquilizers	145	116	120	117
Sedatives	50	51	54	44
Benzodiazepines	141	112	106	109
Opioids^1,3	180	174	144	135
Central Nervous System Stimulants	188	185	183	175
Illicit Drugs Other than Marijuana^1,2,4	--	--	--	283
PAST MONTH USE
Alcohol	550	533	474	524
Binge Alcohol Use	381	374	316	328
Heavy Alcohol Use⁵	198	204	161	163
Cigarettes	349	311	267	265
Daily Cigarettes	266	225	190	179
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Any mental illness (AMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic criteria. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.55D – Substance Use in Past Year and Past Month: Among People Aged 26 to 49 with Any Mental Illness; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
PAST YEAR USE
Illicit Drugs¹	1.07	0.96	0.83	0.90
Marijuana	1.06	0.95	0.84	0.88
Cocaine	0.44	0.42	0.36	0.37
Crack	0.23	0.17	0.14	0.12
Heroin	0.24	0.23	0.15	0.13
Hallucinogens	0.56	0.51	0.50	0.58
LSD	0.30	0.26	0.22	0.28
PCP	0.05	0.07	0.01	0.05
Ecstasy	0.37	0.25	0.30	0.24
Inhalants²	--	--	--	0.26
Methamphetamine	0.40	0.35	0.38	0.28
Misuse of Prescription Psychotherapeutics	0.73	0.61	0.55	0.58
Pain Relievers	0.58	0.52	0.44	0.42
Prescription Opioids	0.57	0.52	0.43	0.41
Stimulants	0.38	0.38	0.36	0.34
Tranquilizers or Sedatives	0.49	0.39	0.39	0.38
Tranquilizers	0.48	0.37	0.38	0.36
Sedatives	0.17	0.17	0.18	0.14
Benzodiazepines	0.46	0.36	0.34	0.34
Opioids^1,3	0.59	0.54	0.44	0.42
Central Nervous System Stimulants	0.61	0.55	0.56	0.51
Illicit Drugs Other than Marijuana^1,2,4	--	--	--	0.74
PAST MONTH USE
Alcohol	1.07	0.88	0.88	0.92
Binge Alcohol Use	0.99	0.87	0.82	0.77
Heavy Alcohol Use⁵	0.62	0.61	0.50	0.48
Cigarettes	0.96	0.86	0.74	0.74
Daily Cigarettes	0.82	0.69	0.58	0.53
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Any mental illness (AMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic criteria. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.55P – Substance Use in Past Year and Past Month: Among People Aged 26 to 49 with Any Mental Illness; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
PAST YEAR USE
Illicit Drugs¹	0.0003	0.3590	0.3041
Marijuana	0.0001	0.7037	0.4940
Cocaine	0.3847	0.3472	0.8578
Crack	0.2206	0.1216	0.9791
Heroin	0.0036	0.0006	0.5798
Hallucinogens	0.0009	0.0012	0.0175
LSD	0.4110	0.9383	0.7011
PCP	0.9396	0.6946	0.0369
Ecstasy	0.1861	0.8406	0.5659
Inhalants²	--	--	--
Methamphetamine	0.2643	0.2175	0.1458
Misuse of Prescription Psychotherapeutics	0.0452	0.1582	0.1271
Pain Relievers	0.0066	0.0137	0.1743
Prescription Opioids	0.0042	0.0070	0.1406
Stimulants	0.7106	0.4335	0.3479
Tranquilizers or Sedatives	0.3392	0.9227	0.4348
Tranquilizers	0.1583	0.7308	0.3769
Sedatives	0.7005	0.6401	0.7788
Benzodiazepines	0.0714	0.9385	0.4237
Opioids^1,3	0.0008	0.0017	0.1079
Central Nervous System Stimulants	0.7632	0.4113	0.3935
Illicit Drugs Other than Marijuana^1,2,4	--	--	--
PAST MONTH USE
Alcohol	0.4815	0.0003	0.1976
Binge Alcohol Use	0.0065	0.0000	0.0601
Heavy Alcohol Use⁵	0.0276	0.0137	0.4289
Cigarettes	0.0000	0.0002	0.6774
Daily Cigarettes	0.0000	0.0002	0.0564
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Any mental illness (AMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Mental illness estimates that are used in these comparisons are based on a predictive model and are not direct measures of diagnostic criteria. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates that are used in these comparisons may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.56C – Substance Use in Past Year and Past Month: Among People Aged 50 or Older with Any Mental Illness; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
PAST YEAR USE
Illicit Drugs¹	372	360	328	365
Marijuana	318	323	295	341
Cocaine	126	107	122	91
Crack	88	63	97	71
Heroin	112	40	28	43
Hallucinogens	66	83	88	159
LSD	26	46	41	26
PCP	*	64	27	11
Ecstasy	33	52	46	35
Inhalants²	--	--	--	32
Methamphetamine	107	113	80	85
Misuse of Prescription Psychotherapeutics	257	179	187	219
Pain Relievers	232	142	145	176
Prescription Opioids	231	141	142	172
Stimulants	44	67	75	83
Tranquilizers or Sedatives	123	129	125	124
Tranquilizers	116	108	118	106
Sedatives	41	82	71	63
Benzodiazepines	96	90	112	98
Opioids^1,3	245	142	142	173
Central Nervous System Stimulants	159	157	148	142
Illicit Drugs Other than Marijuana^1,2,4	--	--	--	260
PAST MONTH USE
Alcohol	466	425	393	472
Binge Alcohol Use	336	245	238	273
Heavy Alcohol Use⁵	162	157	134	167
Cigarettes	401	286	292	325
Daily Cigarettes	294	255	243	291
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Any mental illness (AMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic criteria. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.56D – Substance Use in Past Year and Past Month: Among People Aged 50 or Older with Any Mental Illness; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
PAST YEAR USE
Illicit Drugs¹	1.83	1.75	1.63	1.59
Marijuana	1.62	1.64	1.54	1.57
Cocaine	0.70	0.64	0.70	0.49
Crack	0.49	0.38	0.56	0.38
Heroin	0.63	0.24	0.17	0.23
Hallucinogens	0.37	0.49	0.51	0.84
LSD	0.14	0.28	0.24	0.14
PCP	*	0.38	0.16	0.06
Ecstasy	0.18	0.31	0.27	0.19
Inhalants²	--	--	--	0.17
Methamphetamine	0.60	0.67	0.47	0.46
Misuse of Prescription Psychotherapeutics	1.39	1.04	1.04	1.11
Pain Relievers	1.26	0.83	0.83	0.91
Prescription Opioids	1.25	0.82	0.82	0.89
Stimulants	0.25	0.41	0.44	0.45
Tranquilizers or Sedatives	0.69	0.76	0.72	0.65
Tranquilizers	0.65	0.64	0.68	0.57
Sedatives	0.23	0.49	0.41	0.34
Benzodiazepines	0.54	0.54	0.65	0.52
Opioids^1,3	1.33	0.83	0.82	0.89
Central Nervous System Stimulants	0.88	0.93	0.84	0.76
Illicit Drugs Other than Marijuana^1,2,4	--	--	--	1.27
PAST MONTH USE
Alcohol	2.03	1.91	1.77	1.88
Binge Alcohol Use	1.62	1.30	1.25	1.32
Heavy Alcohol Use⁵	0.86	0.89	0.77	0.87
Cigarettes	1.88	1.47	1.51	1.56
Daily Cigarettes	1.52	1.39	1.31	1.44
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Any mental illness (AMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic criteria. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.56P – Substance Use in Past Year and Past Month: Among People Aged 50 or Older with Any Mental Illness; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
PAST YEAR USE
Illicit Drugs¹	0.0446	0.2678	0.1031
Marijuana	0.0048	0.1374	0.0690
Cocaine	0.2616	0.7297	0.1537
Crack	0.3841	0.7516	0.2669
Heroin	0.0954	0.3496	0.3613
Hallucinogens	0.0349	0.1985	0.5315
LSD	0.7986	0.8375	0.2995
PCP	*	0.1731	0.4417
Ecstasy	0.9566	0.5457	0.6640
Inhalants²	--	--	--
Methamphetamine	0.7274	0.2545	0.9790
Misuse of Prescription Psychotherapeutics	0.3569	0.5755	0.7067
Pain Relievers	0.2495	0.9974	0.9490
Prescription Opioids	0.2227	0.9006	0.9335
Stimulants	0.5504	0.3002	0.5007
Tranquilizers or Sedatives	1.0000	0.1387	0.6367
Tranquilizers	0.8016	0.3390	0.4312
Sedatives	0.6213	0.0606	0.6711
Benzodiazepines	0.9865	0.5951	0.3312
Opioids^1,3	0.1034	0.7781	0.9200
Central Nervous System Stimulants	0.4272	0.2258	0.2590
Illicit Drugs Other than Marijuana^1,2,4	--	--	--
PAST MONTH USE
Alcohol	0.9150	0.9963	0.7667
Binge Alcohol Use	0.3974	0.7186	0.7816
Heavy Alcohol Use⁵	0.8689	0.5367	0.7671
Cigarettes	0.0383	0.6136	0.9354
Daily Cigarettes	0.4855	0.5367	0.3398
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Any mental illness (AMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Mental illness estimates that are used in these comparisons are based on a predictive model and are not direct measures of diagnostic criteria. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates that are used in these comparisons may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.57C – Substance Use in Past Year and Past Month: Among People Aged 18 or Older with Serious Mental Illness; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
PAST YEAR USE
Illicit Drugs¹	330	329	280	352
Marijuana	302	313	259	336
Cocaine	89	103	93	106
Crack	53	64	43	67
Heroin	70	53	18	48
Hallucinogens	126	132	111	183
LSD	66	59	52	64
PCP	17	45	27	5
Ecstasy	53	46	59	59
Inhalants²	--	--	--	60
Methamphetamine	93	88	89	84
Misuse of Prescription Psychotherapeutics	190	154	144	210
Pain Relievers	154	113	110	162
Prescription Opioids	148	109	109	161
Stimulants	78	85	81	110
Tranquilizers or Sedatives	125	109	101	110
Tranquilizers	119	95	100	105
Sedatives	48	65	28	41
Benzodiazepines	101	85	94	92
Opioids^1,3	155	115	109	162
Central Nervous System Stimulants	139	142	132	162
Illicit Drugs Other than Marijuana^1,2,4	--	--	--	258
PAST MONTH USE
Alcohol	354	332	329	327
Binge Alcohol Use	266	230	224	231
Heavy Alcohol Use⁵	113	135	122	158
Cigarettes	237	242	203	240
Daily Cigarettes	198	209	152	199
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Serious mental illness (SMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. SMI is a subset of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic criteria. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.57D – Substance Use in Past Year and Past Month: Among People Aged 18 or Older with Serious Mental Illness; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
PAST YEAR USE
Illicit Drugs¹	1.65	1.49	1.32	1.44
Marijuana	1.59	1.43	1.29	1.47
Cocaine	0.60	0.65	0.61	0.71
Crack	0.36	0.41	0.29	0.45
Heroin	0.48	0.34	0.13	0.33
Hallucinogens	0.82	0.80	0.72	1.11
LSD	0.45	0.39	0.35	0.43
PCP	0.12	0.29	0.18	0.03
Ecstasy	0.37	0.30	0.40	0.40
Inhalants²	--	--	--	0.41
Methamphetamine	0.62	0.56	0.59	0.57
Misuse of Prescription Psychotherapeutics	1.21	0.94	0.90	1.26
Pain Relievers	1.01	0.72	0.71	1.03
Prescription Opioids	0.97	0.70	0.70	1.03
Stimulants	0.53	0.54	0.55	0.72
Tranquilizers or Sedatives	0.83	0.68	0.67	0.72
Tranquilizers	0.79	0.60	0.67	0.68
Sedatives	0.33	0.41	0.19	0.28
Benzodiazepines	0.67	0.53	0.63	0.60
Opioids^1,3	1.01	0.73	0.70	1.03
Central Nervous System Stimulants	0.91	0.85	0.85	1.02
Illicit Drugs Other than Marijuana^1,2,4	--	--	--	1.38
PAST MONTH USE
Alcohol	1.64	1.44	1.39	1.45
Binge Alcohol Use	1.48	1.24	1.28	1.27
Heavy Alcohol Use⁵	0.75	0.82	0.80	1.00
Cigarettes	1.35	1.32	1.19	1.40
Daily Cigarettes	1.15	1.20	0.95	1.24
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Serious mental illness (SMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. SMI is a subset of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic criteria. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.57P – Substance Use in Past Year and Past Month: Among People Aged 18 or Older with Serious Mental Illness; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
PAST YEAR USE
Illicit Drugs¹	0.0009	0.0335	0.0064
Marijuana	0.0000	0.0908	0.0783
Cocaine	0.4282	0.6617	0.8743
Crack	0.3474	0.7166	0.2162
Heroin	0.7043	0.2648	0.0370
Hallucinogens	0.0152	0.0183	0.1030
LSD	0.0817	0.1008	0.6205
PCP	0.2730	0.3274	0.5026
Ecstasy	0.4901	0.4491	0.4522
Inhalants²	--	--	--
Methamphetamine	0.5707	0.8148	0.8492
Misuse of Prescription Psychotherapeutics	0.8413	0.4875	0.1900
Pain Relievers	0.7725	0.5329	0.2371
Prescription Opioids	0.8310	0.4927	0.2141
Stimulants	0.2915	0.4782	0.6535
Tranquilizers or Sedatives	0.5555	0.5190	0.6795
Tranquilizers	0.6350	0.8427	0.8780
Sedatives	0.1101	0.0561	0.2858
Benzodiazepines	0.4849	0.8339	0.9190
Opioids^1,3	0.7343	0.6327	0.1390
Central Nervous System Stimulants	0.2097	0.6775	0.4258
Illicit Drugs Other than Marijuana^1,2,4	--	--	--
PAST MONTH USE
Alcohol	0.8593	0.1155	0.0590
Binge Alcohol Use	0.0663	0.0550	0.1307
Heavy Alcohol Use⁵	0.8660	0.2292	0.2237
Cigarettes	0.2366	0.3989	0.9798
Daily Cigarettes	0.0425	0.2128	0.8801
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Serious mental illness (SMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. SMI is a subset of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. Mental illness estimates that are used in these comparisons are based on a predictive model and are not direct measures of diagnostic criteria. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates that are used in these comparisons may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.58C – Substance Use in Past Year and Past Month: Among People Aged 18 to 25 with Serious Mental Illness; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
PAST YEAR USE
Illicit Drugs¹	141	130	109	114
Marijuana	133	126	107	109
Cocaine	29	38	41	36
Crack	9	3	6	9
Heroin	9	8	1	11
Hallucinogens	60	64	58	55
LSD	35	35	24	21
PCP	16	2	*	2
Ecstasy	26	20	28	27
Inhalants²	--	--	--	27
Methamphetamine	14	11	8	15
Misuse of Prescription Psychotherapeutics	66	65	57	57
Pain Relievers	40	45	33	36
Prescription Opioids	40	39	30	36
Stimulants	40	45	43	36
Tranquilizers or Sedatives	48	33	23	35
Tranquilizers	43	32	22	33
Sedatives	22	6	10	14
Benzodiazepines	46	32	22	29
Opioids^1,3	40	38	30	38
Central Nervous System Stimulants	47	56	54	47
Illicit Drugs Other than Marijuana^1,2,4	--	--	--	76
PAST MONTH USE
Alcohol	143	134	108	109
Binge Alcohol Use	102	99	91	84
Heavy Alcohol Use⁵	35	53	50	40
Cigarettes	62	66	59	58
Daily Cigarettes	34	44	27	23
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Serious mental illness (SMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. SMI is a subset of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic criteria. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.58D – Substance Use in Past Year and Past Month: Among People Aged 18 to 25 with Serious Mental Illness; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
PAST YEAR USE
Illicit Drugs¹	2.24	2.02	2.00	2.20
Marijuana	2.25	2.03	2.06	2.22
Cocaine	0.71	0.90	1.11	1.07
Crack	0.23	0.09	0.16	0.28
Heroin	0.23	0.19	0.03	0.33
Hallucinogens	1.40	1.42	1.54	1.56
LSD	0.87	0.84	0.67	0.64
PCP	0.41	0.04	*	0.05
Ecstasy	0.66	0.49	0.80	0.80
Inhalants²	--	--	--	0.81
Methamphetamine	0.34	0.26	0.23	0.44
Misuse of Prescription Psychotherapeutics	1.50	1.45	1.49	1.61
Pain Relievers	0.96	1.09	0.90	1.06
Prescription Opioids	0.96	0.94	0.85	1.06
Stimulants	0.95	1.04	1.16	1.07
Tranquilizers or Sedatives	1.15	0.78	0.65	1.04
Tranquilizers	1.05	0.77	0.61	0.99
Sedatives	0.55	0.16	0.30	0.41
Benzodiazepines	1.11	0.75	0.62	0.88
Opioids^1,3	0.98	0.94	0.85	1.09
Central Nervous System Stimulants	1.09	1.27	1.42	1.34
Illicit Drugs Other than Marijuana^1,2,4	--	--	--	2.00
PAST MONTH USE
Alcohol	2.32	1.82	1.91	2.03
Binge Alcohol Use	2.08	1.89	1.94	2.02
Heavy Alcohol Use⁵	0.86	1.23	1.30	1.18
Cigarettes	1.47	1.52	1.50	1.59
Daily Cigarettes	0.84	1.05	0.75	0.70
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Serious mental illness (SMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. SMI is a subset of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic criteria. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.58P – Substance Use in Past Year and Past Month: Among People Aged 18 to 25 with Serious Mental Illness; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
PAST YEAR USE
Illicit Drugs¹	0.1137	0.7402	0.2245
Marijuana	0.1078	0.4633	0.6807
Cocaine	0.1832	0.5703	0.3405
Crack	0.4215	0.0914	0.2625
Heroin	0.9558	0.4363	0.0499
Hallucinogens	0.6471	0.7431	0.9328
LSD	0.0041	0.0003	0.1026
PCP	0.1869	0.7363	*
Ecstasy	0.3236	0.8378	0.4871
Inhalants²	--	--	--
Methamphetamine	0.5887	0.4911	0.1457
Misuse of Prescription Psychotherapeutics	0.5242	0.3670	0.8939
Pain Relievers	0.9527	0.2044	0.9128
Prescription Opioids	0.9854	0.4077	0.8608
Stimulants	0.5715	0.8735	0.7578
Tranquilizers or Sedatives	0.2010	0.7616	0.4024
Tranquilizers	0.2640	0.6584	0.3959
Sedatives	0.0968	0.2528	0.6992
Benzodiazepines	0.0786	0.3720	0.9063
Opioids^1,3	0.9244	0.5579	0.6374
Central Nervous System Stimulants	0.2086	0.6277	0.8905
Illicit Drugs Other than Marijuana^1,2,4	--	--	--
PAST MONTH USE
Alcohol	0.9892	0.0621	0.8293
Binge Alcohol Use	0.9963	0.2169	0.4062
Heavy Alcohol Use⁵	0.2018	0.1613	0.1103
Cigarettes	0.6764	0.9379	0.9803
Daily Cigarettes	0.1064	0.0434	0.7396
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Serious mental illness (SMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. SMI is a subset of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. Mental illness estimates that are used in these comparisons are based on a predictive model and are not direct measures of diagnostic criteria. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates that are used in these comparisons may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.59C – Substance Use in Past Year and Past Month: Among People Aged 26 or Older with Serious Mental Illness; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
PAST YEAR USE
Illicit Drugs¹	295	294	254	331
Marijuana	261	276	234	314
Cocaine	90	97	84	97
Crack	52	64	42	66
Heroin	69	51	18	47
Hallucinogens	102	107	103	176
LSD	54	47	46	60
PCP	3	45	27	4
Ecstasy	45	40	53	54
Inhalants²	--	--	--	52
Methamphetamine	92	88	88	83
Misuse of Prescription Psychotherapeutics	184	136	127	201
Pain Relievers	151	102	104	157
Prescription Opioids	144	102	103	157
Stimulants	68	76	69	103
Tranquilizers or Sedatives	112	106	99	103
Tranquilizers	108	91	97	98
Sedatives	43	64	26	38
Benzodiazepines	86	80	92	87
Opioids^1,3	155	108	103	157
Central Nervous System Stimulants	136	133	121	153
Illicit Drugs Other than Marijuana^1,2,4	--	--	--	247
PAST MONTH USE
Alcohol	316	295	295	304
Binge Alcohol Use	237	208	195	212
Heavy Alcohol Use⁵	106	123	112	151
Cigarettes	230	234	195	230
Daily Cigarettes	194	201	149	196
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Serious mental illness (SMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. SMI is a subset of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic criteria. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.59D – Substance Use in Past Year and Past Month: Among People Aged 26 or Older with Serious Mental Illness; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
PAST YEAR USE
Illicit Drugs¹	2.09	1.82	1.64	1.75
Marijuana	1.98	1.73	1.60	1.78
Cocaine	0.84	0.82	0.73	0.84
Crack	0.50	0.56	0.38	0.58
Heroin	0.65	0.45	0.17	0.41
Hallucinogens	0.94	0.89	0.87	1.38
LSD	0.51	0.42	0.41	0.52
PCP	0.03	0.39	0.24	0.04
Ecstasy	0.43	0.36	0.47	0.47
Inhalants²	--	--	--	0.45
Methamphetamine	0.85	0.74	0.77	0.71
Misuse of Prescription Psychotherapeutics	1.63	1.13	1.05	1.54
Pain Relievers	1.37	0.88	0.89	1.28
Prescription Opioids	1.32	0.87	0.88	1.28
Stimulants	0.64	0.65	0.62	0.88
Tranquilizers or Sedatives	1.03	0.89	0.87	0.86
Tranquilizers	0.99	0.78	0.86	0.82
Sedatives	0.40	0.55	0.24	0.34
Benzodiazepines	0.80	0.69	0.81	0.74
Opioids^1,3	1.40	0.92	0.88	1.28
Central Nervous System Stimulants	1.23	1.09	1.03	1.25
Illicit Drugs Other than Marijuana^1,2,4	--	--	--	1.70
PAST MONTH USE
Alcohol	2.03	1.80	1.69	1.73
Binge Alcohol Use	1.83	1.55	1.49	1.49
Heavy Alcohol Use⁵	0.98	1.01	0.97	1.22
Cigarettes	1.80	1.69	1.50	1.72
Daily Cigarettes	1.55	1.55	1.21	1.56
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Serious mental illness (SMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. SMI is a subset of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic criteria. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.59P – Substance Use in Past Year and Past Month: Among People Aged 26 or Older with Serious Mental Illness; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
PAST YEAR USE
Illicit Drugs¹	0.0016	0.0094	0.0101
Marijuana	0.0000	0.0201	0.0618
Cocaine	0.7371	0.8272	0.7853
Crack	0.4639	0.4976	0.2863
Heroin	0.6376	0.1591	0.0953
Hallucinogens	0.0085	0.0033	0.0666
LSD	0.7211	0.9021	0.8347
PCP	0.5455	0.3166	0.4313
Ecstasy	0.8725	0.3062	0.6463
Inhalants²	--	--	--
Methamphetamine	0.7963	0.9543	0.9313
Misuse of Prescription Psychotherapeutics	0.9447	0.2959	0.1438
Pain Relievers	0.6261	0.3248	0.2262
Prescription Opioids	0.6949	0.3727	0.2334
Stimulants	0.2826	0.4019	0.6754
Tranquilizers or Sedatives	0.8658	0.5246	0.8925
Tranquilizers	0.8954	0.7418	0.8918
Sedatives	0.3247	0.0228	0.3184
Benzodiazepines	0.9809	0.6024	0.8655
Opioids^1,3	0.5898	0.5578	0.1748
Central Nervous System Stimulants	0.4050	0.5345	0.3542
Illicit Drugs Other than Marijuana^1,2,4	--	--	--
PAST MONTH USE
Alcohol	0.9641	0.3810	0.0361
Binge Alcohol Use	0.0645	0.1635	0.2091
Heavy Alcohol Use⁵	0.5192	0.4336	0.4508
Cigarettes	0.0973	0.2829	0.9185
Daily Cigarettes	0.0236	0.2189	0.8078
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Serious mental illness (SMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. SMI is a subset of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. Mental illness estimates that are used in these comparisons are based on a predictive model and are not direct measures of diagnostic criteria. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates that are used in these comparisons may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.60C – Substance Use in Past Year and Past Month: Among People Aged 26 to 49 with Serious Mental Illness; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
PAST YEAR USE
Illicit Drugs¹	219	220	210	231
Marijuana	217	213	198	217
Cocaine	53	63	60	61
Crack	20	33	21	19
Heroin	24	42	18	24
Hallucinogens	91	95	90	109
LSD	54	47	34	57
PCP	3	4	2	4
Ecstasy	45	35	53	42
Inhalants²	--	--	--	50
Methamphetamine	72	67	72	60
Misuse of Prescription Psychotherapeutics	131	112	98	113
Pain Relievers	110	85	78	75
Prescription Opioids	105	84	77	74
Stimulants	65	70	66	69
Tranquilizers or Sedatives	78	73	72	73
Tranquilizers	77	65	70	72
Sedatives	32	36	26	20
Benzodiazepines	73	58	64	70
Opioids^1,3	106	89	77	76
Central Nervous System Stimulants	102	105	100	104
Illicit Drugs Other than Marijuana^1,2,4	--	--	--	150
PAST MONTH USE
Alcohol	248	230	230	223
Binge Alcohol Use	177	161	155	139
Heavy Alcohol Use⁵	97	90	83	78
Cigarettes	148	140	143	139
Daily Cigarettes	134	107	106	89
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Serious mental illness (SMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. SMI is a subset of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic criteria. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.60D – Substance Use in Past Year and Past Month: Among People Aged 26 to 49 with Serious Mental Illness; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
PAST YEAR USE
Illicit Drugs¹	2.04	1.85	1.60	1.61
Marijuana	2.18	1.80	1.59	1.66
Cocaine	0.72	0.78	0.72	0.75
Crack	0.27	0.41	0.26	0.24
Heroin	0.32	0.53	0.22	0.30
Hallucinogens	1.18	1.13	1.01	1.23
LSD	0.73	0.60	0.41	0.70
PCP	0.04	0.06	0.02	0.05
Ecstasy	0.61	0.45	0.63	0.52
Inhalants²	--	--	--	0.62
Methamphetamine	0.95	0.83	0.84	0.72
Misuse of Prescription Psychotherapeutics	1.64	1.31	1.10	1.28
Pain Relievers	1.41	1.04	0.90	0.90
Prescription Opioids	1.35	1.04	0.89	0.89
Stimulants	0.86	0.85	0.78	0.82
Tranquilizers or Sedatives	1.03	0.91	0.85	0.88
Tranquilizers	1.02	0.81	0.83	0.87
Sedatives	0.42	0.46	0.32	0.25
Benzodiazepines	0.97	0.72	0.75	0.84
Opioids^1,3	1.36	1.09	0.89	0.90
Central Nervous System Stimulants	1.33	1.21	1.13	1.17
Illicit Drugs Other than Marijuana^1,2,4	--	--	--	1.52
PAST MONTH USE
Alcohol	2.25	1.65	1.63	1.64
Binge Alcohol Use	1.90	1.62	1.55	1.49
Heavy Alcohol Use⁵	1.24	1.09	0.97	0.92
Cigarettes	1.68	1.54	1.51	1.51
Daily Cigarettes	1.58	1.27	1.18	1.07
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Serious mental illness (SMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. SMI is a subset of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic criteria. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.60P – Substance Use in Past Year and Past Month: Among People Aged 26 to 49 with Serious Mental Illness; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
PAST YEAR USE
Illicit Drugs¹	0.0017	0.0609	0.1523
Marijuana	0.0013	0.2263	0.5032
Cocaine	0.9103	0.6643	0.8595
Crack	0.8229	0.1486	0.6953
Heroin	0.8867	0.0332	0.4298
Hallucinogens	0.0653	0.0129	0.1275
LSD	0.5662	0.8521	0.4376
PCP	0.5361	0.9439	0.2169
Ecstasy	0.3695	0.5052	0.2860
Inhalants²	--	--	--
Methamphetamine	0.9008	0.6298	0.5946
Misuse of Prescription Psychotherapeutics	0.5226	0.9820	0.7300
Pain Relievers	0.1289	0.7498	0.8821
Prescription Opioids	0.1535	0.6367	0.8525
Stimulants	0.3803	0.5095	0.6957
Tranquilizers or Sedatives	0.9084	0.9209	0.8880
Tranquilizers	0.9469	0.5121	0.8917
Sedatives	0.1800	0.0606	0.9814
Benzodiazepines	0.8984	0.3922	0.6162
Opioids^1,3	0.1807	0.3595	1.0000
Central Nervous System Stimulants	0.5927	0.6454	0.4806
Illicit Drugs Other than Marijuana^1,2,4	--	--	--
PAST MONTH USE
Alcohol	0.6866	0.2120	0.4672
Binge Alcohol Use	0.0137	0.0100	0.1111
Heavy Alcohol Use⁵	0.0440	0.1043	0.2658
Cigarettes	0.1439	0.1125	0.6746
Daily Cigarettes	0.0022	0.0185	0.0836
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Serious mental illness (SMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. SMI is a subset of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. Mental illness estimates that are used in these comparisons are based on a predictive model and are not direct measures of diagnostic criteria. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates that are used in these comparisons may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.61C – Substance Use in Past Year and Past Month: Among People Aged 50 or Older with Serious Mental Illness; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
PAST YEAR USE
Illicit Drugs¹	189	189	128	225
Marijuana	146	168	112	217
Cocaine	72	73	58	76
Crack	48	55	37	63
Heroin	*	28	*	40
Hallucinogens	*	54	46	137
LSD	*	*	31	16
PCP	*	*	*	*
Ecstasy	*	*	*	33
Inhalants²	--	--	--	20
Methamphetamine	58	63	52	56
Misuse of Prescription Psychotherapeutics	121	87	81	166
Pain Relievers	98	65	68	140
Prescription Opioids	98	65	68	140
Stimulants	17	29	20	*
Tranquilizers or Sedatives	80	76	68	71
Tranquilizers	75	63	68	63
Sedatives	28	53	<1	32
Benzodiazepines	43	55	67	49
Opioids^1,3	111	65	68	140
Central Nervous System Stimulants	87	86	68	112
Illicit Drugs Other than Marijuana^1,2,4	--	--	--	191
PAST MONTH USE
Alcohol	199	178	171	200
Binge Alcohol Use	142	125	110	160
Heavy Alcohol Use⁵	42	84	74	129
Cigarettes	169	178	139	184
Daily Cigarettes	135	167	112	172
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Serious mental illness (SMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. SMI is a subset of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic criteria. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.61D – Substance Use in Past Year and Past Month: Among People Aged 50 or Older with Serious Mental Illness; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
PAST YEAR USE
Illicit Drugs¹	5.07	4.24	3.75	4.49
Marijuana	4.35	3.89	3.58	4.65
Cocaine	2.27	2.04	1.97	2.17
Crack	1.53	1.54	1.27	1.83
Heroin	*	0.81	*	1.17
Hallucinogens	*	1.49	1.56	3.76
LSD	*	*	1.05	0.47
PCP	*	*	*	*
Ecstasy	*	*	*	0.97
Inhalants²	--	--	--	0.59
Methamphetamine	1.84	1.72	1.76	1.65
Misuse of Prescription Psychotherapeutics	3.63	2.34	2.59	4.16
Pain Relievers	3.03	1.77	2.21	3.69
Prescription Opioids	3.03	1.77	2.21	3.69
Stimulants	0.55	0.82	0.71	*
Tranquilizers or Sedatives	2.52	2.06	2.29	1.97
Tranquilizers	2.36	1.75	2.29	1.80
Sedatives	0.93	1.46	0.01	0.94
Benzodiazepines	1.41	1.54	2.26	1.39
Opioids^1,3	3.36	1.78	2.21	3.69
Central Nervous System Stimulants	2.70	2.32	2.29	3.12
Illicit Drugs Other than Marijuana^1,2,4	--	--	--	4.40
PAST MONTH USE
Alcohol	4.88	4.08	4.24	4.29
Binge Alcohol Use	4.07	3.24	3.34	3.89
Heavy Alcohol Use⁵	1.37	2.28	2.45	3.52
Cigarettes	4.46	3.97	4.08	4.39
Daily Cigarettes	3.91	3.96	3.51	4.31
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Serious mental illness (SMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. SMI is a subset of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic criteria. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.61P – Substance Use in Past Year and Past Month: Among People Aged 50 or Older with Serious Mental Illness; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
PAST YEAR USE
Illicit Drugs¹	0.1431	0.0763	0.0044
Marijuana	0.0098	0.0488	0.0113
Cocaine	0.6043	0.9316	0.6159
Crack	0.4928	0.9645	0.3710
Heroin	*	0.8731	*
Hallucinogens	*	0.1249	0.1827
LSD	*	*	0.4433
PCP	*	*	*
Ecstasy	*	*	*
Inhalants²	--	--	--
Methamphetamine	0.6024	0.6771	0.5867
Misuse of Prescription Psychotherapeutics	0.6333	0.1819	0.0871
Pain Relievers	0.5387	0.1430	0.1012
Prescription Opioids	0.5311	0.1444	0.1022
Stimulants	*	*	*
Tranquilizers or Sedatives	0.7246	0.4344	0.9230
Tranquilizers	0.7994	0.8226	0.7758
Sedatives	0.8895	0.1380	0.1166
Benzodiazepines	0.8331	0.8148	0.4719
Opioids^1,3	0.7404	0.1433	0.0868
Central Nervous System Stimulants	0.5048	0.7094	0.4528
Illicit Drugs Other than Marijuana^1,2,4	--	--	--
PAST MONTH USE
Alcohol	0.6857	0.8037	0.0627
Binge Alcohol Use	0.9844	0.5782	0.8711
Heavy Alcohol Use⁵	0.2651	0.7943	0.9387
Cigarettes	0.2972	0.9035	0.8835
Daily Cigarettes	0.5580	0.9688	0.3988
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Serious mental illness (SMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. SMI is a subset of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. Mental illness estimates that are used in these comparisons are based on a predictive model and are not direct measures of diagnostic criteria. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates that are used in these comparisons may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.62C – Had Serious Thoughts of Suicide in Past Year: Among People Aged 18 or Older; by Detailed Age Category, Standard Errors of Numbers in Thousands, 2021-2024
Age Category	2021	2022	2023	2024
TOTAL	418	413	388	417
18-25	164	161	138	154
18-20	123	108	95	95
21-25	150	138	128	137
26 or Older	368	378	348	377
26-49	260	254	234	266
26-29	133	118	129	125
30-34	122	122	132	136
35-39	126	137	112	109
40-44	103	100	81	125
45-49	98	74	87	84
50 or Older	240	275	248	263
50-54	160	130	104	124
55-59	88	128	97	121
60-64	105	146	116	143
65 or Older	149	125	172	157
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.62D – Had Serious Thoughts of Suicide in Past Year: Among People Aged 18 or Older; by Detailed Age Category, Standard Errors of Percentages, 2021-2024
Age Category	2021	2022	2023	2024
TOTAL	0.16	0.16	0.15	0.16
18-25	0.49	0.46	0.41	0.44
18-20	0.83	0.75	0.72	0.71
21-25	0.63	0.54	0.50	0.53
26 or Older	0.17	0.17	0.16	0.17
26-49	0.25	0.25	0.23	0.25
26-29	0.70	0.66	0.66	0.67
30-34	0.51	0.51	0.55	0.56
35-39	0.54	0.59	0.46	0.45
40-44	0.49	0.47	0.38	0.55
45-49	0.49	0.38	0.45	0.43
50 or Older	0.20	0.23	0.21	0.22
50-54	0.80	0.65	0.54	0.61
55-59	0.40	0.63	0.47	0.61
60-64	0.46	0.63	0.50	0.62
65 or Older	0.27	0.22	0.30	0.26
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.62P – Had Serious Thoughts of Suicide in Past Year: Among People Aged 18 or Older; by Detailed Age Category, P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Age Category	2021	2022	2023
TOTAL	0.0223	0.1650	0.0262
18-25	0.1783	0.0897	0.6002
18-20	0.5544	0.1384	0.6109
21-25	0.2412	0.3092	0.7784
26 or Older	0.0023	0.0184	0.0241
26-49	0.1091	0.0995	0.5102
26-29	0.7878	0.3711	0.9112
30-34	0.1879	0.3306	0.5306
35-39	0.7485	0.6702	0.9377
40-44	0.0789	0.2797	0.0193
45-49	0.3142	0.0613	0.9152
50 or Older	0.0041	0.1063	0.0137
50-54	0.7920	0.4981	0.1737
55-59	0.0256	0.7952	0.0491
60-64	0.0865	0.7178	0.2695
65 or Older	0.0846	0.0119	0.4347
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.63C – Made Any Suicide Plans in Past Year: Among People Aged 18 or Older; by Detailed Age Category, Standard Errors of Numbers in Thousands, 2021-2024
Age Category	2021	2022	2023	2024
TOTAL	212	179	188	253
18-25	124	95	82	86
18-20	92	68	59	48
21-25	85	71	65	73
26 or Older	164	150	168	233
26-49	138	101	130	140
26-29	55	60	62	70
30-34	52	59	78	74
35-39	79	39	53	65
40-44	66	47	46	50
45-49	68	26	43	45
50 or Older	89	110	107	180
50-54	28	41	80	102
55-59	29	77	38	63
60-64	73	58	42	100
65 or Older	30	41	45	96
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.63D – Made Any Suicide Plans in Past Year: Among People Aged 18 or Older; by Detailed Age Category, Standard Errors of Percentages, 2021-2024
Age Category	2021	2022	2023	2024
TOTAL	0.08	0.07	0.07	0.10
18-25	0.37	0.27	0.24	0.24
18-20	0.67	0.51	0.47	0.37
21-25	0.40	0.31	0.29	0.31
26 or Older	0.07	0.07	0.08	0.10
26-49	0.14	0.10	0.13	0.13
26-29	0.31	0.35	0.35	0.39
30-34	0.23	0.25	0.34	0.31
35-39	0.35	0.18	0.22	0.28
40-44	0.32	0.23	0.21	0.22
45-49	0.34	0.13	0.23	0.23
50 or Older	0.08	0.09	0.09	0.15
50-54	0.14	0.21	0.43	0.51
55-59	0.13	0.38	0.18	0.32
60-64	0.33	0.25	0.18	0.44
65 or Older	0.05	0.07	0.08	0.16
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.63P – Made Any Suicide Plans in Past Year: Among People Aged 18 or Older; by Detailed Age Category, P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Age Category	2021	2022	2023
TOTAL	0.0082	0.0135	0.0063
18-25	0.0198	0.0405	0.8541
18-20	0.0119	0.0107	0.4344
21-25	0.4060	0.5409	0.6923
26 or Older	0.0000	0.0001	0.0023
26-49	0.0605	0.0045	0.2685
26-29	0.0294	0.2935	0.2520
30-34	0.0377	0.4066	0.4816
35-39	1.0000	0.1291	0.4872
40-44	0.9536	0.1675	0.1168
45-49	0.8855	0.0479	0.7341
50 or Older	0.0000	0.0054	0.0018
50-54	0.0227	0.0593	0.7287
55-59	0.1481	0.4416	0.1385
60-64	0.2342	0.1781	0.1311
65 or Older	0.0003	0.0020	0.0016
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.64C – Attempted Suicide in Past Year: Among People Aged 18 or Older; by Detailed Age Category, Standard Errors of Numbers in Thousands, 2021-2024
Age Category	2021	2022	2023	2024
TOTAL	158	133	116	176
18-25	97	58	55	57
18-20	69	38	35	37
21-25	66	48	44	46
26 or Older	126	116	104	166
26-49	102	61	72	101
26-29	46	41	34	51
30-34	30	37	33	69
35-39	55	14	37	34
40-44	44	21	25	31
45-49	52	15	32	21
50 or Older	76	96	75	130
50-54	18	41	62	38
55-59	7	37	29	66
60-64	23	71	6	75
65 or Older	69	35	30	78
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.64D – Attempted Suicide in Past Year: Among People Aged 18 or Older; by Detailed Age Category, Standard Errors of Percentages, 2021-2024
Age Category	2021	2022	2023	2024
TOTAL	0.06	0.05	0.04	0.07
18-25	0.29	0.17	0.16	0.16
18-20	0.51	0.28	0.29	0.29
21-25	0.32	0.21	0.20	0.20
26 or Older	0.06	0.05	0.05	0.07
26-49	0.10	0.06	0.07	0.10
26-29	0.26	0.24	0.19	0.29
30-34	0.13	0.16	0.15	0.29
35-39	0.24	0.07	0.16	0.15
40-44	0.21	0.10	0.12	0.14
45-49	0.27	0.08	0.17	0.11
50 or Older	0.06	0.08	0.06	0.11
50-54	0.09	0.21	0.33	0.19
55-59	0.03	0.19	0.14	0.34
60-64	0.10	0.31	0.02	0.33
65 or Older	0.13	0.06	0.05	0.13
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.64P – Attempted Suicide in Past Year: Among People Aged 18 or Older; by Detailed Age Category, P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Age Category	2021	2022	2023
TOTAL	0.1603	0.0155	0.0005
18-25	0.0076	0.5456	0.8859
18-20	0.0338	0.9815	0.9455
21-25	0.1027	0.4778	0.7976
26 or Older	0.0019	0.0026	0.0001
26-49	0.4148	0.0073	0.0735
26-29	0.5695	0.6187	0.2615
30-34	0.0406	0.1365	0.1776
35-39	0.7862	0.0143	0.6302
40-44	0.7828	0.2840	0.4252
45-49	0.1836	0.1627	0.8998
50 or Older	0.0010	0.0678	0.0005
50-54	0.2847	0.7457	0.6743
55-59	0.0283	0.3970	0.0756
60-64	0.1333	0.9668	0.0716
65 or Older	0.0748	0.0037	0.0002
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.65C – Had Serious Thoughts of Suicide in Past Year: Among People Aged 18 or Older; by Demographic Characteristics, Standard Errors of Numbers in Thousands, 2021-2024
Demographic Characteristic	2021	2022	2023	2024
TOTAL	418	413	388	417
SEX
Male	274	306	247	295
Female	302	260	276	274
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	379	367	342	370
AIAN	37	16	10	21
Asian	61	77	132	97
Black or African American	137	143	119	149
NHPI	26	*	9	13
White	353	338	304	336
Two or More Races	68	71	108	70
Hispanic or Latino	173	167	161	172
EMPLOYMENT STATUS
Full-Time	272	269	241	292
Part-Time	154	171	151	130
Unemployed	132	81	88	121
Other¹	276	267	267	251
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.65D – Had Serious Thoughts of Suicide in Past Year: Among People Aged 18 or Older; by Demographic Characteristics, Standard Errors of Percentages, 2021-2024
Demographic Characteristic	2021	2022	2023	2024
TOTAL	0.16	0.16	0.15	0.16
SEX
Male	0.22	0.24	0.20	0.23
Female	0.23	0.20	0.21	0.20
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.18	0.17	0.16	0.17
AIAN	2.23	1.20	0.96	1.75
Asian	0.40	0.48	0.81	0.56
Black or African American	0.43	0.44	0.37	0.45
NHPI	2.57	*	0.97	1.14
White	0.21	0.20	0.18	0.20
Two or More Races	1.39	1.33	1.89	1.20
Hispanic or Latino	0.40	0.38	0.36	0.36
EMPLOYMENT STATUS
Full-Time	0.23	0.21	0.19	0.23
Part-Time	0.49	0.49	0.46	0.38
Unemployed	0.94	0.72	0.75	0.87
Other¹	0.28	0.27	0.27	0.25
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.65P – Had Serious Thoughts of Suicide in Past Year: Among People Aged 18 or Older; by Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Demographic Characteristic	2021	2022	2023
TOTAL	0.0223	0.1650	0.0262
SEX
Male	0.0035	0.1910	0.0010
Female	0.6691	0.5072	0.9894
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.0354	0.3874	0.0363
AIAN	0.7709	0.9079	0.1919
Asian	0.0068	0.1612	0.8833
Black or African American	0.1801	0.9791	0.0099
NHPI	0.1395	*	0.9739
White	0.2604	0.5617	0.1554
Two or More Races	0.2337	0.4336	0.5747
Hispanic or Latino	0.3117	0.1192	0.3515
EMPLOYMENT STATUS
Full-Time	0.0838	0.2628	0.1939
Part-Time	0.4570	0.0799	0.7572
Unemployed	0.5924	0.0299	0.1052
Other¹	0.0300	0.2677	0.1046
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.66C – Made Any Suicide Plans in Past Year: Among People Aged 18 or Older; by Demographic Characteristics, Standard Errors of Numbers in Thousands, 2021-2024
Demographic Characteristic	2021	2022	2023	2024
TOTAL	212	179	188	253
SEX
Male	148	125	116	188
Female	146	125	148	166
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	187	162	164	226
AIAN	*	8	6	11
Asian	32	29	44	53
Black or African American	59	79	61	95
NHPI	5	1	7	7
White	171	143	140	200
Two or More Races	33	30	27	33
Hispanic or Latino	100	80	91	87
EMPLOYMENT STATUS
Full-Time	118	99	114	172
Part-Time	80	93	73	73
Unemployed	76	47	55	75
Other¹	136	115	123	161
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.66D – Made Any Suicide Plans in Past Year: Among People Aged 18 or Older; by Demographic Characteristics, Standard Errors of Percentages, 2021-2024
Demographic Characteristic	2021	2022	2023	2024
TOTAL	0.08	0.07	0.07	0.10
SEX
Male	0.12	0.10	0.09	0.15
Female	0.11	0.10	0.11	0.12
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.09	0.08	0.08	0.11
AIAN	*	0.63	0.52	0.98
Asian	0.22	0.19	0.27	0.31
Black or African American	0.19	0.25	0.20	0.30
NHPI	0.52	0.12	0.70	0.62
White	0.11	0.09	0.09	0.12
Two or More Races	0.72	0.58	0.51	0.58
Hispanic or Latino	0.23	0.18	0.20	0.18
EMPLOYMENT STATUS
Full-Time	0.10	0.08	0.09	0.14
Part-Time	0.26	0.28	0.23	0.22
Unemployed	0.58	0.43	0.47	0.56
Other¹	0.14	0.12	0.13	0.16
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.66P – Made Any Suicide Plans in Past Year: Among People Aged 18 or Older; by Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Demographic Characteristic	2021	2022	2023
TOTAL	0.0082	0.0135	0.0063
SEX
Male	0.0088	0.0103	0.0011
Female	0.2283	0.3485	0.5421
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.0023	0.0175	0.0119
AIAN	*	0.8680	0.4293
Asian	0.4658	0.3507	0.7393
Black or African American	0.0220	0.5847	0.1550
NHPI	0.7329	0.2363	0.6054
White	0.0392	0.0372	0.0415
Two or More Races	0.2590	0.4282	0.2818
Hispanic or Latino	0.8301	0.3465	0.2301
EMPLOYMENT STATUS
Full-Time	0.0237	0.0626	0.0519
Part-Time	0.6877	0.0930	0.3938
Unemployed	0.7963	0.3858	0.9661
Other¹	0.0147	0.0076	0.0111
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.67C – Attempted Suicide in Past Year: Among People Aged 18 or Older; by Demographic Characteristics, Standard Errors of Numbers in Thousands, 2021-2024
Demographic Characteristic	2021	2022	2023	2024
TOTAL	158	133	116	176
SEX
Male	102	91	66	122
Female	116	89	95	126
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	136	126	94	158
AIAN	12	7	5	7
Asian	18	12	29	14
Black or African American	55	51	51	62
NHPI	5	1	5	5
White	118	114	74	144
Two or More Races	24	19	17	26
Hispanic or Latino	85	39	67	70
EMPLOYMENT STATUS
Full-Time	88	57	67	111
Part-Time	55	49	40	51
Unemployed	50	31	34	50
Other¹	114	102	83	117
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.67D – Attempted Suicide in Past Year: Among People Aged 18 or Older; by Demographic Characteristics, Standard Errors of Percentages, 2021-2024
Demographic Characteristic	2021	2022	2023	2024
TOTAL	0.06	0.05	0.04	0.07
SEX
Male	0.08	0.07	0.05	0.10
Female	0.09	0.07	0.07	0.09
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.06	0.06	0.04	0.07
AIAN	0.76	0.53	0.47	0.62
Asian	0.12	0.08	0.18	0.08
Black or African American	0.18	0.16	0.16	0.19
NHPI	0.54	0.11	0.54	0.42
White	0.07	0.07	0.05	0.09
Two or More Races	0.52	0.38	0.32	0.47
Hispanic or Latino	0.20	0.09	0.15	0.15
EMPLOYMENT STATUS
Full-Time	0.08	0.05	0.06	0.09
Part-Time	0.18	0.15	0.13	0.16
Unemployed	0.39	0.28	0.29	0.38
Other¹	0.12	0.11	0.09	0.12
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.67P – Attempted Suicide in Past Year: Among People Aged 18 or Older; by Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Demographic Characteristic	2021	2022	2023
TOTAL	0.1603	0.0155	0.0005
SEX
Male	0.1167	0.0879	0.0061
Female	0.5965	0.0799	0.0364
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.0451	0.0822	0.0023
AIAN	0.6300	0.8224	0.6537
Asian	0.2207	0.5912	0.1440
Black or African American	0.7168	0.6258	0.3805
NHPI	0.8060	0.2802	0.5559
White	0.0538	0.0933	0.0016
Two or More Races	0.2030	0.5298	0.2995
Hispanic or Latino	0.3785	0.0192	0.0928
EMPLOYMENT STATUS
Full-Time	0.6163	0.0636	0.1685
Part-Time	0.8696	0.4344	0.3117
Unemployed	0.7859	0.3297	0.3726
Other¹	0.1101	0.2467	0.0023
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.68C – Had Serious Thoughts of Suicide in Past Year: Among People Aged 18 or Older; by Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2021-2024
Geographic/Socioeconomic Characteristic	2021	2022	2023	2024
TOTAL	418	413	388	417
GEOGRAPHIC REGION
Northeast	153	164	170	177
Midwest	159	181	138	167
South	258	217	255	272
West	222	261	205	190
COUNTY TYPE
Large Metro	318	316	320	355
Small Metro	257	276	245	241
Nonmetro	187	185	130	159
Urbanized	112	100	90	92
Less Urbanized	136	151	88	131
Completely Rural	59	56	37	25
POVERTY LEVEL¹
Less Than 100%	202	200	166	192
100-199%	193	241	235	200
200% or More	322	287	269	345
EDUCATION LEVEL
< High School	120	118	126	123
High School Graduate	203	219	195	204
Some College/Associate’s Degree	245	254	228	246
College Graduate	196	173	181	214
HEALTH INSURANCE²
Private	294	304	282	331
Medicaid/CHIP	202	240	213	200
Other³	222	195	207	213
No Coverage	159	146	121	141
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.68D – Had Serious Thoughts of Suicide in Past Year: Among People Aged 18 or Older; by Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2021-2024
Geographic/Socioeconomic Characteristic	2021	2022	2023	2024
TOTAL	0.16	0.16	0.15	0.16
GEOGRAPHIC REGION
Northeast	0.34	0.36	0.38	0.39
Midwest	0.30	0.34	0.26	0.31
South	0.27	0.22	0.26	0.27
West	0.37	0.43	0.34	0.31
COUNTY TYPE
Large Metro	0.21	0.21	0.20	0.22
Small Metro	0.29	0.30	0.27	0.25
Nonmetro	0.41	0.48	0.34	0.42
Urbanized	0.65	0.70	0.56	0.64
Less Urbanized	0.58	0.69	0.46	0.64
Completely Rural	1.21	1.81	1.19	0.70
POVERTY LEVEL¹
Less Than 100%	0.51	0.51	0.40	0.43
100-199%	0.36	0.45	0.46	0.38
200% or More	0.19	0.16	0.15	0.19
EDUCATION LEVEL
< High School	0.42	0.48	0.52	0.51
High School Graduate	0.29	0.32	0.28	0.29
Some College/Associate’s Degree	0.32	0.33	0.30	0.32
College Graduate	0.25	0.20	0.21	0.24
HEALTH INSURANCE²
Private	0.18	0.18	0.17	0.19
Medicaid/CHIP	0.40	0.47	0.40	0.40
Other³	0.29	0.25	0.26	0.27
No Coverage	0.62	0.58	0.53	0.54
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.68P – Had Serious Thoughts of Suicide in Past Year: Among People Aged 18 or Older; by Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Geographic/Socioeconomic Characteristic	2021	2022	2023
TOTAL	0.0223	0.1650	0.0262
GEOGRAPHIC REGION
Northeast	0.0066	0.2540	0.9701
Midwest	0.2012	0.2310	0.0012
South	0.3438	0.2504	0.2903
West	0.7921	0.6727	0.5026
COUNTY TYPE
Large Metro	0.0332	0.0241	0.0079
Small Metro	0.2523	0.7870	0.7007
Nonmetro	0.6297	0.7513	0.1673
Urbanized	0.8984	0.6644	0.6719
Less Urbanized	0.3185	0.6378	0.0642
Completely Rural	0.2359	0.1092	0.2040
POVERTY LEVEL¹
Less Than 100%	0.2215	0.4674	0.0019
100-199%	0.4223	0.3580	0.6272
200% or More	0.0847	0.0751	0.1103
EDUCATION LEVEL
< High School	0.0050	0.1160	0.0119
High School Graduate	0.0160	0.8604	0.2657
Some College/Associate’s Degree	0.6456	0.3797	0.4184
College Graduate	0.5751	0.1758	0.3687
HEALTH INSURANCE²
Private	0.0148	0.2758	0.2244
Medicaid/CHIP	0.0406	0.4381	0.8106
Other³	0.4547	0.0166	0.0417
No Coverage	0.6285	0.1570	0.0390
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.69C – Made Any Suicide Plans in Past Year: Among People Aged 18 or Older; by Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2021-2024
Geographic/Socioeconomic Characteristic	2021	2022	2023	2024
TOTAL	212	179	188	253
GEOGRAPHIC REGION
Northeast	77	74	73	93
Midwest	72	87	69	98
South	130	114	129	169
West	120	93	91	131
COUNTY TYPE
Large Metro	172	120	149	210
Small Metro	110	123	106	130
Nonmetro	73	71	63	90
Urbanized	47	44	33	46
Less Urbanized	44	56	52	74
Completely Rural	34	8	20	14
POVERTY LEVEL¹
Less Than 100%	105	106	98	105
100-199%	99	87	96	109
200% or More	153	125	130	212
EDUCATION LEVEL
< High School	59	58	70	77
High School Graduate	115	107	95	147
Some College/Associate’s Degree	128	116	109	136
College Graduate	96	69	87	126
HEALTH INSURANCE²
Private	144	134	116	197
Medicaid/CHIP	117	114	123	115
Other³	94	65	77	141
No Coverage	84	47	60	71
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.69D – Made Any Suicide Plans in Past Year: Among People Aged 18 or Older; by Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2021-2024
Geographic/Socioeconomic Characteristic	2021	2022	2023	2024
TOTAL	0.08	0.07	0.07	0.10
GEOGRAPHIC REGION
Northeast	0.17	0.16	0.16	0.20
Midwest	0.14	0.17	0.13	0.18
South	0.14	0.12	0.13	0.17
West	0.20	0.15	0.15	0.21
COUNTY TYPE
Large Metro	0.13	0.08	0.10	0.14
Small Metro	0.14	0.14	0.13	0.15
Nonmetro	0.17	0.20	0.18	0.26
Urbanized	0.29	0.30	0.23	0.33
Less Urbanized	0.20	0.31	0.29	0.41
Completely Rural	0.78	0.31	0.67	0.49
POVERTY LEVEL¹
Less Than 100%	0.27	0.28	0.24	0.25
100-199%	0.19	0.17	0.20	0.21
200% or More	0.09	0.07	0.08	0.12
EDUCATION LEVEL
< High School	0.21	0.24	0.29	0.32
High School Graduate	0.17	0.15	0.14	0.21
Some College/Associate’s Degree	0.17	0.15	0.14	0.17
College Graduate	0.12	0.08	0.10	0.14
HEALTH INSURANCE²
Private	0.09	0.08	0.07	0.12
Medicaid/CHIP	0.25	0.23	0.24	0.24
Other³	0.12	0.08	0.10	0.18
No Coverage	0.33	0.20	0.27	0.29
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.69P – Made Any Suicide Plans in Past Year: Among People Aged 18 or Older; by Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Geographic/Socioeconomic Characteristic	2021	2022	2023
TOTAL	0.0082	0.0135	0.0063
GEOGRAPHIC REGION
Northeast	0.2266	0.2090	0.7536
Midwest	0.0032	0.1153	0.0012
South	0.5529	0.2696	0.2985
West	0.1665	0.2507	0.0733
COUNTY TYPE
Large Metro	0.0709	0.0062	0.0106
Small Metro	0.1397	0.9031	0.4018
Nonmetro	0.0961	0.2544	0.2382
Urbanized	0.4023	0.7648	0.3405
Less Urbanized	0.0706	0.3289	0.3334
Completely Rural	0.5470	0.1425	0.6039
POVERTY LEVEL¹
Less Than 100%	0.6014	0.7608	0.2644
100-199%	0.7718	0.6776	0.8219
200% or More	0.0052	0.0102	0.0065
EDUCATION LEVEL
< High School	0.0863	0.1120	0.1398
High School Graduate	0.1098	0.2116	0.1117
Some College/Associate’s Degree	0.2291	0.1917	0.0459
College Graduate	0.1093	0.1581	0.5306
HEALTH INSURANCE²
Private	0.0033	0.1552	0.0023
Medicaid/CHIP	0.4801	0.6444	0.8264
Other³	0.0079	0.0002	0.0024
No Coverage	0.7965	0.0569	0.4198
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.70C – Attempted Suicide in Past Year: Among People Aged 18 or Older; by Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2021-2024
Geographic/Socioeconomic Characteristic	2021	2022	2023	2024
TOTAL	158	133	116	176
GEOGRAPHIC REGION
Northeast	44	54	36	72
Midwest	54	76	37	63
South	101	75	98	123
West	90	46	34	78
COUNTY TYPE
Large Metro	129	90	87	149
Small Metro	80	72	70	78
Nonmetro	44	61	41	65
Urbanized	20	33	22	25
Less Urbanized	21	43	34	57
Completely Rural	34	*	6	10
POVERTY LEVEL¹
Less Than 100%	61	83	79	69
100-199%	74	63	57	97
200% or More	124	80	67	132
EDUCATION LEVEL
< High School	45	38	68	53
High School Graduate	74	88	65	113
Some College/Associate’s Degree	103	82	50	85
College Graduate	43	35	48	90
HEALTH INSURANCE²
Private	92	83	55	129
Medicaid/CHIP	88	99	78	91
Other³	97	78	54	107
No Coverage	48	29	52	49
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.70D – Attempted Suicide in Past Year: Among People Aged 18 or Older; by Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2021-2024
Geographic/Socioeconomic Characteristic	2021	2022	2023	2024
TOTAL	0.06	0.05	0.04	0.07
GEOGRAPHIC REGION
Northeast	0.10	0.12	0.08	0.16
Midwest	0.10	0.14	0.07	0.12
South	0.11	0.08	0.10	0.12
West	0.15	0.08	0.06	0.13
COUNTY TYPE
Large Metro	0.09	0.06	0.06	0.10
Small Metro	0.10	0.09	0.09	0.09
Nonmetro	0.11	0.18	0.12	0.20
Urbanized	0.13	0.23	0.15	0.18
Less Urbanized	0.09	0.24	0.19	0.35
Completely Rural	0.77	*	0.21	0.36
POVERTY LEVEL¹
Less Than 100%	0.16	0.23	0.20	0.16
100-199%	0.15	0.12	0.12	0.19
200% or More	0.07	0.05	0.04	0.08
EDUCATION LEVEL
< High School	0.16	0.16	0.28	0.22
High School Graduate	0.11	0.13	0.09	0.16
Some College/Associate’s Degree	0.13	0.11	0.07	0.11
College Graduate	0.05	0.04	0.06	0.10
HEALTH INSURANCE²
Private	0.06	0.05	0.03	0.08
Medicaid/CHIP	0.19	0.20	0.15	0.19
Other³	0.13	0.10	0.07	0.14
No Coverage	0.19	0.13	0.23	0.20
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.70P – Attempted Suicide in Past Year: Among People Aged 18 or Older; by Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Geographic/Socioeconomic Characteristic	2021	2022	2023
TOTAL	0.1603	0.0155	0.0005
GEOGRAPHIC REGION
Northeast	0.0096	0.1746	0.0264
Midwest	0.8041	0.9126	0.0101
South	0.6424	0.1382	0.5088
West	0.8711	0.0525	0.0026
COUNTY TYPE
Large Metro	0.2905	0.0043	0.0005
Small Metro	0.9881	0.9288	0.9115
Nonmetro	0.0925	0.4686	0.1403
Urbanized	0.0794	0.8264	0.3085
Less Urbanized	0.0698	0.4304	0.2910
Completely Rural	0.2283	*	0.4349
POVERTY LEVEL¹
Less Than 100%	0.2285	0.9575	0.5193
100-199%	0.5403	0.4119	0.1627
200% or More	0.4539	0.0102	0.0010
EDUCATION LEVEL
< High School	0.1520	0.1818	0.5271
High School Graduate	0.1778	0.3189	0.0704
Some College/Associate’s Degree	0.3082	0.5617	0.0116
College Graduate	0.0157	0.0080	0.0579
HEALTH INSURANCE²
Private	0.1133	0.0321	0.0005
Medicaid/CHIP	0.2946	0.7146	0.0671
Other³	0.1220	0.0398	0.0009
No Coverage	0.6367	0.1745	0.9543
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.71C – Major Depressive Episode in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, Standard Errors of Numbers in Thousands, 2021-2024
Demographic Characteristic	2021	2022	2023	2024
TOTAL	152	134	128	119
AGE GROUP
12-13	81	68	59	58
14-15	99	99	93	85
16-17	126	97	95	85
SEX
Male	95	81	71	63
Female	121	104	102	99
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	127	113	104	98
AIAN	*	8	13	5
Asian	38	42	29	36
Black or African American	50	56	47	39
NHPI	*	*	*	*
White	136	118	114	98
Two or More Races	38	22	23	27
Hispanic or Latino	88	73	77	65
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Major depressive episode aligns with DSM-5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. NOTE: Respondents with unknown past year major depressive episode (MDE) data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.71D – Major Depressive Episode in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, Standard Errors of Percentages, 2021-2024
Demographic Characteristic	2021	2022	2023	2024
TOTAL	0.61	0.54	0.52	0.48
AGE GROUP
12-13	0.86	0.80	0.72	0.71
14-15	1.00	0.99	0.92	0.89
16-17	1.18	0.97	0.96	0.83
SEX
Male	0.74	0.64	0.55	0.49
Female	1.00	0.87	0.84	0.81
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.68	0.62	0.56	0.53
AIAN	*	3.73	5.04	2.46
Asian	2.40	2.20	1.87	2.24
Black or African American	1.32	1.39	1.20	1.02
NHPI	*	*	*	*
White	0.93	0.78	0.72	0.66
Two or More Races	3.20	2.46	2.27	2.36
Hispanic or Latino	1.39	1.16	1.18	0.99
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Major depressive episode aligns with DSM-5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. NOTE: Respondents with unknown past year major depressive episode (MDE) data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.71P – Major Depressive Episode in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Demographic Characteristic	2021	2022	2023
TOTAL	0.0000	0.0000	0.0000
AGE GROUP
12-13	0.0015	0.0055	0.0584
14-15	0.0001	0.0001	0.0171
16-17	0.0000	0.0003	0.0096
SEX
Male	0.0001	0.0002	0.1623
Female	0.0000	0.0000	0.0000
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.0000	0.0000	0.0001
AIAN	*	0.2214	0.0820
Asian	0.3481	0.2992	0.5058
Black or African American	0.0274	0.0004	0.0754
NHPI	*	*	*
White	0.0000	0.0000	0.0019
Two or More Races	0.1574	0.3595	0.5253
Hispanic or Latino	0.0000	0.0057	0.0913
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Major depressive episode aligns with DSM-5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. NOTE: Respondents with unknown past year major depressive episode (MDE) data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.72C – Major Depressive Episode with Severe Impairment in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, Standard Errors of Numbers in Thousands, 2021-2024
Demographic Characteristic	2021	2022	2023	2024
TOTAL	132	122	118	109
AGE GROUP
12-13	62	54	49	51
14-15	86	87	82	69
16-17	108	85	85	75
SEX
Male	76	70	64	54
Female	108	98	97	89
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	112	103	98	87
AIAN	*	7	5	5
Asian	32	34	24	30
Black or African American	42	46	36	31
NHPI	*	*	*	*
White	115	103	102	79
Two or More Races	29	13	22	23
Hispanic or Latino	69	67	70	65
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Major depressive episode aligns with DSM-5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. NOTE: Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. NOTE: Respondents with unknown MDE data or unknown impairment data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.72D – Major Depressive Episode with Severe Impairment in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, Standard Errors of Percentages, 2021-2024
Demographic Characteristic	2021	2022	2023	2024
TOTAL	0.53	0.50	0.48	0.44
AGE GROUP
12-13	0.70	0.66	0.62	0.63
14-15	0.91	0.90	0.84	0.77
16-17	1.09	0.92	0.91	0.77
SEX
Male	0.60	0.55	0.50	0.42
Female	0.90	0.81	0.80	0.73
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.60	0.56	0.53	0.48
AIAN	*	3.47	2.20	2.35
Asian	2.14	1.81	1.55	1.94
Black or African American	1.15	1.19	0.96	0.82
NHPI	*	*	*	*
White	0.81	0.72	0.70	0.59
Two or More Races	2.86	1.59	2.16	2.09
Hispanic or Latino	1.10	1.06	1.08	0.99
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Major depressive episode aligns with DSM-5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. NOTE: Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. NOTE: Respondents with unknown MDE data or unknown impairment data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.72P – Major Depressive Episode with Severe Impairment in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Demographic Characteristic	2021	2022	2023
TOTAL	0.0000	0.0000	0.0005
AGE GROUP
12-13	0.0281	0.0704	0.3650
14-15	0.0001	0.0002	0.0117
16-17	0.0000	0.0012	0.0261
SEX
Male	0.0011	0.0024	0.1767
Female	0.0000	0.0000	0.0006
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.0000	0.0000	0.0003
AIAN	*	0.3918	0.5184
Asian	0.5533	0.5483	0.9153
Black or African American	0.0161	0.0028	0.0446
NHPI	*	*	*
White	0.0003	0.0000	0.0026
Two or More Races	0.4051	0.1549	0.2899
Hispanic or Latino	0.0016	0.0398	0.2928
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Major depressive episode aligns with DSM-5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. NOTE: Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. NOTE: Respondents with unknown MDE data or unknown impairment data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.73C – Substance Use in Past Year and Past Month: Among People Aged 12 to 17 with Major Depressive Episode in Past Year; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
PAST YEAR USE
Illicit Drugs¹	95	76	77	78
Marijuana	88	69	64	69
Cocaine	3	12	12	8
Crack	1	<1	*	4
Heroin	*	*	*	4
Hallucinogens	27	21	27	28
LSD	24	18	16	20
PCP	4	<1	10	*
Ecstasy	17	12	8	10
Inhalants²	--	--	--	36
Methamphetamine	9	3	9	4
Misuse of Prescription Psychotherapeutics	51	31	35	33
Pain Relievers	45	22	29	25
Prescription Opioids	45	20	24	20
Stimulants	33	20	26	17
Tranquilizers or Sedatives	31	15	16	20
Tranquilizers	30	12	14	17
Sedatives	12	10	8	11
Benzodiazepines	27	12	14	13
Opioids^1,3	45	20	24	21
Central Nervous System Stimulants	33	23	27	18
Illicit Drugs Other than Marijuana^1,2,4	--	--	--	52
PAST MONTH USE
Alcohol	67	48	55	46
Binge Alcohol Use	47	32	39	29
Heavy Alcohol Use⁵	11	6	6	7
Cigarettes	37	23	20	21
Daily Cigarettes	3	2	<1	1
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Major depressive episode aligns with DSM-5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. NOTE: Respondents with unknown past year major depressive episode (MDE) data were excluded. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.73D – Substance Use in Past Year and Past Month: Among People Aged 12 to 17 with Major Depressive Episode in Past Year; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
PAST YEAR USE
Illicit Drugs¹	1.50	1.34	1.39	1.60
Marijuana	1.53	1.24	1.23	1.53
Cocaine	0.07	0.25	0.27	0.22
Crack	0.01	<0.01	*	0.11
Heroin	*	*	*	0.11
Hallucinogens	0.52	0.44	0.59	0.70
LSD	0.46	0.36	0.36	0.51
PCP	0.08	0.01	0.22	*
Ecstasy	0.32	0.25	0.17	0.26
Inhalants²	--	--	--	0.90
Methamphetamine	0.17	0.07	0.21	0.11
Misuse of Prescription Psychotherapeutics	0.93	0.62	0.73	0.84
Pain Relievers	0.86	0.44	0.61	0.63
Prescription Opioids	0.86	0.42	0.51	0.52
Stimulants	0.63	0.41	0.57	0.43
Tranquilizers or Sedatives	0.59	0.32	0.35	0.52
Tranquilizers	0.56	0.26	0.32	0.44
Sedatives	0.23	0.21	0.19	0.30
Benzodiazepines	0.51	0.25	0.31	0.35
Opioids^1,3	0.86	0.42	0.51	0.53
Central Nervous System Stimulants	0.63	0.48	0.57	0.47
Illicit Drugs Other than Marijuana^1,2,4	--	--	--	1.22
PAST MONTH USE
Alcohol	1.14	0.90	1.09	1.13
Binge Alcohol Use	0.87	0.64	0.81	0.75
Heavy Alcohol Use⁵	0.22	0.11	0.14	0.18
Cigarettes	0.69	0.47	0.44	0.56
Daily Cigarettes	0.05	0.05	<0.01	0.03
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Major depressive episode aligns with DSM-5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. NOTE: Respondents with unknown past year major depressive episode (MDE) data were excluded. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.73P – Substance Use in Past Year and Past Month: Among People Aged 12 to 17 with Major Depressive Episode in Past Year; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
PAST YEAR USE
Illicit Drugs¹	0.0547	0.0018	0.0458
Marijuana	0.0679	0.1313	0.1115
Cocaine	0.0466	0.8558	0.9597
Crack	0.1954	0.1608	*
Heroin	*	*	*
Hallucinogens	0.1649	0.1878	0.4579
LSD	0.3373	0.5915	0.9079
PCP	*	*	*
Ecstasy	0.5910	0.8262	0.3719
Inhalants²	--	--	--
Methamphetamine	0.6380	0.9529	0.3920
Misuse of Prescription Psychotherapeutics	0.0616	0.6399	0.6324
Pain Relievers	0.1741	0.7830	0.7104
Prescription Opioids	0.0577	0.8974	0.5708
Stimulants	0.1825	0.6300	0.1719
Tranquilizers or Sedatives	0.8466	0.1279	0.4595
Tranquilizers	0.5218	0.2481	0.5758
Sedatives	0.4974	0.2919	0.6371
Benzodiazepines	0.3466	0.7838	0.7684
Opioids^1,3	0.0760	0.9672	0.6888
Central Nervous System Stimulants	0.4309	0.5746	0.3234
Illicit Drugs Other than Marijuana^1,2,4	--	--	--
PAST MONTH USE
Alcohol	0.4617	0.5686	0.7356
Binge Alcohol Use	0.6251	0.4410	0.4039
Heavy Alcohol Use⁵	0.8378	0.2371	0.3068
Cigarettes	0.6325	0.6492	0.4392
Daily Cigarettes	0.3682	0.7772	0.2019
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Major depressive episode aligns with DSM-5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. NOTE: Respondents with unknown past year major depressive episode (MDE) data were excluded. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates that are used in these comparisons may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.74C – Substance Use in Past Year and Past Month: Among People Aged 12 to 17 with Major Depressive Episode with Severe Impairment in Past Year; Standard Errors of Numbers in Thousands, 2021-2024
Substance	2021	2022	2023	2024
PAST YEAR USE
Illicit Drugs¹	92	67	69	67
Marijuana	83	62	57	61
Cocaine	3	7	12	8
Crack	1	<1	*	4
Heroin	*	*	*	4
Hallucinogens	24	18	26	24
LSD	21	15	15	18
PCP	4	<1	10	*
Ecstasy	17	7	8	9
Inhalants²	--	--	--	32
Methamphetamine	9	3	9	4
Misuse of Prescription Psychotherapeutics	48	27	32	28
Pain Relievers	44	19	28	24
Prescription Opioids	44	18	23	20
Stimulants	29	16	25	14
Tranquilizers or Sedatives	31	15	14	15
Tranquilizers	30	12	12	13
Sedatives	12	10	7	9
Benzodiazepines	27	12	12	13
Opioids^1,3	44	18	23	20
Central Nervous System Stimulants	29	17	26	16
Illicit Drugs Other than Marijuana^1,2,4	--	--	--	46
PAST MONTH USE
Alcohol	57	42	47	40
Binge Alcohol Use	41	29	34	26
Heavy Alcohol Use⁵	8	5	5	6
Cigarettes	31	22	18	18
Daily Cigarettes	3	2	<1	<1
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Major depressive episode aligns with DSM-5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. NOTE: Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. NOTE: Respondents with unknown MDE data or unknown impairment data were excluded. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.74D – Substance Use in Past Year and Past Month: Among People Aged 12 to 17 with Major Depressive Episode with Severe Impairment in Past Year; Standard Errors of Percentages, 2021-2024
Substance	2021	2022	2023	2024
PAST YEAR USE
Illicit Drugs¹	1.87	1.55	1.64	1.81
Marijuana	1.85	1.47	1.47	1.77
Cocaine	0.09	0.18	0.36	0.29
Crack	0.02	<0.01	*	0.15
Heroin	*	*	*	0.15
Hallucinogens	0.64	0.50	0.77	0.83
LSD	0.55	0.39	0.45	0.62
PCP	0.11	0.01	0.29	*
Ecstasy	0.44	0.18	0.23	0.33
Inhalants²	--	--	--	1.10
Methamphetamine	0.23	0.08	0.28	0.14
Misuse of Prescription Psychotherapeutics	1.16	0.71	0.90	0.97
Pain Relievers	1.12	0.53	0.79	0.82
Prescription Opioids	1.12	0.49	0.65	0.68
Stimulants	0.76	0.43	0.73	0.49
Tranquilizers or Sedatives	0.81	0.42	0.41	0.54
Tranquilizers	0.77	0.34	0.36	0.46
Sedatives	0.32	0.28	0.22	0.31
Benzodiazepines	0.70	0.33	0.36	0.46
Opioids^1,3	1.12	0.49	0.65	0.69
Central Nervous System Stimulants	0.76	0.47	0.74	0.55
Illicit Drugs Other than Marijuana^1,2,4	--	--	--	1.46
PAST MONTH USE
Alcohol	1.33	1.06	1.24	1.33
Binge Alcohol Use	1.02	0.76	0.95	0.90
Heavy Alcohol Use⁵	0.21	0.14	0.16	0.22
Cigarettes	0.80	0.60	0.53	0.62
Daily Cigarettes	0.07	0.07	<0.01	0.01
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Major depressive episode aligns with DSM-5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. NOTE: Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. NOTE: Respondents with unknown MDE data or unknown impairment data were excluded. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.74P – Substance Use in Past Year and Past Month: Among People Aged 12 to 17 with Major Depressive Episode with Severe Impairment in Past Year; P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance	2021	2022	2023
PAST YEAR USE
Illicit Drugs¹	0.2350	0.0113	0.0574
Marijuana	0.1045	0.3448	0.1211
Cocaine	0.0580	0.2770	0.9593
Crack	0.1956	0.1593	*
Heroin	*	*	*
Hallucinogens	0.4220	0.4763	0.8638
LSD	0.3073	0.4635	0.6030
PCP	*	*	*
Ecstasy	0.5118	0.3828	0.5243
Inhalants²	--	--	--
Methamphetamine	0.5778	0.8814	0.3597
Misuse of Prescription Psychotherapeutics	0.0125	0.5422	0.6015
Pain Relievers	0.1872	0.3966	0.8918
Prescription Opioids	0.0618	0.6344	0.7576
Stimulants	0.0828	0.5602	0.0955
Tranquilizers or Sedatives	0.2116	0.5347	0.7460
Tranquilizers	0.1464	0.6756	0.8800
Sedatives	0.8911	0.6373	0.8199
Benzodiazepines	0.3049	0.7195	0.9325
Opioids^1,3	0.0818	0.5162	0.8898
Central Nervous System Stimulants	0.2714	0.7971	0.2176
Illicit Drugs Other than Marijuana^1,2,4	--	--	--
PAST MONTH USE
Alcohol	0.8643	0.6251	0.9254
Binge Alcohol Use	0.5464	0.6583	0.3713
Heavy Alcohol Use⁵	0.4037	0.1927	0.2724
Cigarettes	0.3936	0.8141	0.8204
Daily Cigarettes	0.1566	0.4658	0.2484
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Major depressive episode aligns with DSM-5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. NOTE: Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. NOTE: Respondents with unknown MDE data or unknown impairment data were excluded. ¹ Does not include illegally made fentanyl (IMF). ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ Some 2021-2023 estimates that are used in these comparisons may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. ⁵ Heavy alcohol users are a subset of binge alcohol users. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.75C – Major Depressive Episode in Past Year: Among People Aged 12 to 17; by Past Year Substance Use Disorder and Sex, Standard Errors of Numbers in Thousands, 2021-2024
Substance Use Disorder/Sex	2021	2022	2023	2024
SUBSTANCE USE DISORDER	83	64	59	62
Male	50	36	27	37
Female	71	52	52	48
Drug Use Disorder	69	56	54	59
Male	45	32	25	35
Female	57	47	47	46
Alcohol Use Disorder	61	38	36	38
Male	*	21	14	17
Female	52	32	35	34
NO SUBSTANCE USE DISORDER	175	147	137	123
Male	88	79	73	57
Female	145	114	112	106
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Major depressive episode aligns with DSM-5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. NOTE: Respondents with unknown past year major depressive episode (MDE) data were excluded. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.75D – Major Depressive Episode in Past Year: Among People Aged 12 to 17; by Past Year Substance Use Disorder and Sex, Standard Errors of Percentages, 2021-2024
Substance Use Disorder/Sex	2021	2022	2023	2024
SUBSTANCE USE DISORDER	2.61	2.43	2.18	2.32
Male	4.01	3.21	2.84	3.57
Female	3.57	3.25	2.89	2.88
Drug Use Disorder	2.92	2.65	2.37	2.57
Male	4.56	3.42	3.25	3.87
Female	4.10	3.57	3.16	3.22
Alcohol Use Disorder	4.10	3.87	3.90	3.85
Male	*	6.06	5.25	5.83
Female	5.12	4.98	4.46	4.86
NO SUBSTANCE USE DISORDER	0.62	0.53	0.51	0.46
Male	0.72	0.63	0.56	0.45
Female	1.03	0.84	0.86	0.82
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Major depressive episode aligns with DSM-5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. NOTE: Respondents with unknown past year major depressive episode (MDE) data were excluded. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.75P – Major Depressive Episode in Past Year: Among People Aged 12 to 17; by Past Year Substance Use Disorder and Sex, P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance Use Disorder/Sex	2021	2022	2023
SUBSTANCE USE DISORDER	0.3269	0.5320	0.9784
Male	0.7727	0.9719	0.0810
Female	0.2717	0.3357	0.3303
Drug Use Disorder	0.8740	0.7123	0.8614
Male	0.8442	0.9880	0.1877
Female	0.8593	0.5005	0.7988
Alcohol Use Disorder	0.0846	0.7421	0.6090
Male	*	0.6494	0.4382
Female	0.1796	0.7820	0.2202
NO SUBSTANCE USE DISORDER	0.0000	0.0000	0.0000
Male	0.0000	0.0001	0.0189
Female	0.0000	0.0000	0.0002
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Major depressive episode aligns with DSM-5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. NOTE: Respondents with unknown past year major depressive episode (MDE) data were excluded. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.76C – Major Depressive Episode with Severe Impairment in Past Year: Among People Aged 12 to 17; by Past Year Substance Use Disorder and Sex, Standard Errors of Numbers in Thousands, 2021-2024
Substance Use Disorder/Sex	2021	2022	2023	2024
SUBSTANCE USE DISORDER	76	56	55	54
Male	40	27	25	34
Female	65	48	49	40
Drug Use Disorder	64	50	51	51
Male	37	26	23	32
Female	53	43	45	38
Alcohol Use Disorder	54	32	34	34
Male	*	13	13	15
Female	47	30	33	30
NO SUBSTANCE USE DISORDER	139	124	116	103
Male	70	67	62	45
Female	115	100	97	88
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Major depressive episode aligns with DSM-5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. NOTE: Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. NOTE: Respondents with unknown MDE data or unknown impairment data were excluded. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.76D – Major Depressive Episode with Severe Impairment in Past Year: Among People Aged 12 to 17; by Past Year Substance Use Disorder and Sex, Standard Errors of Percentages, 2021-2024
Substance Use Disorder/Sex	2021	2022	2023	2024
SUBSTANCE USE DISORDER	2.71	2.30	2.16	2.18
Male	3.76	2.62	2.74	3.38
Female	3.60	3.21	2.97	2.81
Drug Use Disorder	2.93	2.52	2.41	2.42
Male	4.05	2.96	3.10	3.66
Female	4.06	3.52	3.27	3.21
Alcohol Use Disorder	4.25	3.54	3.86	3.68
Male	*	4.48	4.94	5.48
Female	5.29	4.93	4.88	4.75
NO SUBSTANCE USE DISORDER	0.52	0.47	0.46	0.42
Male	0.57	0.54	0.50	0.37
Female	0.88	0.78	0.79	0.74
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Major depressive episode aligns with DSM-5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. NOTE: Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. NOTE: Respondents with unknown MDE data or unknown impairment data were excluded. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.76P – Major Depressive Episode with Severe Impairment in Past Year: Among People Aged 12 to 17; by Past Year Substance Use Disorder and Sex, P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Substance Use Disorder/Sex	2021	2022	2023
SUBSTANCE USE DISORDER	0.6758	0.4276	0.5866
Male	0.3786	0.4015	0.1083
Female	0.1965	0.0615	0.1300
Drug Use Disorder	0.9771	0.4545	0.6964
Male	0.4265	0.5686	0.1735
Female	0.4673	0.1095	0.3149
Alcohol Use Disorder	0.2980	0.6843	0.4611
Male	*	0.8859	0.5222
Female	0.3698	0.4431	0.1862
NO SUBSTANCE USE DISORDER	0.0000	0.0000	0.0009
Male	0.0001	0.0004	0.0195
Female	0.0000	0.0003	0.0075
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Major depressive episode aligns with DSM-5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. NOTE: Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. NOTE: Respondents with unknown MDE data or unknown impairment data were excluded. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.77C – Co-Occurring Substance Use Disorder and Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year: Among People Aged 12 to 17; by Sex, Standard Errors of Numbers in Thousands, 2021-2024
Co-Occurring Substance Use Disorder and MDE/Sex	2021	2022	2023	2024
Substance Use Disorder and MDE	80	63	57	61
Male	49	35	26	37
Female	68	52	50	46
Substance Use Disorder and MDE with Severe Impairment^1,2	74	56	53	54
Male	40	27	24	33
Female	62	48	48	39
Drug Use Disorder and MDE	68	56	53	58
Male	45	31	25	35
Female	56	46	46	44
Drug Use Disorder and MDE with Severe Impairment^1,2	63	50	50	51
Male	37	26	23	31
Female	51	42	44	37
Alcohol Use Disorder and MDE	59	38	35	39
Male	30	21	14	17
Female	51	32	34	33
Alcohol Use Disorder and MDE with Severe Impairment^1,2	54	32	33	34
Male	28	13	13	15
Female	46	30	32	30
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. NOTE: Major depressive episode aligns with DSM-5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. NOTE: Respondents with unknown past year major depressive episode (MDE) data were excluded. ¹ Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. ² Respondents with unknown MDE data or unknown impairment data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.77D – Co-Occurring Substance Use Disorder and Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year: Among People Aged 12 to 17; by Sex, Standard Errors of Percentages, 2021-2024
Co-Occurring Substance Use Disorder and MDE/Sex	2021	2022	2023	2024
Substance Use Disorder and MDE	0.32	0.25	0.23	0.25
Male	0.38	0.27	0.21	0.29
Female	0.56	0.43	0.41	0.38
Substance Use Disorder and MDE with Severe Impairment^1,2	0.30	0.23	0.21	0.21
Male	0.31	0.21	0.19	0.26
Female	0.52	0.40	0.39	0.32
Drug Use Disorder and MDE	0.27	0.23	0.21	0.23
Male	0.35	0.24	0.19	0.27
Female	0.46	0.38	0.38	0.36
Drug Use Disorder and MDE with Severe Impairment^1,2	0.25	0.20	0.20	0.20
Male	0.29	0.20	0.18	0.25
Female	0.43	0.35	0.37	0.31
Alcohol Use Disorder and MDE	0.24	0.15	0.14	0.15
Male	0.23	0.16	0.11	0.13
Female	0.42	0.27	0.28	0.27
Alcohol Use Disorder and MDE with Severe Impairment^1,2	0.22	0.13	0.13	0.14
Male	0.21	0.10	0.10	0.12
Female	0.38	0.25	0.27	0.25
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Major depressive episode aligns with DSM-5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. NOTE: Respondents with unknown past year major depressive episode (MDE) data were excluded. ¹ Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. ² Respondents with unknown MDE data or unknown impairment data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.77P – Co-Occurring Substance Use Disorder and Major Depressive Episode (MDE) or MDE with Severe Impairment in Past Year: Among People Aged 12 to 17; by Sex, P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Co-Occurring Substance Use Disorder and MDE/Sex	2021	2022	2023
Substance Use Disorder and MDE	0.0229	0.1059	0.4267
Male	0.2928	0.4228	0.1356
Female	0.0404	0.1472	0.0443
Substance Use Disorder and MDE with Severe Impairment^1,2	0.0932	0.0872	0.2457
Male	0.9291	0.9535	0.1519
Female	0.0302	0.0314	0.0155
Drug Use Disorder and MDE	0.3147	0.3125	0.8142
Male	0.4357	0.5724	0.1472
Female	0.5024	0.3942	0.1931
Drug Use Disorder and MDE with Severe Impairment^1,2	0.4356	0.1940	0.5147
Male	0.8740	0.9841	0.1339
Female	0.2543	0.1148	0.0654
Alcohol Use Disorder and MDE	0.0114	0.7763	0.7711
Male	0.0992	0.4366	0.5507
Female	0.0420	0.9063	0.5400
Alcohol Use Disorder and MDE with Severe Impairment^1,2	0.0527	0.7170	0.6226
Male	0.2752	0.7958	0.6187
Female	0.1011	0.7793	0.4407
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder is based on DSM-5 criteria. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder. NOTE: Major depressive episode aligns with DSM-5 criteria, which specifies a period of at least 2 weeks when a person experienced a depressed mood or loss of interest or pleasure in daily activities and had a majority of specified depression symptoms. NOTE: Respondents with unknown past year major depressive episode (MDE) data were excluded. ¹ Major depressive episode (MDE) with severe impairment is a subset of MDE. Impairment is based on the Sheehan Disability Scale role domains, which measure the impact of a disorder on a person’s life. Ratings greater than or equal to 7 on a scale of 0 to 10 in any of the role domains indicate severe impairment. ² Respondents with unknown MDE data or unknown impairment data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.78C – Had Serious Thoughts of Suicide in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, Standard Errors of Numbers in Thousands, 2021-2024
Demographic Characteristic	2021	2022	2023	2024
TOTAL	128	113	121	103
AGE GROUP
12-13	72	62	53	54
14-15	79	86	86	63
16-17	91	83	80	70
SEX
Male	76	72	68	56
Female	102	86	99	83
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	112	94	96	91
AIAN	*	7	6	5
Asian	35	39	26	28
Black or African American	53	44	41	32
NHPI	*	*	*	*
White	103	92	95	82
Two or More Races	31	20	18	25
Hispanic or Latino	71	65	72	54
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: For youth suicidality measures, responses of “Yes,” “No,” “Not Sure,” “Don’t Know,“ ”Don’t Want to Answer,” and “Refuse” are categorized as valid, known data. Respondents with unknown suicidality data for other categories were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.78D – Had Serious Thoughts of Suicide in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, Standard Errors of Percentages, 2021-2024
Demographic Characteristic	2021	2022	2023	2024
TOTAL	0.49	0.44	0.47	0.40
AGE GROUP
12-13	0.78	0.70	0.65	0.63
14-15	0.83	0.83	0.85	0.68
16-17	0.94	0.89	0.82	0.72
SEX
Male	0.57	0.55	0.51	0.42
Female	0.80	0.69	0.79	0.66
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.58	0.49	0.50	0.48
AIAN	*	3.02	2.53	2.40
Asian	2.10	2.01	1.64	1.75
Black or African American	1.34	1.14	1.03	0.86
NHPI	*	*	*	*
White	0.72	0.61	0.65	0.59
Two or More Races	3.02	2.25	1.81	2.18
Hispanic or Latino	1.06	0.98	1.06	0.79
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: For youth suicidality measures, responses of “Yes,” “No,” “Not Sure,” “Don’t Know,“ ”Don’t Want to Answer,” and “Refuse” are categorized as valid, known data. Respondents with unknown suicidality data for other categories were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.78P – Had Serious Thoughts of Suicide in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Demographic Characteristic	2021	2022	2023
TOTAL	0.0000	0.0000	0.0001
AGE GROUP
12-13	0.0482	0.1958	0.9224
14-15	0.0038	0.0000	0.0001
16-17	0.0017	0.0011	0.0320
SEX
Male	0.0037	0.0002	0.0145
Female	0.0004	0.0000	0.0024
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.0003	0.0000	0.0015
AIAN	*	0.8691	0.1415
Asian	0.4123	0.2549	0.6086
Black or African American	0.0630	0.0160	0.4323
NHPI	*	*	*
White	0.0146	0.0000	0.0044
Two or More Races	0.3343	0.6851	0.2323
Hispanic or Latino	0.0128	0.0086	0.0453
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: For youth suicidality measures, responses of “Yes,” “No,” “Not Sure,” “Don’t Know,“ ”Don’t Want to Answer,” and “Refuse” are categorized as valid, known data. Respondents with unknown suicidality data for other categories were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.79C – Made Any Suicide Plans in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, Standard Errors of Numbers in Thousands, 2021-2024
Demographic Characteristic	2021	2022	2023	2024
TOTAL	97	88	82	66
AGE GROUP
12-13	53	48	28	35
14-15	55	56	54	37
16-17	60	54	56	46
SEX
Male	52	48	44	34
Female	81	72	68	55
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	80	72	62	57
AIAN	*	*	2	5
Asian	24	25	19	20
Black or African American	31	37	28	25
NHPI	*	*	*	<1
White	66	61	54	44
Two or More Races	9	11	13	17
Hispanic or Latino	59	47	54	32
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: For youth suicidality measures, responses of “Yes,” “No,” “Not Sure,” “Don’t Know,“ ”Don’t Want to Answer,” and “Refuse” are categorized as valid, known data. Respondents with unknown suicidality data for other categories were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.79D – Made Any Suicide Plans in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, Standard Errors of Percentages, 2021-2024
Demographic Characteristic	2021	2022	2023	2024
TOTAL	0.37	0.34	0.32	0.26
AGE GROUP
12-13	0.59	0.56	0.35	0.43
14-15	0.61	0.58	0.56	0.41
16-17	0.68	0.62	0.62	0.49
SEX
Male	0.39	0.37	0.33	0.26
Female	0.64	0.57	0.54	0.44
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.42	0.38	0.32	0.30
AIAN	*	*	1.05	2.32
Asian	1.62	1.43	1.24	1.26
Black or African American	0.83	0.96	0.74	0.68
NHPI	*	*	*	0.02
White	0.47	0.45	0.40	0.34
Two or More Races	1.05	1.33	1.34	1.56
Hispanic or Latino	0.90	0.72	0.80	0.46
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: For youth suicidality measures, responses of “Yes,” “No,” “Not Sure,” “Don’t Know,“ ”Don’t Want to Answer,” and “Refuse” are categorized as valid, known data. Respondents with unknown suicidality data for other categories were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.79P – Made Any Suicide Plans in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Demographic Characteristic	2021	2022	2023
TOTAL	0.0003	0.0000	0.0071
AGE GROUP
12-13	0.0680	0.1022	0.1880
14-15	0.0028	0.0000	0.0000
16-17	0.0913	0.0462	0.2960
SEX
Male	0.0619	0.0628	0.6840
Female	0.0015	0.0000	0.0037
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.0593	0.0001	0.1305
AIAN	*	*	0.5251
Asian	0.5704	0.5052	0.1594
Black or African American	0.6153	0.0293	0.8066
NHPI	*	*	*
White	0.0648	0.0002	0.2606
Two or More Races	0.0903	0.7241	0.7163
Hispanic or Latino	0.0007	0.0325	0.0148
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: For youth suicidality measures, responses of “Yes,” “No,” “Not Sure,” “Don’t Know,“ ”Don’t Want to Answer,” and “Refuse” are categorized as valid, known data. Respondents with unknown suicidality data for other categories were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.80C – Attempted Suicide in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, Standard Errors of Numbers in Thousands, 2021-2024
Demographic Characteristic	2021	2022	2023	2024
TOTAL	75	71	61	53
AGE GROUP
12-13	45	35	25	30
14-15	39	46	40	28
16-17	41	40	38	35
SEX
Male	43	46	31	31
Female	59	52	50	43
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	60	57	49	46
AIAN	*	3	3	5
Asian	14	20	15	15
Black or African American	26	26	23	21
NHPI	*	*	*	*
White	50	47	41	34
Two or More Races	8	12	9	11
Hispanic or Latino	42	40	35	27
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: For youth suicidality measures, responses of “Yes,” “No,” “Not Sure,” “Don’t Know,“ ”Don’t Want to Answer,” and “Refuse” are categorized as valid, known data. Respondents with unknown suicidality data for other categories were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.80D – Attempted Suicide in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, Standard Errors of Percentages, 2021-2024
Demographic Characteristic	2021	2022	2023	2024
TOTAL	0.29	0.28	0.23	0.20
AGE GROUP
12-13	0.50	0.41	0.32	0.36
14-15	0.45	0.49	0.43	0.32
16-17	0.47	0.48	0.42	0.39
SEX
Male	0.33	0.35	0.24	0.23
Female	0.46	0.41	0.39	0.34
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.31	0.30	0.26	0.24
AIAN	*	1.16	1.12	2.26
Asian	0.93	1.20	1.00	1.02
Black or African American	0.71	0.72	0.61	0.59
NHPI	*	*	*	*
White	0.37	0.36	0.31	0.27
Two or More Races	0.92	1.35	0.93	1.04
Hispanic or Latino	0.63	0.60	0.52	0.39
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: For youth suicidality measures, responses of “Yes,” “No,” “Not Sure,” “Don’t Know,“ ”Don’t Want to Answer,” and “Refuse” are categorized as valid, known data. Respondents with unknown suicidality data for other categories were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250616

Table 9.80P – Attempted Suicide in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Demographic Characteristic	2021	2022	2023
TOTAL	0.0095	0.0032	0.0464
AGE GROUP
12-13	0.1089	0.4137	0.5831
14-15	0.0137	0.0010	0.0010
16-17	0.4447	0.2961	0.6803
SEX
Male	0.0748	0.1603	0.7734
Female	0.0436	0.0055	0.0080
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.1448	0.0184	0.1252
AIAN	*	0.4051	0.8075
Asian	0.3654	0.6143	0.3337
Black or African American	0.4957	0.1694	0.6380
NHPI	*	*	*
White	0.3338	0.0766	0.2649
Two or More Races	0.5690	0.2013	0.6294
Hispanic or Latino	0.0118	0.0702	0.1935
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: For youth suicidality measures, responses of “Yes,” “No,” “Not Sure,” “Don’t Know,“ ”Don’t Want to Answer,” and “Refuse” are categorized as valid, known data. Respondents with unknown suicidality data for other categories were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250515

Table 9.81C – Had Serious Thoughts of Suicide in Past Year: Among People Aged 12 to 17; by Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2021-2024
Geographic/Socioeconomic Characteristic	2021	2022	2023	2024
TOTAL	128	113	121	103
GEOGRAPHIC REGION
Northeast	49	42	36	46
Midwest	65	44	50	38
South	81	69	89	68
West	68	71	54	54
COUNTY TYPE
Large Metro	107	113	111	91
Small Metro	90	73	62	64
Nonmetro	59	34	45	38
Urbanized	42	21	26	23
Less Urbanized	36	23	33	28
Completely Rural	20	*	*	11
POVERTY LEVEL
Less Than 100%	63	57	51	43
100-199%	67	67	61	48
200% or More	108	106	105	94
HEALTH INSURANCE¹
Private	100	107	106	94
Medicaid/CHIP	97	92	74	66
Other²	42	32	33	18
No Coverage	36	20	19	18
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: For youth suicidality measures, responses of “Yes,” “No,” “Not Sure,” “Don’t Know,“ ”Don’t Want to Answer,” and “Refuse” are categorized as valid, known data. Respondents with unknown suicidality data for other categories were excluded. ¹ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ² Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250515

Table 9.81D – Had Serious Thoughts of Suicide in Past Year: Among People Aged 12 to 17; by Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2021-2024
Geographic/Socioeconomic Characteristic	2021	2022	2023	2024
TOTAL	0.49	0.44	0.47	0.40
GEOGRAPHIC REGION
Northeast	1.18	1.03	0.89	1.13
Midwest	1.19	0.83	0.93	0.71
South	0.81	0.69	0.87	0.67
West	1.09	1.17	0.88	0.88
COUNTY TYPE
Large Metro	0.66	0.63	0.68	0.57
Small Metro	1.01	0.75	0.67	0.65
Nonmetro	1.38	1.04	1.11	1.02
Urbanized	2.47	1.51	1.73	1.37
Less Urbanized	1.48	1.49	1.40	1.51
Completely Rural	3.68	*	*	3.98
POVERTY LEVEL
Less Than 100%	1.02	1.00	0.86	0.73
100-199%	1.06	1.07	1.07	0.83
200% or More	0.67	0.58	0.61	0.56
HEALTH INSURANCE¹
Private	0.67	0.62	0.67	0.58
Medicaid/CHIP	0.77	0.77	0.63	0.60
Other²	2.72	1.96	2.13	1.30
No Coverage	2.59	1.89	1.55	1.46
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: For youth suicidality measures, responses of “Yes,” “No,” “Not Sure,” “Don’t Know,“ ”Don’t Want to Answer,” and “Refuse” are categorized as valid, known data. Respondents with unknown suicidality data for other categories were excluded. ¹ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ² Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250515

Table 9.81P – Had Serious Thoughts of Suicide in Past Year: Among People Aged 12 to 17; by Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Geographic/Socioeconomic Characteristic	2021	2022	2023
TOTAL	0.0000	0.0000	0.0001
GEOGRAPHIC REGION
Northeast	0.7467	0.6173	0.8755
Midwest	0.0000	0.0031	0.0000
South	0.0667	0.0002	0.0042
West	0.1147	0.0017	0.8628
COUNTY TYPE
Large Metro	0.0025	0.0000	0.0003
Small Metro	0.0274	0.0007	0.2661
Nonmetro	0.0437	0.6704	0.4563
Urbanized	0.0064	0.6537	0.3578
Less Urbanized	0.6854	0.4382	0.5084
Completely Rural	0.8704	*	*
POVERTY LEVEL
Less Than 100%	0.0083	0.1538	0.3329
100-199%	0.0026	0.0007	0.0089
200% or More	0.0086	0.0000	0.0035
HEALTH INSURANCE¹
Private	0.0098	0.0000	0.0012
Medicaid/CHIP	0.0222	0.0101	0.2046
Other²	0.0023	0.0488	0.0548
No Coverage	0.0263	0.3030	0.7065
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: For youth suicidality measures, responses of “Yes,” “No,” “Not Sure,” “Don’t Know,“ ”Don’t Want to Answer,” and “Refuse” are categorized as valid, known data. Respondents with unknown suicidality data for other categories were excluded. ¹ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ² Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250515

Table 9.82C – Made Any Suicide Plans in Past Year: Among People Aged 12 to 17; by Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2021-2024
Geographic/Socioeconomic Characteristic	2021	2022	2023	2024
TOTAL	97	88	82	66
GEOGRAPHIC REGION
Northeast	36	31	28	25
Midwest	46	36	36	27
South	64	52	57	38
West	44	56	36	39
COUNTY TYPE
Large Metro	68	80	73	50
Small Metro	71	47	39	39
Nonmetro	42	27	29	26
Urbanized	32	15	19	11
Less Urbanized	25	18	18	23
Completely Rural	8	*	*	5
POVERTY LEVEL
Less Than 100%	48	42	36	29
100-199%	44	46	41	31
200% or More	74	73	64	52
HEALTH INSURANCE¹
Private	73	69	69	54
Medicaid/CHIP	66	62	53	44
Other²	31	25	10	15
No Coverage	24	10	12	13
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: For youth suicidality measures, responses of “Yes,” “No,” “Not Sure,” “Don’t Know,“ ”Don’t Want to Answer,” and “Refuse” are categorized as valid, known data. Respondents with unknown suicidality data for other categories were excluded. ¹ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ² Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250515

Table 9.82D – Made Any Suicide Plans in Past Year: Among People Aged 12 to 17; by Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2021-2024
Geographic/Socioeconomic Characteristic	2021	2022	2023	2024
TOTAL	0.37	0.34	0.32	0.26
GEOGRAPHIC REGION
Northeast	0.87	0.75	0.70	0.62
Midwest	0.84	0.67	0.66	0.50
South	0.63	0.51	0.56	0.37
West	0.71	0.91	0.59	0.63
COUNTY TYPE
Large Metro	0.45	0.49	0.48	0.33
Small Metro	0.84	0.57	0.45	0.46
Nonmetro	1.09	0.86	0.83	0.83
Urbanized	1.94	1.10	1.41	1.01
Less Urbanized	1.26	1.20	0.96	1.26
Completely Rural	1.92	*	*	1.88
POVERTY LEVEL
Less Than 100%	0.83	0.76	0.65	0.51
100-199%	0.77	0.77	0.73	0.57
200% or More	0.48	0.45	0.40	0.33
HEALTH INSURANCE¹
Private	0.51	0.44	0.46	0.35
Medicaid/CHIP	0.59	0.56	0.47	0.42
Other²	2.14	1.59	0.70	1.06
No Coverage	1.78	0.98	0.96	1.11
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: For youth suicidality measures, responses of “Yes,” “No,” “Not Sure,” “Don’t Know,“ ”Don’t Want to Answer,” and “Refuse” are categorized as valid, known data. Respondents with unknown suicidality data for other categories were excluded. ¹ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ² Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250515

Table 9.82P – Made Any Suicide Plans in Past Year: Among People Aged 12 to 17; by Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Geographic/Socioeconomic Characteristic	2021	2022	2023
TOTAL	0.0003	0.0000	0.0071
GEOGRAPHIC REGION
Northeast	0.2917	0.3162	0.2610
Midwest	0.0008	0.0073	0.0054
South	0.0335	0.0022	0.0541
West	0.5592	0.0491	0.7562
COUNTY TYPE
Large Metro	0.0398	0.0000	0.0025
Small Metro	0.0124	0.0367	0.5740
Nonmetro	0.2864	0.8387	0.9857
Urbanized	0.0039	0.0763	0.1055
Less Urbanized	0.2386	0.2333	0.1404
Completely Rural	0.6794	*	*
POVERTY LEVEL
Less Than 100%	0.0325	0.0389	0.2161
100-199%	0.2264	0.0366	0.2109
200% or More	0.0068	0.0009	0.0314
HEALTH INSURANCE¹
Private	0.0092	0.0014	0.0072
Medicaid/CHIP	0.1609	0.0119	0.2067
Other²	0.5772	0.2134	0.1509
No Coverage	0.0315	0.9669	0.6902
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: For youth suicidality measures, responses of “Yes,” “No,” “Not Sure,” “Don’t Know,“ ”Don’t Want to Answer,” and “Refuse” are categorized as valid, known data. Respondents with unknown suicidality data for other categories were excluded. ¹ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ² Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250515

Table 9.83C – Attempted Suicide in Past Year: Among People Aged 12 to 17; by Geographic and Socioeconomic Characteristics, Standard Errors of Numbers in Thousands, 2021-2024
Geographic/Socioeconomic Characteristic	2021	2022	2023	2024
TOTAL	75	71	61	53
GEOGRAPHIC REGION
Northeast	28	23	20	20
Midwest	33	28	28	26
South	50	37	43	32
West	34	45	25	25
COUNTY TYPE
Large Metro	45	55	50	39
Small Metro	50	41	32	30
Nonmetro	33	21	22	22
Urbanized	27	9	12	10
Less Urbanized	16	14	15	20
Completely Rural	7	*	*	3
POVERTY LEVEL
Less Than 100%	38	34	28	25
100-199%	33	43	31	28
200% or More	50	45	43	40
HEALTH INSURANCE¹
Private	55	39	47	38
Medicaid/CHIP	47	58	38	40
Other²	19	14	8	11
No Coverage	19	10	9	13
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: For youth suicidality measures, responses of “Yes,” “No,” “Not Sure,” “Don’t Know,“ ”Don’t Want to Answer,” and “Refuse” are categorized as valid, known data. Respondents with unknown suicidality data for other categories were excluded. ¹ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ² Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250515

Table 9.83D – Attempted Suicide in Past Year: Among People Aged 12 to 17; by Geographic and Socioeconomic Characteristics, Standard Errors of Percentages, 2021-2024
Geographic/Socioeconomic Characteristic	2021	2022	2023	2024
TOTAL	0.29	0.28	0.23	0.20
GEOGRAPHIC REGION
Northeast	0.68	0.57	0.50	0.50
Midwest	0.61	0.53	0.52	0.48
South	0.49	0.37	0.42	0.31
West	0.54	0.74	0.41	0.41
COUNTY TYPE
Large Metro	0.31	0.35	0.34	0.27
Small Metro	0.62	0.49	0.37	0.36
Nonmetro	0.86	0.70	0.64	0.72
Urbanized	1.68	0.73	1.00	0.89
Less Urbanized	0.85	0.96	0.79	1.17
Completely Rural	1.62	*	*	1.35
POVERTY LEVEL
Less Than 100%	0.68	0.63	0.50	0.45
100-199%	0.60	0.73	0.56	0.51
200% or More	0.34	0.30	0.28	0.26
HEALTH INSURANCE¹
Private	0.39	0.27	0.33	0.25
Medicaid/CHIP	0.44	0.52	0.35	0.38
Other²	1.33	0.93	0.59	0.83
No Coverage	1.40	1.00	0.69	1.08
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: For youth suicidality measures, responses of “Yes,” “No,” “Not Sure,” “Don’t Know,“ ”Don’t Want to Answer,” and “Refuse” are categorized as valid, known data. Respondents with unknown suicidality data for other categories were excluded. ¹ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ² Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.

250515

Table 9.83P – Attempted Suicide in Past Year: Among People Aged 12 to 17; by Geographic and Socioeconomic Characteristics, P Values from Tests of Differences of Percentages, 2024 Versus 2021-2023
Geographic/Socioeconomic Characteristic	2021	2022	2023
TOTAL	0.0095	0.0032	0.0464
GEOGRAPHIC REGION
Northeast	0.7773	0.6489	0.2434
Midwest	0.0472	0.2340	0.0710
South	0.0838	0.1978	0.4264
West	0.3192	0.0071	0.6877
COUNTY TYPE
Large Metro	0.0867	0.0090	0.0886
Small Metro	0.0553	0.0377	0.1501
Nonmetro	0.5898	0.7040	0.7284
Urbanized	0.0590	0.3674	0.8774
Less Urbanized	0.2340	0.1612	0.3407
Completely Rural	0.5176	*	*
POVERTY LEVEL
Less Than 100%	0.1933	0.3933	0.8095
100-199%	0.4021	0.0681	0.2290
200% or More	0.0265	0.0224	0.0780
HEALTH INSURANCE¹
Private	0.0206	0.2665	0.0331
Medicaid/CHIP	0.6933	0.0332	0.8731
Other²	0.7890	0.4183	0.3869
No Coverage	0.2014	0.8312	0.5467
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 that are used in these comparisons may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: For youth suicidality measures, responses of “Yes,” “No,” “Not Sure,” “Don’t Know,“ ”Don’t Want to Answer,” and “Refuse” are categorized as valid, known data. Respondents with unknown suicidality data for other categories were excluded. ¹ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ² Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021-2024.